var title_f1_12_1216="24h plasma amylin";
var content_f1_12_1216=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F74823&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F74823&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Twenty four hour plasma amylin",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 424px; height: 548px; background-image: url(data:image/gif;base64,R0lGODlhqAEkAvcAAP///4CAgAAAAP8AAAAz/8DAwP+AgEBAQICZ/0Bm/8DN/wBmM//AwCAgIKCgoHBwcDAwMNDQ0P9AQFBQUBAQEPDw8MDZzXCN/7CwsJCQkBBA/6Cz/+Dg4P8gIECMZv+goFBz/4CzmWBgYPDz//8QEODm/yBN/2CA/zBZ/9DZ///g4P9gYP/w8LDA//9wcP9QUJ+y//+wsP8wMP/Q0JCm//+QkA8//9Dj2RBwQCB5TX8Zf7/M/zCDWS9Z/2CggODs5nCpjaDGs/D28z9m/19//1CWc+/y/5C8prDQwK+//8/Y/x9M/3+Z/79NgP9/f99mgN8GH09y/z8mv79AQN/l/4+l/3CDz/8fH4BZv7+Mv385n+8DD/+fn28cj+DW78C874CPz3CAv982UJ9Tn2+M/68PT58zf4CJ718/v79soM9Zf68/fwAs378MP6BzvzA/gG9cz58yf+8TIFBi77Cw7w8v7+9zgO+ToO+zwICDj7CzwK8/gJ+T369gn48Wb788b3Asn88JL78sX59Sn58TXx8s33CJ769Qj8+Zv0A1z+/j7885X6+Av89Jb28sn3B874B531Azv9DJ718fnwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAACoASQCAAj/AAEIHEiwoMGDCBMqXMiwocOHECNKnEixosWLGDNq3Mixo8ePIEOKHEmypMmTKFOqXMmypcuXMGPKnEmzps2bOHPq3Mmzp8+fQIMKHUq0qNGjSJMqXcq0qdOnUKNKnUq1qtWrWDcWKFBBYIQCHBw6OBAhq9mzaEsKEJABAIe1ARwGEFAgrd27eCuubQDgAVyBYw+07XvggIiyc+tGEHFggoO8kCNHFtBAAAYKleP6fTCBLYAGAR5gBpD4LYQAIiZIXs3arIDGFCjMjYs5wNwDAAo8OEBBAGm6ESg/yNC1tfHjUF9jEPBgNgDKtgM4WD4BAwTfiQFg4C0AAvLv4JG+/85dwXnnAAUc2BYQAEPl31tFYCgQO7z9+z/HC3ReQURv2RVc18B7pV3XXVn4Jajgggw26OCDEEYo4YQUVmjhhRhmqOGGMBUQ3YcghijiiCSWaOKJKKLH4YpEBXBAijCiWFiMNJb4Ios4AmWbSjvyGFeOQO7UI0pDEvljkEjaVKRJSzJ5ZJJQxtQkSVNS+WSUWLJUpUhbcnlllmCe1CVIY5L5ZZhoeunjSmWm6SZGbXYUp5xnvmlnRnNulKeedd6JkIci1pXkVgztiWefavop14shCopkl5WtJQAFJkW6FqWVSjqpooUimmAEGUhXXAXqOVBcpwqJoKlqJakqKautrv/K6UKGHqcpbgBcd0B3ciHqgKaDkfSrpMEKC+ysCtVq3GNv+UYdAJ1h0FCXza6FIEnVCnAttppui2xByhqnG3u/xeVcQYB+eKNCBvJ1UrspwfstQuG2NhZz5eaLbojrJuSXACKg9G/AAq9F8LwG1WvcrgVkgK9fxSY05nICPHYSxRZfvFbGCBOkcGQFnPYvB281UEBlYaG60Fopn8SySi93DK6n93HQrrQAOFBZAxwnS/MB3qUE9EpDyzyzm2WGxuMDbDJttMc0A1lmBDijRPVKVz890McVcq11VF5PGPbXTo0dodlkL4X2g2unjVTbDcLtdlFyL1j33ELdnaDeeP//xPd9f/fNU+DhES54ToZ/l/jhSkad4+KM0wS5cZNHLqXjOFZu+Uuar6ZsChoQoEEKm7eIOUGk9pi6qQNhEEAGLRd+OkEmEGC7CaUPZWgEvR3grq689tVdbLErPvtAtiefe96MgujoQZVd+2y0FWzqsNM9OdBzSsomb3sJy+vY/IfPFxTcgAKo5txsBYzXPq49FeaSsrXfHr6Os7cPQcgVr8/e+7nRT/zgx6bjCQR0BDAB6e7nkz0FBzezuZ7wMhAc7zwLJ+myTQMIuCaKJAAEDMSfRCpjHbqU7GQCCAsJO7O9mcxFUwIsYEUIkIAQ+u14EbgOBSymM8pYLIeTwt5N/zJomxaKyYACoaENG4jEDClrBEpc4uCaqJSqyURZCoiiFHXSOZdAp3gtwaIWt4iTLrYEA51JnxGNRJENaKCGZEQcFZfCgQBUhgIPAOMRKYKAE2ggjnKUTAFcVb49TgQBCCAAIMs4x6dUgIIS4UCoiCOQrViyVxQBwQYUucjGTWhXawkaDDE5kQRksZOetEthVlkYIUIEAxWoQGXqspZLTguJpuQkKl3YyKPAcC0cHGEKn/OaCRQyN/xCIgGguEvJ9VIyEoQWaiYFRiK6SJkA0GUzYWLGl2SgMVaUiF8ONhCG3XIizFTgNi+Xl3+tJZwP6Qxo0BOyaVLgVD6biAJqaP/KdXLzmb6MSwUmEEyHwDAANgultyRmwH0CoJ/+nB9AjWIZgexGohPZAAghGlEtTfQi1lxjRzoDNM+E0YCIfKgCOnpSF/6yoB8ZaBA5h1IEqJSlHp2Jw14THZFCpVaavClOOyiTQVImYiN5ZE8xKpF+XsCmQ+XeRzHyyLWgxFIxJCpE+pnSqLJRJhwQDQUOg5L0WXKhX43IMgHQVa86yaXdWaUrQ/IAcjJVrQJpq1upNL7oHJNKLzXJsIB514cwk61Q3StfA5WVScm1sA5xKGIVW5JuCsR1sDsJaK54PMnqlbJmqok7KYDWjzxgntKBbEM0KpAWwDFBDDCAbGcrWwb/SMiyZr0MrEYCSsK2NCJdlWyCDDCA4hq3uAa47VQvsr/9wNQjXzmrahkS3NeihAYJSMAFRjAU4h7XuMk923ItshvbzMinGqlAAUqb1ocEFQDCPckJCEAEJixBA9wNine/O4DwQsiyvZXUczcyWAjgU6sOgWh8S5ICAuxAIEZYwgmEst/v+pdt461IdC25XpLUZpzTXYiCrVsSBPSAIEwgcU8qfNwLO8iyLKGAoC76W4isFb4oSAkNbEAQIqiYJywGr3LzEpr4GJO9IzGULg97khLQVyA7IMAGcjICPxIABAv8QAf4i9wh4yXAvkUwQ5icTZVs0gY9IMCEc4ICG1Qh/wlD0MAdOtABCXB5ABJQgXjzoh4QoTe0EImvNk8CghOYgAYxSQEiwUeQFhBACQLhAhTk8AEAxJa2s13BAFbAAgxjUAR/lcqeBK0SKI4AAReAyQUIsIQlECDVA0HAEADAhStcYRA/LogKVkACA3SaQTD2CjCRXLbZsRZ5ZgbhglWCBx2swQlOWIMO7GCALCTABI6wNRcAQAQQNoQBEiBBDYCd4Yx46M9qm51eB12SoJJ5JUEubhP6AAUoaIEKAKgCAVoAEQbIoAMxUJBllVpEs+xp3fk1iakFgoKVtiTexe3AB1JQv1dPxAUvEHi5JxLgAX8kAqyrsUPeKxCOluTYAP84QWLhfecVEEQBCgABrCOiAhJovCbdkS5K2gegnG7V4SUHerunLBCUs5zLLgaAkxkdkQ7MYG8bl8hpXOKhfkk1Ilh4Am3joHXbkmThAinBHx9+56QD4ALeZsiqbXeBFYwbP5Y97VJNsmFiJ3l2Oij7ydMuEA0wXSUQN/sINCB0hFzABjDYAQxsAIiMwz3qEem4SdyZ1atDJO9IH3pBSA54vR8EAbkmCAFgMBAYEMDmj6/JhjusFtkUfCKSfN2oSnVghkJkBJjnr9k7AvZYr3klT/D8QUxA9IQ8eiBR7oDX7RNslWz2Ir0NGvCCprLI5t7CJDG6QBSQ45WUQAqylYD/BGi7fINsAHcKGX3pCbCC3VMO8gYtgORLshudSwSWsqTL9Cpa/YYo4PotRhKchzwJhxIXsGZu9xAJsHIG0WaJt3gX8AESkHoyQRa78VglMX8VgTL+8yXWZHUMsQEAKGQi0XsEYXIK53cCoXwPoQD4hRAngAJrd2UAwAIDQIES8RUpszqngll6VBN99noUIUEdaBAfeDoIMIJdJhLaNxBPpRII4G02GBEyZxAjkAAokHCoJhAyUH7GMxG8Qy658hrB4xcQQDy35GdBAWIAIEEQc04PkYTCBxIDOBCudRKKhgCEJxD+FhFLRxAjgAIJUIB3CAAu4H6scU2NshAGEhf7/wdL1oMvDPFLlecRFshKc+UQ8mQbYEEZKPSDR+NebiBbJNABMtAETWAAXsh7N2YQTmYSq9ZqFgcABuByEYF2A1ECKPB7A3FYMTCBzNdXnJgseEQuHQhAAMQQHGZ/IUEXGhgRB5UzO4NueQJRAxADMvBZH9GEtLNAIpFFpAcAprdSL/B2t7eHoMOLtLNSNvhr4OFAllGE7OM+lYgQQZhaWVGNDneDA3AG6vgRdUgQJ4BoI2FiBNEDNuV0h1RxM1cQA8mFASc7EfFCkvI6D8MWFaQd6fMQzwgSy7gVdpcoDrFWM2BzEpAGoacRJmgQNPCPHiFrBDEECDCFE3F4D2gDDf85EDTgbS7gAsw3OxwQHwBDMp6IMp9hGSz0EBu2QyRBiR53dzbGhxNYA4KQkhnBjQRBcdlnA5AGAEpgAxsAbhShfgJhegehlQCAjT9JEefSQzzjFTqUiQ3RGFaihiK3EIclljOwBVaJEQFZEARQApeGaatYEW1GBmRgAzlmAD45EccHZezWd4w2AO6IHJbVZ37xlBrBFZzVgnDEmCsIByXYigmRAC0Qb4gYEaemASiAANz1ApXmmOEojpH5UPwGABIQkV9IEwEGTyDBG2RFU54pELIlECtwCEyYdoNJmKiGmh3BUQpZk4ineDiJEFtIi425mzOxYaDoEQ7QLpTkc6v/5W0JCAASKBIkF3j75JwcAVE0SREzmJMv1319+I7w9xDaM1B2RRL0UZHiSV1QJQFe5wWUCRK9F3hQxJ4bAVFiORJMNgB6pp0y0QAZ4CpIBRLfuRcisEH/uRBdJaADEQi62RFGF3gAgAaLkHnt6XCgSRINJxASEJuWeZ/xBwEHQGMksSvyMRAh+RFz8l4kEKEAoAPZ2RGcB3HFVW8quqAOB5sloXLEaYszWhOywR4uYhKcyU4Jto8EIQUd8BEmaKIiuKQaoU4AEJ0jcWwz8KUSGhP/EjL7CRIEh48dqhD99J7ZFKQeoX0mWgJKmJoSwUkqcIMMNnYAoKdTShOPBEsB/9CjGIFVmhkSc7JWDZpE5egRA2iiABAJWidbLjAAXdgRnPSLJ6GCAOCkiToTc4puGGFWIBliB8FJlZpNHyADrFiAlmYAEtABhCkQnPcBAyCjGsFJLVoSCTBl4DZ+vRoZAHYrkxenMtQQh1UDjtd3XoCoGoGVEmed6giswooRnBSjJ7GFmgoZuLU/r1oSg1WPb+V/n3lhprQCRUoRKZAAySOf5smmB8F9BgGsh4hptRWoAkECT2cS/FquREajDTF1KeFYrQSrBSFZxTkQplSSFzECJtADSbADREAAhXem3wqYuGqed9ZfAltzKaFICIsXcYdarHoRz/dPDnFsuXmCK/8lAyELEZtkBAMxBHyXryL2sYY4h/6XY6SKEg23snfRrAI2eS4LsQTxoeXXT+dZETA5EClWENuqEE9oEEq7EA41sSfxVF+bFpa1eo4Kfc56lwnRVWh6UzYopBKxsz3Ld1pGXcSHq2WbEA5VsyixAQmwt2fRfCmBtlA7EO9FqBTrcPJaERirsRzrsQSxtQgRiATQAzYwOgQhuPtaQ9hqEmLHufmosArhjGuLFXFijQUhg+DDAPo6EfV6O7cpEHerECfAlQBgBFFgqLRItAyxTyirEhqACLT1qe1XmGZLuglxiRgoLL0RZtHKEP20pgORAihwr2c6ovqkYpSLEBowm1T/ILnE6btgmwBHmxID6AK26jnKaxPoA5yHm0TcVako0AP4tngIQK0X0UcFUbvplwSiR0MqF3xk2hA7KbYowb8FIQPzyrLti3PL0RfQ2q4MMarA2GD4JhBMYAJxaxFQOrk5u3mzJhD6lgIK0EdYoANqAG3QpgNPgLxtiwB+mxL8qmskoL1L+8A0QRenQVDxe1gTe0oDkQSK1H4WYXL+qxCgswRM0LEMSAAAjDxC66EI8LkoQZoCEQNWbBeK6DxZAQEi8EJyScEKIbHh5WSzGQVG+7oSIQWdKlt1BsMEUQInkF2zOxAoEAXr93cOgQCQgHor8aIGob7MKowqwhKrmhIZ/3Ch7XUQI7ABMSgQlyoQt8sESRAF+7aCOOwQflrAE+FoUZAETGADXRDCCoEAWgCMK9G1BsHA5qrDB5FG0GsVXUJxBDAECZQCIBprtaMBs1uLFPF/nvzJ16sBJpDEfewHgBoShdivA/Cv5GdwsGwQzOGM0yxmJ9gDPGsEPZAAuzyfBDGolRmHf8oRUFQC3dsQF9AGmwy6vLu55DsVuEUfdRSpNMF6ucFhpIQQUDzEBFCgBmGqkmyOEHEC5cwRIEADyCy9EOoSZloQoltsVOoAE9AAFGDPMREBtzEQowSH/PxgkKm4m1d8acnGCdYEw2wRLZBj6bwQcADILJHQBxHRTf9xmQ7AO6QlWM/LrgsBSvBTS4Ti0cNHBANBBIUA0wShfSyoVgSMfR3hdwutEGNQrSzRkjMdz6J2zTDxvmNVEclITI1xTEeoEI42BEyAy4ygygUhdgXhAlLKyQSgoBvxkC2dEI2wzN+IfhCN1WCj1QORyGoRwXXl1QI0AfZUTckEtiBwZQowq6srdOIcaIGb0iqdY1GNEN/cEljcu5Td1zUBqSbBwwHgwxTx1eVEF0JtfAJRA29dEBeQk+IahydQA/21rE9NOnV9EAMgCTBhml7L1z/l1wLhqvg8EmAsxhQBKjmnXqehKveU2gfxirTofjU8ELVa0AggA3iNESeQapf/XRAzAAV8vMoMyNm6J82iNcEkscgVEWBgYSAQ0KNlIlmHqBACPbAF2xAJ8AfrWxItgH65TRAfUAYxgQB5SxDLaQAvwKtyHNxAeLokUXeHK1mZbRDp29oKIQVbLBKa+90D4QI68BKWi7maixCDKrdXgVsX/bAlIcs8bSUMYdW4KcfaV3PjjBCKsAWmDBKvvYI7jptS8BK3C2m6+84FsQIYXhWWFbMucxpCGL0xjN8KwdYLTNAJ8QJioBJo6eEAMAB18BLfOxDhO8UAYOPoTRNy9+QicaOdScUCIdIIIcjWTQI//gFb8AgrYaYBvqa1eRL9LMUK8QLbnW410ZEhQR/N/wvlCIEFaiBbtR2wBtHj4E0CDTwQNYcG5V0Skv7dHyAGfW4SIDDC+UYAmT4QDIDUSi7cAGC4JbHTLw6VC4HSw1zdBLGmSQ4ADIyCJgE6A9EBVj4QK9AEfTkSS9zEamYCCeCNBhHbKa7q+TkB6t0ReNTmCrEH8XzfA8ECMpCbmPYC/SUF420SJnCbH0CwByED1gYTdGzHeUXqCMHlEk0TFGqhk3cAzIjNBaGEJnsQf8kCdnZnIc4SBzjn+T0QA/AFw74S9WoCChCfPo66qs7DN4rRFmHojXwQ+r57WCnJd9YELcHrH94Blem6y0YTNKAB0wmB5qnWVGFZVWpegvUhL//rEWPSySlN5QgBcU/gEihwxysgA+5IrSVPE2RJmwPb4EwRd7UExoXbnZXlKcJM2XL+251NEjI+EOIH7DUw9DPxmAAQZcRJ1fKs6otaHmlb8fJhLVAb9edtePg6vlU/EjgvENpui114nTlR9GZZgxv+FDAm4YHtO0zPtgWBAFiwqwALw7S+13E/Ej1fECzQAT55g9pYEzZJnTOH5LR8PLEXnjzYOq/j9AVBeRSvF/QRxqXPEWOCSAHuveFu3k7dEjtpECX585O1Ew5v6Q3d8scTfQIxfRY1PBQg+gNx0ezRAGPcERBQGRWa+nyyEBegBSbNEH9J0yHhZCNbkhlX+Tj/8dCx1QGCHs3x/kqxNEuPWD2UEk0NQRcCUB67JRL0AQEcQAGMTMYHkQBQ8OMHgZUJDhAGmjRhAMDgQYQJFS5k2PAgigQRNyD88AEAAgQONW7k2PHghRMHDQwgWZKkAY8pDbJgUFClwQ8SZgCQ4EJlgAMBdO4MUIBjAwEcAggIAGBoTwEHABRI6lEAhgMTICh9WdXqVY06NY7pULWEBo8nMmIla3CEhiVMiBAImRBjWbgdU4A1ONJkSZRxFbogGaPqyIIGLKbEyXOnT40ZBDwwSrQxUqVMqXJ8EACDAAEO9GqMMOHAZ8abbxZ12GHwSxQKOiZQLfrlhSVGDO4gkCLh/wkarnU/bFH3Lt7dADqQXGFQhYEYK2TGqAlghoGCDAw8HxDYovTkEvw21PrygQARBhUz/p4hggAIAC5PeBkhQnCFEDBjngyfO2mGH6BcvXChI4ES7OMoASYQ6mGsg1gTcDMaQPDttwHyci2GAWogYQAWAGCAJAkGIKGD4T5QYYAXAHhhgOOqA2AACQAYiYQOUbzvpQkEaECnAjiwsQCgOAAAKAxq1GyjAoo0soD3FsxMAABEwG9BhbpjqINJrlIABY5KIABKjRIgAiEbckNIQS7L0nIEFyEcoAMJDKiBgQzjWgHFOa+LkKYBNLyzwxFLBGzFFv/ky6WFpHRqPsccAP+qgSEjkI+C0DZCdL764BOAxwIeqLRMo55MSD8TsNIgQI0USIBThmggYAeD1iI1wdZQvQqE3Oz6bYUYDHghRgleQI5QlVjgcDgZ9ESpQ2MB+GAAGQbw608W0wxMRYYMlRUhw3QaUsAbRcCMvWs7baiDNE6ddSKNEGgr3INOIKAHGwhAd8xY2U1pAyxtvUvClRiowQAJmoXRhQ/i3KiGAVYwwIDhZtjw2DwfBoCFC0nwraBo//yzWk/tXSrJMt2rYIIJKmDX2oM+6MBUrDZwUCOxPD4oBQRMmJdemVUaVbqFe14YWIYcBpiEFYBeqNk4+XJBYmQlBmBOm6QFVOqNC+3/ONwK5GsqZ1RRNiiGGBDw76qvNiKTawTMTSg1rsMauywVXADRABVEa7busry+1gH05NvWvs8CB+3kqw96Cyu2HQKwbQDOqtcgAtBkfCMFQt0sORYLhmuGaOHSW9YA0gMAgsJdm5Q+wh2KGav+HNJy8oteRmhL2Dcy4XG4WPhABqJn4vrzrm8MoIGc/q7dNeDPtspdAgh4GyGWJz/rVciP1wik4OIGsQa87QWe06Em3VQ3qCZAzPvSAVD+NRtg2AEGG543SN3a6Z/detc1kDy4GE584bRrfa9MBciW8XRznvn4CH0OGRVWCACDg8CAdghZ3eS0RL0J4m8hKLhZcFhQ/wPercB3XUufBj1HAQxggAIlXBDwMlgVAijhILRRyPradoJ1AeCFJjyIy8o0Axd8qAYGg5IAeXgVnBgkJ2VB0kEq4IAAOMBkHHEhWR4YQXklZHG1u6BBUmC5IyJkBFssU/9ItJ0WsjCMVQkfosbHkQgMZTLyOQB6OvK5K5HlAu17nw1AYAKbAeACzXPe8VYXvTUehFbX+mAHSOCCEQbHiIkkzOneuJE6bm09AKgRBqhYOkTyh5Bj24AJNMBH+MmPa19BUygT2QIssWsGKyCBDIYoSTVS8lqSMchRHqMQAhpmiQxpgdpcc0WDSPB4IMiIKxOpAdt47AP+Q2NKeOazn//1Mpe6RBUvf+nLhASTJ8NcyOF0E8MZ7pBrCtCfM9d4AlWGSwU1AJELuscRfZkkL5PkJqe8OR4AlOeTDTHnMSGYTHVyLQEIcGcY5zK5WdZScxvJJ3DE1c+2RUAxEChABXTUAB4FZaAMwU1w9ui+VFqvcsXEKABM0JvJ6a5DuNJIRU+izZZyLZOY8YmibGRAjjXEhpsZZPPi2bazNA8E0dQlCEYJu+PU854HYcGcILTPbebUhJ8bqlZVggIbVCEJQ4CmLk/ax6PKjAG0bNOuYrQmNWHVq1r9HBnn+pIWoNMgS8hhGJEJAGVaT3eCaUmcbHqni961n3VVrFUQMASEMMH/mH6V4WwSqsHDyrWx3NTbGDf7kg3YQDatkt0a/yrBBHRQNyNQgAL2R5bM4vSzlPTaCC5gAgRQb7YOOUsUqACAKhAApok8K/xOUErc6lYvG9BA8zSg2qpkwQxOoK4TzNAE6Mh2t2FE2VdsMIQeZHG7GvkiIRFEyaIW0iAKcBcIhhsXLRHBCEZwFUdGsAEEbOC1AChmDwx03sJk63zjZRzKQNCD0RJBfwQulQKU69UR0ACQNNjvVRDg34P0oK8LKe8QCGAC26TgAhowwSAPKsF6BdgwA2ZwzlD2VyMQAHctpjF/nXqCeqU3rV5sQdpMANmDeLh5JogIRjbQWoMkAMEA/zBCD1BgygtEc5BLWIJ6D8LPGgewYzCWcZa9fJAS1MxmtkVl/MSoABqcIAEfXmgL9jhaI4RpvQrAb9oSYAJCJuEgSRCuQmiGAKZeOatfLpOBlwwABVeY0DTeQAKae1DACtfHBEgAblwrRg30AAYw6MGCNbKqdI5m0ZPr7inBK95RE1pLlQUAbdoc6IWUwKkEAMGDFWKCL7UKjHccdKrtU1saYMTWvm7xaS8Ll7wOgQkefu9Iie0xLD+7xsU1M3wUAIIEgGDGWem1tJHXbW8TWMf4i3a4RVNuc6dby+oGHbjZ/W4BoRveSHT3vO197nrf2yPy1neWS9BaJFul0SlIQf9q953vfm+E3wlvMQIIeex0yTjM27Yaw3Fp8XcrgNIGwW8LQLDUxl2gyADAL8cz4nAHM5TkCPA4yCuO8W/DXN0aN9eaTYCCD7tUA2IL1ZqTvCWUazwjNsf5rrGFcJknZOFJny3Nf24QnANAAxoQS4B8rj6gy1joWId6QpfO9KOD3dtO5zrXU/BHAozq6j4POgGGTrurRwnpYv+62OdaAlWxbe1bSq2pauNUEIw46611e9njrvS5g73udteqwwlp+C3NOpDlBUHU2/72p7+c8fTefOcJk3imL97zDBd96EE/en2XPumqR729WQ/z17f+3bH39ZFYPCPZ517QL3liFKf/mO5J8Vr3wy83He2obp4WSfjDz320N9lJ5CfFfMtnfuuj7UtwmnsCAfAWBRSIEHHu5DPZIn/5zX9+9Kdf/etnf/vd/374x1/+86f/+ccvYO44JvvqruPtw6+T+6s/AQTAnBhAAQxAA0xA9kNABWxAB8SRhgAogTK3AiCd7vs9h6A9q9DAl+DAIjq9u/qokPo+b+MArYEAkOG2AgNBrPDANGI3n2IUxnPBz2sbGvw1Fqw+zspBzvsdHiy0H9TBNbpB6pMZIrw4IUy1I1S4IBS1llrCJIQdKMzAJqzBJ6zCKMQf5WubLcyZLuynL8xCMRxDMixDMzxDNExDNVxDNmxD/zd8QziMQznklAqwPQyEkiYyCA7IgADIgDsMF9vToCKZogjIkYCqFAc4gBQ8iAg4AKA6RDesw9tjF6ZAlEkMjjjaGgDYKdHxmODDH8zIAADQkUTxlKGYRKG4xDpSuksxw+94Cq6RRL4RqYMoAM84AFEEACiCigeoABFQRKvIpMnAgAqoAKAYMALCgF/0JPXwjFxsRlw0iF0kmUXkiORjMSgqgAMQAZNJRpKpAJx4RN3AjAYIKMwoCigyiM74jEsRCgzQlKJIxV46gMrQjDoKkgmIAA6oIxEQx+oDCvCYHG8JD2xxkjqyRxsBCgqoo3K0Cm9CiB7BFgFYSMzggPX4Dv/GuMjF2EQbkY+GTAn6mD6E4MfvYI+hoIBHgQAKoEUBsZGnoACgKIpV5AAKWKH+q8QDWEkHYIqiKEk54sgG8MgIAAoIiJQsvIwMWMk/ZBdSJEEAqIAMkArHWEWe5MireEjx2EiJ9InvsEUBMBmV5KSvHB0KsMrRYRKV2L7uI8FVPMvG8ImmOEUokb6a9KVVVAzNOMWqvAykKAobMYimaEv5eMsy9BYO8BZ/RJWBjA8KyADFkEkmqcq2rAqs/A6C3Mq3bMtV1Ewm4cyr6L+RRMtVlMu4bEUlOYDLqIypZBK51EvH4Mmq3JrAFE3WNE0xrAD6IEquqUSnBIAd+Q7IXIr/1bQKjUKPjhJL4Rmw1ryUx9yk5hQA9vDMlKhA7ptIDOw/xTDJVizNSzSdyADH4WQK87nJ1ySKqpQPDOAbpfDMo+jO4VMMJxkeAajGa6kjozyIWayj4JRMtHyJndpORHmS5eTKlSwZg3iAAjUZ6fQIE8QMFEwIhkwKkyFNpZDL07yy4TRHlLyUqoRNxxjKpJhNJWISDgAKcMlC+ZgijJzDhZjMzSoADCAgrWRRGlUIF22sWaQAbqxRHu1RH/1RIA1SIR1SIi1SIz1SJE1SJV1SJm1SJ31SKI1SKZ1SKq1SK71SLM1SLd1SLu1SL/1SMA1TMR1TMi1TMz1TNE1TNV1T/zZtUzd9UziNUzmdUzqtUzu9UzzNUz3dUz7tUz/9U0ANVEEdVEItVEM9VERNVEVdVEZtVEd9VEiNVEmdVEqtVEu9VEzNVE3dVE7tVE/9VFANVVHl1D3swynqPSkaVTHkRIMwvk7Ew+MEgELsTYZIRPpU1X4iRmO8lOeDRYP4PwjUi1AcxXO8I9vE1bnqEexzjF/NFnKCC3I0R2ZNxGg8xG18DwtFVq8CqGVNn9JzSRWKSXN8gBoRxRtB0HLMVm1tKcvMSvIQgGfUPGiNirp0DJjUiabIlJysTfdc1yOqkeQUwYjEvbhIitT0JRvZCQdYDwwYTHX1V12aFHRclMT81v/v9KUa6QkoOgoMAArChNgvs1gMLQpfXMkVypqE5FeQDVksXFl2m0KXfTaYjVlfm1maHTWbvVlC88Aw1FklbMKc9dkVjLeWFdqtAtqiNVpyQ1qlrVmmbVqcfVqo3VmpnVov88CgTaSe5VSsTVq68lo87dq52tqYC1Wx9SoXzFo41UCAxIyyzKm0Bds71UBvmY8Txai4FVUNnMVhhdsqVNs31UBSxIxbTaS8Ndsg1JqPvMIXRFz7eMXLZFyi1dsgvIzMsA+yLVscpNyWZMndoMHDBVUPPIBX/VwsDF05dYDENN14u0/dAN2/xcLMJdLPaDcBiQBmhA/YbdzJZdLaJaH/r/1A3t1cI/0/4rFdvxXe3bimKZiCnjGazQBcurMk5JXc3tWN2ELCIgXW1X1dudVc4sXeuNLd721S6e1BAZld2Bpf7SXS3F2g5NUlFWiJtWJf1jXShKVVIAxetaLfazIAF5AAAQ4Yk4ARAR6OqyLfIw2Sb+ne+7Xe3WCJf9GVAZaACykJGahgF/AZ/4XeNFGTNokkvThfsRMKhXwA/eWIPFyKI1HB+N2MGfiAoWERhSEs+p0qrDgsF0gOR/ofHEbfJC2Auu3XhcjEyfhEgsVbhJtfA1iBZmET5BDh4Mhe56iBE5GBHc6b8mU+qCzchhDGg7hG8HPWLR7hbmOADwjg/wupiTe5lv/l4IVgABdoFgmoASkuQjB9yJBERjLGKJ5pXjheCBXIlRdoFhnwlRj4YR7SHVoimonC44RoCeNgAEVWiJgQ4UvWi0xGiABONcEJHNf1iIdUy4lM4cTSJSr2lwD2kJr4AA/GqBmogQ7B4lfWkIUB5GxKCJLwDX5xCGhpEamJi6qBiV5uCGTZrNPRxJfAyhF1TxJOicM6YGZRGEpusRiYYxKxY4WwqWLe5TRBCRYAmBfYjgCWABGSlmXpALoZiRpQDr/4l7qogYSQ5Zpg4rqRjhSx4heYCRnOCwbYFReIk2mqiRgYjuzqH3Ou5SwrTo6qQwu0TirEqGj+gP87rjEVmKYPwRXDSmBdjhCAuRPeMYBmmQl1DqKuAAy+gBHqgBGSUIE5mQHOKY6DgBqRlg4VAYyRaBMSsJggyhMKeQG+8BMSYRhaypxl8RVfmasMiIr3VYn/zJET9OJTpiQqfrbnmOUm5miE+I3pYJGsRgk5tuA8+eWLAYBB2RAX4ItI8p/s0pjqEBQVQZYTWZjhAIAPWQkWOGaEkQHBmKtXxIymVl5uqmpvY4FrRuB9UQhvHgno8Oqf+ekYaBap6Ry3LghH6oBiQYiqahZnqezKxhM88ZmpOYhjdpEYiZqccoyRuSQF7ifCNjduVuw8+Wa7JgFXrgEZjpCCHmsVWRP/Sv5su5BnhFiBN+GLGthrhnnrComBnTYIZEGYF2CA5DCRCvlnBuiQGIjlpTlqr/JVTaleVLZfdYvtjuZl5ziRNYkBFnjiunbrAaCOaSmIEcGQhDCAirGJvGaWE7HpC+kA3znm5CaRiSnqDhjkC6mB3SYRIsKoGiFdeAVvSmIAEvAVbFJoX7MpCVjwBaEQmSaL+W1uXxuZiQzl4Y1wEtDwebMpRzIAFA+O/YaLFwEgMXxmj2gTi3vjn7lu0whSqFRYCF8jCW9xmSvoDrBwN2xbZeYSGueIpB69D1DpHoVOI5HqB04kFTjx1gtnoqnkNnyAyP3xI1IY3XNpEmBxFuXb/yQX7DUaES7fPBWwYOGOw4kEZTA3oRXocOZjABnogGpqwxuB3zWXkSRUGQkwcjF8AOGJojrHnzsXQy1fgTZfVTda9OMRlkjPPRZQGiEXw0KcckqvnSY+QxV4gTJfwzqk8vY1IYq59OrTcRkfQ76FgKW8Xh4CGDZUGRkwdN1Q3xq713YF3iOiGF1PQguRAFbHN2mjAMT4bmCvdWB2w3BOmE33XmkLgAcoEhEwH1SP3jL2CGGXQzI3czX3ZOrdXx6Kic3jdayYAQt+9SpPtY3lCQc24yMq8s3zQAYAkWHfwG6v9n7fiN3pPBp8cplobTNccoTY8Xtv2Uc/dic8+H93CP+V8bwjrKoImXY2ininNSGFX3hZeXMSiPO4QPhwiYBUbfbjmXiK/14973gtpsCJDIBZT3XYkQB3V7wtJvR9DyoKLAzw0XiFyHcvU/eX9xj7fgGHl1df6/QVNvfjqeOrjd2cyfQBCGggTrW/TvMSZ5wgj/qtZ5dwx3ilH7WY15ZPtxcb93pazxlX70Cgt5c/T53a6Xq1D1/GKehc94gWeIO3ZxdN8XSUZ5wmr3uDh51iv3QUYAM9kLb/ZG2az5krF/vPQl3YaXiH0LjCe7Z4V/TA5xoxp9qvn5ywJynnGjaYW2FUnXntahs2XzTKtx52t22D+LfWyitC2jAvU0RNofP/qjDig3BVF2acRnf9KrQCK8gZgGstjMAIkYuIBMA5QtIA52+uh6O4FruUxg9G1FEP6BTLwA47xml94heQEQAkRcMK2m+tOsMIbJv+h4MI57+A5Weo5IcJNnEJ6iekyUo6bwKIAAICABBIEACAAgEWMjxwECHEiBInUqxoseKKFRc3cuzo8SPIiQtDkgSAgAABBBcVsGSJ4CWCCwlmJkCBEqUGmglAwESwoaWCEiUhsjBAYgWfm0rdMBjq9ClUiwWmUi0QwWkBAQcQGiw4EKJChgsdRi0bkcUAFSSnmm0bdaTbiSU04AShk+5NFDov9ASqIO5HFiva6ChsuEsZA4AX/zNGKOAxZK1YJQPIIOABgAcCMlyE25ikAY0kPTdm+zkiabMKNsjEezMBUKGn46qQMOA27gGKZ/N2Kpahg6ERLEMoUIGDgAYFGgjg0Plh740sSKgdDZ1x6s/ZSaZogQCECQIoeLbYoBTl3+iADeTGvVs9fI/Gox6IXACAA+YNgj+Pf9GABENtF9eAixVoUQkKIHCCTSYk4FN6ECVwHgEJ+NcWe+3pdiGHFR1AgQhXXXhgWaZxNF1TJZFY1optWWEFRyMoQENrFV5AgwIjWGQehQRs0CFUGbb3HpBAOgDBYw1kUEF8LT7lJIC+XWfglIyNYIIJOkqUwgYIJBAeCicgEP/URy3w1VNMLRTplJC5EblmhwVQAFmV2tXZVosoSjmbk1GdlFIJ3oHQ4IMtpAAnnG26h2iHRyYpQgNbqdengHdG9EGAe55GqVMKuJbTBT8xOioAit72Jqm91ScCBhCJGB2n1nXUQYqV8mkpVCVscEJ4Sp2QaqoMGDAssQbUCmxv83UYa0grfiADVMw2iytJuvKqAQg00EBhhMh6+21vFWQAnH/SfrRiBx9ES+1b7MbYAq8V0nAoQhOeZyG4+eq7GHOQSQqfuR6R+EEH7d7q1Ahm2vRgtwjxSOGP+0o8sVMCTEDVq5O6q6lF6Rq86cYIJXzBwmNeZCaaaVK8MssdPSD/ApABd3QgwSyGbGtHCk6IwgUtaNky0EGX5UBk/2oM8kUSqPvxZ2GAsZKX4vX8s9BVW12SABQcsDVmTd4sa0UMFBxVC298TRIKWW5Jw4QmnODz1XHLHVIDZ7slM0cFSlBDWSiwkcdpCqCkUgo0gKCB2xvINjfjjV/0QN0L8Qew3efWyQAJLEQlOAGGQJWCX0C9ZK8GiJ+guOOpq05Rff6WW7nAdUqAKncg4ASTTDrp1GuPDupO0wUnKAXC6sUbj1AEVWUMK+wdOU0R5pp3lKCC39WEk1ImwBR6S/SS9OdNDR8/PvkHf5Y21Qi98KaMMy44E04z8YVjeuCjx5hrKOFb/z7/VTsw52OMxrzPcE4lEFHAFwhxhtzhZSZiGlOONpK/Ci3mYUqJWP8yyLIGMOdDMPPaZ4RHgJz0CgWJmMNLWkCmkljwJhhsS/V60rOKgA4o3nuKd0xWkQ0kIAUpSMALIfLDIKonARcoiRGdwsNDJbF8AsCAADLzQco1pgRK6SFCVJCWssQQd2rqkL1eszmlfHEiJwmKDiUiOANaZI2L8UlJ4DiUM5qEiMUTQAEgEIAJCLA3eLOI/QiQnoykDnTCO4ECCmdABNCgjmwz4Ai8BIIyIiRBANjW/hCSArtMCI1/4eFO1CS44CXgiyU4QQJOcCjhPQgAkQwlQthmxMXVEf8hcEwBKkHwIzgqCF6lREgLUvkSicCxSy0AAQjoJcsLJAgBQlFQCehYTAQcM5mrg4AIBHKZ1zVmghbSYnVSdxIDCs+HBPjVCC9gu0aiQAMIsMkNIWKeX0FkLu7spBtBwJfwJIgA2oPnXFCAgNIBgFAFdSc8hccXFHSLggCokBUFegLiUfAkOUFJoMSDgPBIhIJtaxAAFPpOBQnSJIKko0f9CVLjZYAz3KxgjzZAyNWNEyGjvAABDkXBEVQoBRVaUEomciUN0HJbuxSkG6P5JaQGtQUp2ZaY8BlUnz5IeN8hAE8a5tCe+vNGOqpoSXGqgAkJZUIdtZBZC0oAANguqyb//csZUYrWtapVgwNcTBdfcgE6bJGmQUWICRCHAoRsFTY/fUnDUhDYeEqTqc7UAAp25VgArPEkD3SmGwX3IMSOgEEooWRhARBMugwWrHAVZFrTCpGU1mutnbUJAbxT0riWlLUAUK1dkRad0BivprZESSMfylDhNbJ0P6HBCz11zmEeEKtjdazgQPBclpxTAfD0KQpUeAHQYVVNxp3RrnCE0+AihC7Bq5AC3uYpDTzUQo1VAE6pydGI2NasJxAvAbSl0fCQ9C/1pWtudcub6YRTdb4FgBUJoKURmleTtvMnJQMpEZxCdrLCqzB16aKBiLUAtigo6wgBsEmUmMA7Gj5i/0Q2UDqcJqAEHtape2cryBG0bb6rnWtrTXJiV+7Mdv1t723pitsAY6d5IIlS/5xKTyATGcE/UfFgmzw0AFKGigMmwbHI5+MbSzkFeLGmlKPCQa2A6KWzQXKY06zmsjwxii8z82f0tOY50zkkeNQjH+EcF2ENawUkGFaW6yzoQSMEm9rsmpUXY6oNEbrRjm7piIxskUXTztGWlnLyprI8P0q6IpS+NKjTPIGi6dktnw41qgMsAD1KrtQY0hCjUy3r/h0A0ZFuzKlnrevxyWlrtW5LVe7TH8bketfGVh2VqxyVyERx2IqGdaWPLW2rUcDWbXkMVTbyx7AVi1iBnja4hf/2gANg7NpauVhEwiIWsoS73aBuXQDbMoEAiCBrzkGIuhvSaXfz23gOEMvk2lIfYVdk2/0+ePEicO8S6bHeFGCSRQyO8InL7QCsesymh8IBJK0646jZN8VDXrUnHqAB2HS1yFNOPjyCKAB95I3EVS5ziUGAORkQwcvNN/OdG09OEOAABVyaaJ4T3d0xLzrSERUBPnIN5Ul/Oss4Hm8QQr3qQRMA0QCQTadbvevfwqNyxs11r5OdVHWrt8XGXva1rykCEajABCYA8aGzve5hPvrab2CBve/9Bmb5gQWEYJEgeOAGN/BAEChy+MTv2teOtzan7d4WDyyg8pX3QFSEgAT/HizAAhYJQed/EALPT8QCCwjBRkyPekEze+p0l7xT9O6DBfjAAjc4wupDcAQAhCAIR/DA6oUQAg8UAQkSMX3lSR+RGxTBA5S3gOg9T3jiG9/0QPCBB4wPgB9g3wd+nz3wASB86iPk9x4Awg+Kjne2g371szc87QGwABwAoQgL2D0PcBACzvtdIs+XyA/ggP49n+oBQBEAQQjkwAIA3gLkwP4twA0EIA+EgAACAOflAObl3wPewOwhIA8oXwZhwAGgG4es39q1H0JYHxBAoPxhnhAsQOHBYAjM3upFxP9FxBEsQOKB3t6d3vYNnwL2IOohwenloA8MX+cV4A3IIA3a/18RjF5uRUBkLBzVwV5ZoCBC5AAO5AAPIAQMeqEHmB7whQAU+l/nSQQP8l4Snp4EBsHsCSEAqB7oHSEZMiDqiSEZjp4Q+ADnLYD2ZVAAUAAGYAAFgNy0WKFZYKEa3p8XfuDs7Z4ABoEFHAHjIYQQWADnHUH/peACFIEFEODpmZ4ngmLt8d8S8gASWAAQ6F0nGl8kTqIbHoEqMqIGuRxCsJvaIWJHKOIPVJ7gyZ8ALgAQIATzVV4O/GEcWt4XRsQK4gDnweHsOeMa4sD8Md7mVR4PpB/l4QAAFGMDIgEFzt8w2pU2kVoV6mJbEKEPQMQyomM5us45omNZ2J/ytaM8rv+JCd6jPjJKPt4ANeLAJu6jQN4VYyigMQ4kQkZeYyjj5T0hEgRkQkYk0ywGQ+pdEABhAwKfJP4isOwd4V3e3gmNP84fREbHJfIdSqakSuJeHrakQeZASc5cPhpkAyoeODbf/J3f6KUffHgkGTrfS1IeQ/bhAvCA89GhLIYkSaxg5Y3j36HkRdKkA7YkEDifVV4lVmIlNTIkV3ZlVn5lVtJhS4KeMnIj0vUjNcJkRwBeCFQlNRJfCDxkRQiBUHoAR1qETw6fBwTlGEoiCHJlRPAdS2KfBxClUXoAUvKdRDCl5Tnl8aEkVV4lUeakVT4hQ47l6KmkZqYkT14IV97lzuX/oyU6xSVe5F5mZO8FHgAI5eWloAVcpF7yJRn6pUdwZWd2hGCSIWEaJmsqo1VuJTZeJQLmYUpuBEPe5soA5/wlnWgCxg3c5DZ2ZUb2pVI+RW9iXlz0IFfyHXKWhVSK5EvGpMw152n04nE2Bl1eHmi2RVd+xkiqZdV0J9GR52lc52zIp1swZlPOxnpK5LIYon+kJwz2J8UwpmP6Z/HQ530iqD4qKIM+6ERCqISmioNOqIVazoVm6GlUwL85wNwVHIBqqIgCAJLUBwRoW4iO6IVC0QQAwKi1SsSlqIpOaFd0Bb79hss5BI7uKI/2qI/+KJAGqZAOKZEWqZEeKZImqZIu/2mPEpzRfYWNJgSObg2TAimVVumPXimW9qiWbumU6qiX7miXhum6gSmZ/gYuuptlYIZmCB1FNCd5xqmMQoScwtycftzBIYdyMAcVisSdFsSfAqqd6pydDKqh9lt+JEfAvemf1imhFtmhFmqkql+jBqqjSqqAYWqmUuqjQmqnAsalaqqoEp2JlIaTmipvlCpjqOqqnmqrJourzqisziqt1qqt3iqu5qqu7iqdhQWMAgCHBoCHukWwDitgDIewQlyxfmhUBOtBLGtbBOuvQmtUWAVEcMC4LAlEYEAAZECfhoS14ltVbGu3futHhCuw/pu2IgS3eqvIZQWdFJpWrJpblP8ovQKGOdrriZpFBMxJycmriZpFBSAJknSNvkJFBAjEv8DbvmoGBFAABZgrRyRslTEbQjgsxErsRVCspAzsvD5cZqxaxoYcB9wH0WwFi7roE5lFyr4oYAQHckRRy65sWTDHq8zsrz7FmgIAn+LsU7TOv2BABVQAcxhH1lTGNpEE0EIEtrFFBRztzobE0iYEvQ7c01IA0kLewTnABAiiVxBElEYLlH4FYBSAZoDt2EqaFI5Zi9Yo2YotZgyc2zZPVvQRn9Yt1eYcR+CtY5zbfeAt34IrZXhszcEM4CpbuJWjsD3AwwbH3JrF475sfWBG5EJFVhQHkvxb2pZFzH4IHlX/7lAELkLs7OHq7UYE7rw5XMlKhuie6+CKAAUwBwRUQOn2W8lOxYc+RtaGrJvq7Da1aWMM3M4Cb1RI4VYYxPBuBr8KK3PsLvFOhtFoxgdJ4YmmbEm0LgAMHPUCgPUKrqRYBkGMWgBsb/ci3B7tUXIAgJ4uR3OYxfryaVzkUQBoRnO8b/vW7BMhSQHYr8aGhAMUwKhhBv8+xXCs2nyMWuTcB3NgwKgtqkcUcHHQbsNlDZMscAOTBAQbB9FgLtbx7BNdMMVhQL8cgIgk6n64hQk7cFRsXJLAaAq3RQQgCQXwxwubRZI8RA07BbzhEQAwG0HEcNZobUfs8P5yHASICBBX/1tJEHFmzEndII8MCzGvTjEVV7EVXzEWZ7EWbzEXd7EXfzEYh7EYj7EGVQWzplymYYwDkDCBbM2F/JrSSvHaRQYFxCrF7bBWKET/kgTRzFtWBGpEIK7AqHDd6e7Z7lzy1JsIWIUe40cAiOADVADOiQgA19qHcgDOWTIHrEoB1BtZVIDLTUCrcEAAFAAGBNy/QbIks7H64lyIJATTuZQgIwQpY8AkQzJXBIdC2PIB5CzZPUYA1Nwemy/ZCsR91MeYaU36sqhmtChYOIQiR4DsOkqkkGghIknyZI2yITNzKHMDqC8F6BHEFkQ21UdwzDLVfuyYnfPxZk3rDHPRBRBzAP9yndmoMWdvFP0xPqvsQjRvRDgAzknGPeuz8dLbQGQF5NUH1RKEQltGOeORuEwAkhAEOuuzQuuzQPOwZtgx1OluDzdbaBYzD1/0Vyh0fYhFRGjGA+DtQH9F3TLEVLwtRJA0Q0eRQGTTQmxc0IFvD+ecRefzV2T0fdzzHOORZXwzz9nzSAN1TSPtxdhyRNTHKQs11YoyAEDs/2bA/8r0LTL1PlMvBpjt2pptUG+FFELHTy90T3vFUPNwUQeQx4WcUh+zVyt0QfSLMyOPv1I1PmPt0rWwPksETe8z9xoxBxDNvFL0VlgGFaY1RrdzW3M0GcvjBEzRZOPqBMDzZW82Z3cqtmd/NmiHtmiPNmmXtmmfNmqntmqvNmu3tmu/NmzHtmzPNm3Xtm0TWUAAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Twenty-four-hour plasma insulin and amylin profiles in healthy subjects. (B) Mean amylin +/- standard deviation versus time after a meal. Amylin response is absent in patients with type 1 diabetes and impaired in insulin-requiring patients with type 2 diabetes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Buse, J, Weyer, C, Maggs, D. Amylin replacement with pramlintide in type 2 and type 2 diabetes: A physiological approach to overcome barriers with insulin therapy. Clinical Diabetes 2002; 20:137. Copyright &copy; 2002 The American Diabetes Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_12_1216=[""].join("\n");
var outline_f1_12_1216=null;
var title_f1_12_1217="Pancreatic cancer MRI";
var content_f1_12_1217=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F76159&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F76159&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pancreatic cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 361px; height: 305px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Magnetic resonance imaging from a patient with pancreatic cancer. The pancreatic duct has patent portions (white arrows) but is partially occluded by tumor (red arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael L Steer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_12_1217=[""].join("\n");
var outline_f1_12_1217=null;
var title_f1_12_1218="Patient information: Acne (The Basics)";
var content_f1_12_1218=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15326\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/0/1027\">",
"         Inflammatory acne",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?19/40/20099\">",
"         Patient information: Acne (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Acne (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/acne-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H22661689\">",
"      <span class=\"h1\">",
"       What is acne?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Acne is the medical term for pimples. Pimples happen when pores get clogged with dead skin and oil, and bacteria build up. Then the skin gets inflamed and can turn red or swell (",
"      <a class=\"graphic graphic_picture graphicRef70916 \" href=\"UTD.htm?1/0/1027\">",
"       picture 1",
"      </a>",
"      ).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22661696\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to reduce acne?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. The way you take care of your skin has a big effect on your acne. Here&rsquo;s what you should do:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Wash your face no more than twice a day. Use warm &mdash; not hot &mdash; water, and do not use harsh soaps. Instead, use a gentle non-soap facial skin cleanser. Do not scrub your face, because that can worsen acne and damage the skin.",
"       </li>",
"       <li>",
"        Do not pick or squeeze pimples. This can worsen acne and damage the skin. Plus it can lead to infections.",
"       </li>",
"       <li>",
"        Use a moisturizer. Moisturizers labeled as &ldquo;non-comedogenic&rdquo; and without scents or dyes are often best.",
"       </li>",
"       <li>",
"        Avoid oil-based make-up and skin products. They can worsen acne.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22661703\">",
"      <span class=\"h1\">",
"       Can I treat my own acne?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have mild acne, you can try non-prescription acne products. You might even try using more than one product at once. That might be more effective than using one single product alone. If you do not improve after 3 months, or if you have moderate or severe acne, ask your doctor or nurse for advice.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22661710\">",
"      <span class=\"h1\">",
"       How is acne treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Doctors can treat acne using different types of medicines. Sometimes doctors suggest trying more than one medicine at once.",
"     </p>",
"     <p>",
"      There is no one medicine or combination of medicines that works best for everyone. Instead, people often need to try different medicines until they find what works best for them.",
"     </p>",
"     <p>",
"      Many of the medicines that doctors prescribe to treat acne also come in non-prescription strength. The prescription products include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Retinoids",
"        </strong>",
"        &mdash; Retinoids are medicines that help keep your pores unclogged. Most retinoids are available in a gel or cream that you put on your skin. Examples include tretinoin (sold as Retin-A&reg;),",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?2/34/2596?source=see_link\">",
"         adapalene",
"        </a>",
"        (sold as Differin&reg;), and",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?25/32/26116?source=see_link\">",
"         tazarotene",
"        </a>",
"        (Tazorac&reg;).",
"       </li>",
"       <li>",
"        <strong>",
"         Products that help skin shed",
"        </strong>",
"        &ndash; Products such salicylic acid, glycolic acid, and",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?18/34/18980?source=see_link\">",
"         azelaic acid",
"        </a>",
"        help remove dead layers of skin. They can reduce acne by helping to unclog pores.",
"       </li>",
"       <li>",
"        <strong>",
"         Antibiotics you put on the skin",
"        </strong>",
"        &ndash; Antibiotics reduce acne by killing the bacteria inside pimples. They also help bring down inflammation. These medicines include",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?41/6/42080?source=see_link\">",
"         erythromycin",
"        </a>",
"        ,",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?42/59/43952?source=see_link\">",
"         clindamycin",
"        </a>",
"        , and others.",
"       </li>",
"       <li>",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?14/55/15221?source=see_link\">",
"         Benzoyl peroxide",
"        </a>",
"        <strong>",
"        </strong>",
"        &ndash; Benzoyl peroxide kills bacteria and helps to unclog pores.",
"       </li>",
"       <li>",
"        <strong>",
"         Antibiotics you take in a pill",
"        </strong>",
"        &ndash; Antibiotic pills work for the same reasons antibiotic gels or lotions work. But they tend to be stronger and can cause unpleasant side effects.",
"       </li>",
"       <li>",
"        <strong>",
"         Birth control pills",
"        </strong>",
"        &ndash; Some of the skin reactions that lead to acne are controlled by hormones. For this reason, birth control pills can sometimes help with acne.",
"       </li>",
"       <li>",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?32/34/33318?source=see_link\">",
"         Isotretinoin",
"        </a>",
"        <strong>",
"         pills",
"        </strong>",
"        <strong>",
"         (sold as Amnesteem&trade;, Claravis&trade;, or Sotret&reg;)",
"        </strong>",
"        &ndash; One of the retinoid medicines comes in pill form. This medicine, called isotretinoin, is very effective against severe acne. But it can also cause serious side effects and birth defects. Women who want to take isotretinoin must follow very strict safety rules to avoid pregnancy. (This medicine used to be sold as Accutane&reg;, but that brand name is no longer available in the US.)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22661717\">",
"      <span class=\"h1\">",
"       What if I want to get pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you want to get pregnant, talk to your doctor before you start trying to get pregnant. Many of the medicines used to treat acne are not safe for a growing baby.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22661724\">",
"      <span class=\"h1\">",
"       Will my diet affect my acne?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Studies have not found a strong link between diet and acne.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H22661773\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?19/40/20099?source=see_link\">",
"       Patient information: Acne (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?1/12/1218?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15326 Version 6.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-83.177.194.223-4E972C53F8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_12_1218=[""].join("\n");
var outline_f1_12_1218=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22661689\">",
"      What is acne?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22661696\">",
"      Is there anything I can do on my own to reduce acne?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22661703\">",
"      Can I treat my own acne?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22661710\">",
"      How is acne treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22661717\">",
"      What if I want to get pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22661724\">",
"      Will my diet affect my acne?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22661773\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15326\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/0/1027\">",
"      Inflammatory acne",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/40/20099?source=related_link\">",
"      Patient information: Acne (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_12_1219="Venous lake lip";
var content_f1_12_1219=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F82615&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F82615&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Venous lake",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 384px; height: 308px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAE0AYADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD0uG+4barDJwu7BXPpSMJnZN2wDd83bjPrVGJJAxbaFBO3PbPtWokbCHB2gbc5Y5C1y6vRn0srR2HzGRkRZVVEU8BRjj1NEbQrKYkjzvzgY+7+Pr/KovM3Da+ZVyOh/X3q5G0hOyQLHgAbVIH5k/rRfsZSdlYhaRUSVlT5jxx0z9fT29abbK5DbhtOckE+tDsJp5FLKI0X5Qo4OPSnBRtD4DBcFsNjimhX0FkjUsFR9rt2H+etVfLMsUULhhnJJx0xUgYhsfOMrx+JqVirFX8wlUYq23II44/WtYq+wczRkWrE5M0nKkxg9Bjr0qe4vRbrCscihipdph1Vj0A98fzrOazEsHm/e2hnYl/vEnjPr0qhcO9vIjXEigu21FXBy3+AFO7s5Gz5Xq2dVbNJZafHJEgkhmyZEc4JHQNnsevNaUQstSlt5zPJyqK0JT5uDjdnuD61FOILfSra4vSnkvCqrFnG7HJH+Pt9azrG8S51y1+0ZFwmJYSDsG0nGzjtjkCuhWSOLmc05x311/r8yvMbOe6mm81fLDFtqgtnmpYo4rOwmnt8LvkUgheSeoyKq6xaXDXE01y2XMhSEoMHG4jJArSigistLkRnLMQmwN3PpRfVo6ZTTirPsV411JmW5nuQSTwo4yT7VoPHcxwpcyyTzzbxmJTgLioLNvsyCS5YPKSWbuBgZq3D5g0+2ZG3XUkhc88gNUxaXu9zlq1Luysal4Xu9ISWZSWjkBKY/h7E1VARbaRAfMRjvZh0UelVzqslvqUtjdblRSuxgODkd/xq9Ntii8mVFUucsyfdNW+pzRTULMzbYQ6iI2mkwkJ3I3Y+xq/ruli50x4k+aVivzL2U9aT7AtvZNCqLliCMdD6VXSc6dqM6y7hBHEBIScjJ9KVtrim22nB7HNTaPHppEj7XY9s5wK5zxT4QtdQCwJApkmG5jjPFd1NZwtcKxLPFjfnP5Ul4u2+heN8b8KeOi0m+WLSFJ31PmHxh8J7ywnc2fOSNqVw8/g7XI32G0kbBwMV9p30dtfXNxcogaOAeWgP8TY5xWKulRbcvCBnnJFRKK2iSouSvJHybpvgTWb28Fubdo2z1avX/h78NIYLP7TcRA39s+TnuK9z0bw7aPIg8td33wcc5qW4s47C6aZFBVgRx0akordsltLSJk6No9vbW0kShRFJ8yf7LGte0hWKN47n97sHA71ItsYvssroywOwDewPep9YlCMRGMsndejCrl8Og72du5lW9vLd6pLLK+6AqQq9QMdK3YlSSwhljTMqtyjDII7is2w/cWdxMQVTA+X61q+Hj50rRyNtaNdyEdjUx0+ZVRtfIhudPSX5rPFtMvzbQ3B/3T/SpNKdbmKRnj2yxgqQeVcEdR/hUmrgId67WSRSwGeAR1rHilnkurO8kfbE0uAi9D27UN2ZDvKJVvdXuGv4jYlTJaDYU25yMc7v5Vzmq3aMmyGGKGCfAKZ4Vj39q7WeCMQ3TmJo5mDq+zou0khs+9crd6a93chUUZQCNQD0c/xH27fjWdTm1XfY3w8orYp2EtwIJBcRyOIE2q6HO5VIBGPbIP0q1BaHUNB0+aBn82z3I0TqVaY9QAOrAZwKp+fefvZLWVY5PLaFgVwWIX8g2O9W7b/j60zS5ZzvtELC5UnFtOwG1Qe4AHOfWlF9GVJvm06EOmZsBZ3DtslyyvC443BhuQdjwQRWtIkcWpxReaGsriRYmcjHyyfcPtg4P4Vqagh1OwFvqFvbyzRrumicZKMcAYIwRuAyDWDaieGCxjkWJhHeGEbmJ8yAYcp7svJ5wcitGkocppGvdXZZtC8FrqEcwUbJlYZPDbTtOD/SpYg8qiAKUMjbcnqDjiuLtLu+XxVqWkyybFnRpopEi3Bv4xkE/K/PpXafamjszIs5kdsNIWwTuA4xxwD7VEXeNux0Qm38ye3dUuws0bcfLgnPI70RFHkkY5KqckJ0NSicnLRYdmO48dKrxF4JC3ylWODioehd+a/cqyptbdb43nJ244IqIPGu1XKw4yC+Mrk9iO1aghE68BFc5+82P8msooxIV8Bc9CMjP1rJ3uXCd9GIyZjEpXKBtu8DcuR7iqdyHEW2NsAsMk8g89qlceQxVZAAfvBT1H9armYBxI67k647iiUtDeN90RSCdJRk5UHBUU6R1FrI7E7VOMHqfbFTl0aDzNwCjgZ9KpySQyqCjFcAnAHJP17Uk9bsvmct0bsayLcneFVQflGTnB6irLeUZgmCxAyY1BAH1PemWipAz5cNEcfLjJBx1zVyMh2zCpQHPQ8k/WqZySkPthld3zIucBFALMf6Co5cW4ZsgOc/KeTn3qUl4UcYVFAw2DyTVa4jVijO3lttJxnOfSkY9fIrvEwcKH3Z5z6CrNxAY52KOzwkhRx7VUij81gCxMn/ACzXPJOalsGkuJZI5EZdkhAGe/r+lVGK2Rp03EeeVbs27MSyKAo7A9eaeHcWNwJF5jlKNxyue3+FV77YZRMHHmxjcykc+v8ASpbKWJdHEpZVIk8x9x6s4G0/TIb8q3g7OxnUlZKxz89yLCDdlUhYsTuPGBz061lRpJqltJdSqIpHG2KMHBiB7Y98g1ZiCzwCecNcx3cu1UI+7HkscfUAfnVm0b7JqenXUKlDK52pJznaclsdh2FEo8u2xkql1zHUa4lqjWVlJkQ6dGkeWOS3ygnJ9SePyrJEKyL5118qnMrlODgfwg/lUt5cDUL64O7L7t0nPy89V9z0q7eWqq0dhbgLcTxmSbjiOPsg9z1qnZ6LZf1/XqRTm4wtfV/0yC3uLrUxaSiNPNALsxbmRV4zj1Het2JUdhG20lMNkjg/T6VWt9OCy2cUJCjIVSOMDqTSQXlrJq0nkvL9pDPHEGHyEjr/ACxVQsviZEpaWRRuZIYLxkK5cMVKHoxb0rX02NZfEDK8bhTGVTHbiuf1pWuJYb+AEJ5wR1J5ibuPp6V0Vyz214blVPl+R5m/PXinJe9cTvt1szJnN7ca7GJ1wN+wr/situKYtG5mdfIBKhCMkYqGxvIrmN7u9hZChC+avQ5/rVVr6zi+aKUyAsdwZeCaOdL3u5tfn93l2OobCWxQkGQJuQDqa5u/uRcwykOrNLtXH86taReJe3c1yWZCVCRH+6e4p6WttPftbj926sJOnQ0J6aHFH93L3ilPbtHNJHGNkWBsf1wKkSUTy2yz42/xE+1Wbq0dpXTzyoYFgOwx2pZLA3Fiku0eaG247EeopbNpbmlRqyaZnyxwxyrbWQVsMWxnge5rQt7aN3/erujI2uR2+lZ+lQo810JIyVPEe08kjrW9aCNVaJ1CgjIYHoaISsJ+6V7IC2nbyVYwKcqXPP0q0sNtfo6K20v/AAN/AaghUMkkMuF+YncT39KzpbyeC7kQo4mGQgx96pdnr5kuHM3y7mhGgEAgu2LbXMWPT0qLWrZ10OExJmSOQq5HUjtim6XO96k5ZCJAytJnqDVi6v0nNwMkRqoyD296UZJ6dCbNSRliUXFv5mDtgxvTHJPriptIkFjPPL5hMU5ATcOAx5NUpopGR5YiLdtwBLf3B3qQXXnWjxAoqxuGSXHBI64qFKz1NpLoX9dlMOl3UdvF5jeZyQfuA9qxZWW00i1UOz3Am+RVOSWPY+wraRBqenoMHbLl5yDg4HSq9naWkMksqfvBaDMKLypc9ye59q1Sc9e5nFq1n0LlnFJFbzi9O6S/lyyg4McYH/1q5/w8nk+KJ4ZpQonQttPTaOR+WBV3Vftj2Fy1qZLiec+XMEIEkeRyV9sVnwyQW+jw6s7l761jkhjeUcgAcbl7kDNTJe8rEx91O/UzlmisTqlw3lMbj95FG45yD9/H93pVqK1trbT57q6d7iFxHOyEbXMh5wT6HPNYeu3VvbrHc7ZLiedAyO6/LLGfX0HbitfwzZ3GpWdrNezZ3PhCo4DEYCn1VhnDeoqHJOVl5m+0eY0NJ1BrmRJdRVcO5tbkgBSgPKOPUdiPasnUtSEVldWt7AJWluDHLgnLoq7SV9WAwfcVZtYZPs99HPGWXynAYHGWT5wMjocD9TVbxZZh7fTNXsvMm01kCsCMlWb+I49emR6VNST5X3QRUea3RlC2giDyQRNN9utI3ZMruMkRXIZT3I4IB7CrOjqt1ZTgIHVoI5xtzgkHk49CCaXQmcalJBeGSW1hRxBdI2WwFw6F+hIJwB7etW/BLQJp4F5MyXllui3S/dkhycZHb8fSnCfNa4RqezbsXImMTSJ8qIQMAHpx0qdUjis4y+T5nIbsKjms1ivIo96mCRfMEqkEEZ45+holDvKISwVEcrntmqlG2x2RmpWsxkMrbnU5ZV5wR1pzReYpH3VPfrSGPbsUHD98dqW3ZlKktheg+tYS8zR90U5LSM5IzlvbiqjxNEMBA57cdBW38rNggA+3rVeaNi2cZPqahlxm+plTKkW0qHGeCOxrFiUyTPK8KtIWxg8BSK3NR3YwDgEdaq2MSjqpZs5LMKW5vCVo3Nu0wmEwJMjA4q3GAgwx5HHv/n3qsoCZ8wEH160+LCBlVsueRmqRzNX1LoaNI5BtIbdkE88elUDMJHbeBtC9e9S3MoLIBuLDqSf0+lZwZWmcKd2OoqkTGPUuRgOw8scx/N15A61esFVrdg+AzHchXrk5qlblkj81TmHd+p6/WnzZto5358tm3JtH3fatY6O5E3fQp7Vl1G4ibhEyJWQc8fwj/aPTFUNUkeZJvsoSANby7QvQbVJ2+/T86sLJaITsWU+W4+RTjLkZKk/5NZ+szo1qEsYka9unMUUSDdt4y7Y9Av6kVTasZ1ZOxHoE0d1pCCNs21pFHAJlG4EiMMSPctxWfqNwqtbyCfYVQu2ThYkB7/4dTV/4eWF3ps2o6QshEbLuhc5C7o8gHHoVP5iqqXF7JdsJms2JcoEeFSybThmOOpJzjNS23GzOanLovU0fC+rRR6pbfarV4rYIZhJOMB1YnDkHp04HvXS2lwlxcSSSECSVeWxy2eeB2ritHk1K71DUJ9SkkFtOohjjXAUKDyT78YFdRbllhTMbLLnC59c1MXpc1VP3nc1lugYN9uuJ4iNpb65wfyqqbcwAzyJtLMZ12nIUk9j9eKvNPBGvkSxsZGTeCvAAHrUiMl/Cxi2iEsMKT9w960k7NEXs9DLureN9KllkBjmkcMAp43VPYzNPoyQoDIUf51bsPQe1TmKN18m8wArbkIPBPv7VlaRJJZzyRXUTBAxHmqeCO1VKTUk/kaJX2NONFHn2kT4S5QSR+m4VREG63vLW4VUm2gKR/EM0tyYIr4TAnynI8sg/cP8AhVvVIJ5olk2bsDJ29QO/50pe8nYFLlfqZVvAlon2LzXt5twdWDZAbtWpcSzwJFcXeEkOE89e496x7mWJdi3KMtwwwCoyce9X9GvpIo/Ku186IjAGOfyqISs7EVoua5kaEaX0c4ib9/lgQ6nIKtWpeOEMCxgGONWLHPQfSs+wuPs86tEFkidSgCnBX8KpXt1slWCD95Gw3SOOoFaNKKvc5U3JqLNjSQmYbqRxtDHOBwB61svYhJJnO3a3KD1B7Vy+nPLb27mAB7Yr8wYc4HpXS6dPDqekx4G6RAU68qR0qab6MqqmnzLY525eWOOdZVOMgA91FLdztK8QJ3hesmOU4pNVnmtWkt7xWkXaP9IUYwT2NR6NZypNKGuRPgcoOdy1SvzWRtbqy5LMYbOSWPIYcIV/jPvUWkstxp90XQ7mi+fI756VcMaTafNCoIaFgypjr71m27TRvOnSNyF2jr9aOVtpi5U4u25LOxudO8u5UxqQcD1xwKp6LaRrmSTlAGQqegP+Nbd3E11pLRsCkmNowORz/Ks+1m8h1aVRK6MAyr9xSepJqZw95OXQhTumkRxbvJnIlxGT/qh7cVmaa7wahIlm0qpIdxd+VDY6AdAa1hHGHuZLZw7Sybn44APAFYF1dyaa58uM53hcMfkkP+e9XJqMU/M2oxvGxbnlL2wvIC/kwuUniBIaM+ufQ+tVbhBLZ21qgzK0YdHJyJWz91vU44zV22BszNOF3IFDSxMOHjf7w/ClNr/Z7Wzxss80MZaI/wC8cqfoBQ19ozqWvoVdY06C+vE05xGtm0QaMBvuSAYZR/s54IHtWF4Mu5tM8M2ZiBVrG4ZDA5+9DvOVP0IyPetHxOrxaXKdKjVLh/39uxPzQM3EhI9AefxrH0Ng+iSTzho7oxR286jLDl/9aB6Hv71lUfvXX9f1uTDVWZ0uvrJc6zqPlXBhjkAkCH5d0ezO4e4z+RqDRxc2NhZaWlw7QXUUsiOwzHG2dygg9CRkZHrmtfxFOtvqbyBElgt4drq3AcgCMD8S/wClc3rTPo7PawpcypJausajkpIEJTJPQbQcfSnK3Uz5nZJHN6leRaDcJBbGZLB7kK5VxtYOOMk916lvVc12OpvpbRzTWu6S5QCCdIW/enHRiOn3gPm6Y71yvju6t5tEOp3MIhmeyMkWyFncI5IZyvRj82PzrSsVW2a8jv5I7+2eJZYgZQjhdqkhlHPpwaino7IJS15nuaLS2sMEdqt6U2xrIivEcAE4ZSRnkHir9tHJCJBEoljABBU7hk9+ax9WuLS7tbRtIhmZmkdBc5zlh95GHUHoc1chM0cTSST4lK/MQfvVrJa2R2UneFy1EVBYylgQOBjmmK6+ZjJznr6U0wSMQftPmuw4B6L7Uk4jtztLDcSDWFSFtkdMZJ7FuJXZQVIPc5rRngje13q7bx1B7mqNm4ZSGH41bkVFCqHJbPPtU+ZE22zLuYVDAkc4qv8AKsmFA56kfzrXkSMD396qSKqqSF4z+VQ3YpTutQ8pirKTz/SpIoPIRxlie3HQf0ohTDFiOhwBnmlnuPKtpPmIDEZFPQtt7Ir3UigyFhlgB93tVOGYmKQwBFL5+9zUyXESxuZEDnHBPrVK2ESSzMsoUqQQnrWsbldGrFuzuHjuPKVPNCozew461Y1C7gs7e6G0zeZANqgdZDwPwzTIXjivgY/kWQ4Yjpg9qh1OJw4MDxM1sDnPcjoce1bRWhzz95lOxRYrOe3MhlnDjbJnq2Mtn154zWlZW9vBPbT+X+9YG3WRRwpbJY/hkCucW48m1UZdHif5mzyTnkVr3dw8OlaZdLlGjuCeDwpwTk+o5WoTSbRz172H3/8Aot5b21rE/mxTmTMx2cHDdfTPP1rnNRkj0ua31FFeJd5Z49uWLZJx7DuD3rrbu+Z72+vTZtLNcsLeJJASFRQCWA7ksQMe1cpreh3V3cvHqUggvnUPhWzg5yF4+7xwaU+aSskZUUotNm9oSOln5t0oZ2Jn2g8H0H51sMYxa/aJHDSy/MP9hQeT9SaxrSfJuVRtphj25PIBwM496l0ZXubV/lKBm6E/dXHLGtVZx5ToSWrudTYIk0aNkMpxHkdSD2/CsbeLOeeKLfIfN2D6en41qW91CNnknYsMRKknmTjrWJJJsQBixeVgWYfXg0pr3UFOLbdzaaHbYRvLkPuzgjkD0qrpqlfNifLKxIBJ4Oewo1LUmuNNZ5DumjYoex9jTdNnM4QvF+4YY68hvWm7XSGk7O5VvYWj1JBbrtjU4wTkA4rV0/zrRPmka5jcncMcj3+lLNAizswbc/Tr1qW1mZtwVVCkcYNEVZsJLmiQ3dgkhc+WBJj5ZAear21vJNFIk0eZ4hkFeGPuK3rRreSFFJBlx8rf0NQxKy6iZQcFVwfcVbs7MOa6afQpeH44mY20qsJTlo5Mf6v2NZsVpcQzSGVT9qjdgAOjqema1My5Sa2fAkfkj61aZpJ45WdMuz43DqKhxT0IcLSutmLp1u4too48hdpeTn0606R1tJ47mzchJRtMQ6f72fWq7mZGEMPH98noT6VpWWmojl3JG/gAcgZ7Yq4pJWRMkkrzZBdsrwKt3GTLJzhvustUFshY7ZrZwkkXDgH71aO1lidJH3TRHZEc/wA6ju0EdlLK23ftwSfX0olG5UNrFvTLqMvJJcfJNzhR12moks0inmlkPBOUVTnIA61U04PalJGZVWVepGT7ii4cupMOco2HKnlQaUZdw9naTszMnurm4ErNJKULZYDpjNJDMlvo+1vM3tJ8ueA3PGavagEjsmjtmC44461myFbhIzKR5MIxGAMfN6moqK5p7NPZWRasZI4LXaQGLOfmzgEdz+dYt3OmpXCKoxEj4XJ6gf41oWNo91frDchfsdupLhf4vx96yWaOEiCFMbW3mU8FUz0X396ipzNK+iKUUm7bmndMIbUJKPLbqQDk8chSKpXAK3ExaQiWGIKwVuVz8wH4Gm292zXC3N1HuLHIXOSccgY9elZ97KViuL1SDeOWVo2BOVbqTWl9PQycLbiwXRbRo7+4VpZvNlhY7eWTAz9am06ERQ27xtHHHEonnD8eZGOmce+BWRPPJHoqeWx8oySSBcdU2hciluLh4bKzRJg1qSDLJF/GF5KN3HHY1C0gr9jOcexof21OPBX2jUYIri/cPqN1ayoP9UZSFHH/AH0Cewqva6sniTTrOW3Vre1aU23mMNrP6RxjOCwOfmGQBk1gahrDL4yV7aGJpJJ/MZsfIF2ARxv2K7eAvoT3NVtU1qzvdAvNQ0hrx53ykZnXabePlXihAGEA6E9SKhX1XYwlG1nbcsP4luNS8Qa2dPjt206zWOyUOhYoq8Bih65fLD1Ug1W066Z/FN1LfYaSOFBIgXAjxu3OCeCADyvcCse2UaLbjUdPTzb+aEi7jDnFxAsncEcOM8kdAo9a09LtWnYXC25Fs0U0kxQ7kbchUbT6YJ+XswI7VMbuRLskdhp2lMrtch40YgFo4DlCTxv/ABHNWntVTZmTuV+tcr4TYWKLBDcNO0fysrEjKjpn8K7SeZIkR7TaVkxnOCYz6VurTRrTlJaCCXZFJFDGDIy8OPSsu6mihkVmIZ8gEjkCteacyWyvHsHl5UkcE5qpJCkkZJRPMPQ9KmotLHZRly6s0YHaKRR13DOO2DWkreZDgIMnuaxraKfzVDsCQoyM/wBa24kZV2nDr7Vg79EaSaK9xtRVXrx3qAp8hUMfrWlJA2csMnpmoZIx04qJIlSVipG4BbgFsYBx3pt1Msu0OqA8FiKkdQGDOu1s8epFVETzp3wRkdAehqlvY1stylIivPjzCEYkr7/WmeWkf7pUBkZgCwFXGhEB2T43jJZsc4qKJ0dXLDAYfLgc8961S11CUrrQnadjIFkjVoyvUdBjis/VElt4buSNIpJl+7/tDtn2rSt/LVSjb+Y8ZA6nNLdwRK0jw5UOoGzsfWt46mF9bHO2ttFd6ejWYdrmLrI4zuI6nHpnPJq3G8dhYb76RHMWGj3DnexVc++MjHuRU7IlrBxEy2yqS4TkyvnIzWbqd5aX15daRfQqZYobeZvmJAyTIy59lUDPqaznGyOaq9fI2dHubmGaRJnEcsKy7ZJTnyLfdkyE92J6D1Irnp77z70PGiq8i4hUDqeeXY8s3OSaSKVdVsZHd5LcXMxuJ1fO4Rp8safiTnmkOnyOZHaSQuuDGegTjgge54+lKzasiadr3ZtwRhLeIFQAi/P7n6/jSz3a20UyEbVxtIU9fao9Pado2e4wskaK8pPKgKf8e1JmOaORnIfcNxx2zwKt67HStNzV01VZEZl3xjnkdu4+tNlDwu3AeIt07gdjS6c6wQGEnawXgH+KnfbIpXC5COnzcnrRGGmhrFtskuLUXFrJJCCuAN49R2OKdBCbfT45knIR3wB2UjHWmWl5HCXIJUdiOc+30qnd6rEqLEqMYyWZgedp7YrT2abuNqV7HRzW032koqg7OQw53DrioLjcgV7f5GGCUPWsWz8SuG2yFQV7dc0+81SGQLLGwJBPOetW6aeolCSdmdBFNAsoeNgAwIZR1BoaVWJ2PiQdM8ZFc81yWbzBhSR1B61El2zsMtjnBJoUGNQXc6eK9jKvEVClujdh9KuRXkUcACYBx83vXItfxwwkZDMD941Xj1uJpwUBI6Eg8D60/ZsfsIyO6t2jkhfyyM53Zz3qxJdMIQyr1OBjvXF2upiMhUkGHOTWvb6usgVQeg/io5LGc8PZ3WqNSKOKN47lmDKzMOTwGpussk9qsSgbZGDE1Tk1W3EMkW1CCQ4K9j3rOk1aBoQz8BRxzxT5GyVTk5cz6GhczMBE0eFABwCc/lSR3YkAdthXbzj+tYV/qsbRgRY5GeO1Y1reyNDMU65I69vpU+zaZ1QpKUbs6ppohMcgiPOTiq0l4ouvnZdr/KsZGQV7k1z0OqoiAzKWbpxTrvVtzK8MakJ0z0qORsqUFsdTPMgs1a1fy7EKQXY/NnvkdzXN3Fyi5ZlDCXkAdfZawbu+nmmkmup12hfuDgAew7VStr15nS5ndwsalUU9Mev196U4ufupGHKo9Tpg8BnillVpmDAJsONpPtTr9F0+APNmBSSdiH5yvoPc+vpXNnWzCyG28ssDnJ/nVeS+R5T5koG/55JmOT780nS6ETab0Zv3F35zmRYVCBNtsi/djjHQH39azNStzBfMltP9nhmiILLyX38AEdwCevXish/EcA3Pb7vITgqO47c1Sk1wStE05Mqq67UQY+8w/SplB2sZS0R2Wrx2sV/sljT9ykMUzbck5jUbsDuCMVx6ajP4eQLZKlzFJM11LbSpkSQsGTA/ulvm/Sq1x4oeLU9W1C+ST7XeNJDDCnMYAPGT2AKim6ddPdR3+o3Eb3TRxo2yIBW8vJyB3wB+VLldjjk+5kzRXE/jOG3s1S3tB+9Mr3BIS22hwxU9D2PqRivTvAF+uo6HrBhhS3v7dWuZLN3/ANW+4MWQd1cfkTXn8McSXH2yS/swk8DQ2yEBJZ4D13BvRuODgnNdxounRWlnBqdtMiObSOJFKY805IZWHuBUxTTuZvUyrNBBrZvYW8qJlyYmGc5PK/XmuyiYi4HmRIYyN+d2PwNc8kOy9lmgiP2YHd5LHJUH0/GtycxSQIylhkjII+7Sj7l7nbHWxatYEfeZXPX5ABworQUQyNtKgIpB3KPvU2OLy42k4dSoUbehp9tIYiERcMeShqpIpyuyxb+SJiACwPA4q9HKQQysMDjbWcVLNiPEUucsPWrKKQAN+4k9v1rJ6aI1sX97MTv3KBzg1SmcCUsnSrBjMZBWQuh5we1Vp1Jf5Vzu9O1ZyXQaSuWEjW5g3OwDjJU8nPtWBBvS5ldx8xOQeo/Kuig2oiiT5IhnkcE1lNGpLkAfewGz0FaWelty4ytddBH2uhYuBJnkEdqy5d9pIGRy0bjDgdx3FaTkIrDdx0xiop03RkcEYweMmqtfckghU3BCrhEkYBSW6Dr1qR5ZJJIleYsgIG7byuP6VQaMQrhG+VhkhjyKmhaIyYDsycbsdh3+taKQ3Ykv5Nku0P8AugeAOQTjrXFWrGe5upo8F5cL5j9Si8bc/wCeldVPIjgrg4IO1e4HvXPwac7yLeInLAKEB429wfelUTdkYShoS6bbzTTSXmBFEzfKhbcvtgd62llUWruZI4gLhFdwfUH+tZ+mXD/voiqwujlAgGSe42n0p8aCaeVJ2EcUyiPYo4tyDlSx9Sfx5pxXu+ZzNWZekmLQPbwrIqK3mtuHLemR6Y/nUMMsBgkXY6AlVO7qD9OwrGlu5bOdkQswTho+/wDverfhVOfVomaN1Zgy8vu9fUHuK6KcLvU3g0dELuC3zEZN3PAY5I+lY11flZw4BIH5gVizzuQZIWe4RSSwVsOv1Hf6is3UNZt0tfNMrsoOfuHK+2RW6omyrqK0O5t9ahmtBvlBXHBHBWsu71+GMGJm4zhW7GvMtZ1uKe1aaw1ywDDkoIyrgehFcDeeKLwySRO67ehMLHB+mabcYbmMq67nvE99BE++G5B3HpnkVXh8V6batIt1cqpPRs4/D6V89T6vObkvbFoY+0ZcuB+dQvqV26bWmJHHYVn7aK1SMnimfSsfjfTliCzXihoyRjOPxpbfxnZtPgXcTRvjDbuhr5x026ElyxupFLud2+XnJ9Ca7DQNHMuZrRFkGMbl+cAe3PFCr+QvrNj2OfxHalSVmUqeSBUNjqcN/DJdW7tEgO0Aj73qSK89j8GTTZH76IsoUhWYZHrVweF5o1VYru4gMZwWSRgWA9fWn7eO9i44y2x6QmvWkUD4lDTRkA4q6+v/ALoGORPX3ryGbTLm0nLwyPvkOCN5O4/jWfc3t3DMXgkmIYsvBAAI4PX3q/rEXui1jUe2/wBqSunLgK4yDnioF1XCskhjCoOTu6V4wbvVbjb+9mO3jmTGPyqe4GpLCI0RnOeCXyPx9aFiIIcsYmerRXzmYqXIjPOWPygVFLqcce94p8x7gST0NeTyDWZIfKedo4SfmUNy319qztbuLiHTDPLJIgh+SNVc4LdiRU+1h2M/rXc9eTWS00qsSozlcHsfap49esIy6S3CKoAXJ7mvAx4jWWyjiZ3hkH3mwTu992c0x9YRTzdbm67gmSfz71PtIvoTLEtntereINEWFljvzNcH+PIEaf41hXvjO38qO3JSR1XH7tuF/wB6vI7nX7tw6wysEb+8qk/yqg99dOxZriXcep3YzS9tFbIyVZ9T1y78c6dZ2/ksWmkI+YRL8o9s1my+NbCWEmV3AYf6tQa8+i1zUooBCl5L5X91sMP1qg8jO5ZzuY9San2zWyJ9oejweKftMYitoGWPdnGOn1NWGv8AzIJfM3cccHvXmCysvQ/rV621ae2j2xqnplhkirjWX2kaKpF7noEdxcXU0PkoW28FWzlj6/Suh0631KPVrW/ExW5gO75Tgbe6YHYjg5ryqLxFeoABcSKPate08azQIFYsy9wBjNZynGRo1GS0aPVtQ0S11bzLq0uFewQ+Y1nIoMlq/fDdWU+v510urXSQDT7U5EUdspWMfejY8g/livKdH8VfbNJlksFna/hbdLEqj/VdMr6nPWuu0/VJr9La6u/NMs8fzDaBtk6AHv0rnlBrbqEIrS2qR29vqzTxK+Al4gCsQPllX1+tdHp92gd2ubVZYplw0Y4wexFclZ28UbRSKxZ2QB15+Q11VihWMKgLA9GNTFyW50umrbFixcxoYCGOSDn0qcxO05lYHMY+YZxxU08qLEpxmZQPujg1bSImLdJyzj5j6Ur62BJbtCQrvbew+UjrUoEcTACTLKMj3pyuqRPk5A4GKPKhdFlAIcD8xU269R9SSMrLMGjkzkZYdMU+YBRlcY45qGzCLP8AMcRsP196tXLJ5e4AbQPSoYS3siFJWkkwzZ5wuR+tY9yoEsqZLFW+UgY/OtO3AEQ3qwA7+tR3KeY80giwwwVA9APT1rRK+rKvZ2KLg7CW+bJB9qguJVRShi+c/MGB/Spyc+YPKOSMgHtVWYII2xkMSflJzii99RSKM0RkT1PXp/Kq1s08kzu4C7TgHpkVduLoiBY2XAQbVJ4x9Kpo8TpvycgfdJqrApaE0q/uj5YVWKkEj9aCIrWJFj388lVOKzrnUHidOoiIPKDkH0NQXt7P9idolydvDI2Np9cGrir7ClCRDqh/4mR87KGbHlxxg5fjGPb61ieINSbTpCqsgjXqA2VVu4Hr9agv9eRtMvIrbzG1VGRYkicNI5bO5hjPygDnnvXKHwl4jvcGTNmjLuxJITkfTtWsKdyY4e71NCXxhBchFtpI5ZYusbuFbj+645/CubvPE0SySMGcpuyyD5XQ9ztPWrlx8LNUWxa7U20u7Ko+WHz9cV554i8Ma7pP7zULWVof+eqfMv446VtzTgtiatJU1zJXOg1PxvKIkhWSG4Rf9XLHuikT/wCv9DWBP4s1PzQ0N9cPkfN5oXk/h1rnACSAOvpXceF/hxq2uJHIFMUbc428gVlKrJ9Tz5VDj728nvZmluH3uxyeAP5VXAycCvoK1/Z+kOiSX010SQdipuwzHuQMdBXVfDX4K6bZOZdQBuZyfvOM4HtWbd9WRc+V1t5m+7DIfoppJIZYx+8jdP8AeUiv0Hsfh3oEUag2KN7kVoN4E0J4/LbTLd09GQGlcZ+cop8UksRzG7ofVTivurxT8H/DurtB5Fhb2roeZEjAyvpiqM3wO8KtGq/Yi20YznGapWfUenU+StD8e+JNGjMVrqMkkJ/5Z3AEqj6bun4VsN8WfEjDDLpx+totfQGq/s/6BMpe2jlhI/hBrGi/Z+0641RzELtdNVgP3rASMMc4I465quV9GNRizwPVPiB4g1AYNzFAP+neFYz+B6j8KxNP1q+sUKRSBoydxSQbhn1r61074A+H7O4mb7ObiJ4Wi23J3lWPRwRjBFY+o/s7aasaG2mfcMA5J55pNdbhaPc+fYPHF2m3zLGwkx32MufyNap+Jsyoog0WwQgYyzO2T64zXvDfs7aAFBDXBYdTu60w/s8aESpZrgAejdakVkfOtz491aYtiKyjB4AWDOPzJrA1LVb7U2U3tw0gX7q4AUfQDivq3TP2d9CS8ka4lnmiHKp0/OtCX9nvwuyHbHOpPTD9KLhZHxpg04RueiN+VfYsXwB8P28sToXIX7wZc5rvdP8Ahj4ctLZVj023zjGSuTQDsfn2QQcEYNKwIOCMV9x+Lvgt4f1mB9tnHHJg/NGMEVxvhj4GeF4NTa11mCeZm/1ZZzg0roR8m4pK/QCw+EfhTTLXy7fSYdh/vLkn8683+KXwh8Oy2U01lbJZ3KjcrR8Z/CmtRN2Pkepra3muplitonllboqDJNd7eeBrOAAG9YOOoUZP5V0ngrSIdPmDxwHbjAOPmPuTW8KLer2NYUpT1SOb8M/DDUtRaOXU2FnbHkgcv+XavUdK+F3hy1iVmtzO2OsrZzXRWDRGRQm5SezVsfZ3VyJVKOp6V0KMIK9j08PhIrcw9O8M6fp12kmn2kEQB5ULgNVltI8jUJL4RqXL79hHyj6VtnCHG3nHemSyOIyYZB8oztIrGrVTVjteHjHVBbo77JryNIXPzYXuK27ECQ/KCyHkCsWxhlmuDLI++Pbx7Gte0kdI9gXAB698Vw8zlqzGVJLYvQoRKVCYQ8c1pRxtJGYzw/c+gqnbtgFTwBzViNpCy7CTk9KSOWT1sTx2aoVMRyT1FLtVPUADgY7VZhAKglduf0NOKpnLAsT0IqbdiebuUHuFt5S4j3xMMZx0qOW4WaHaFHPWrF4gSIgH7wzVRY18kHgc49KUrpGqaauWJJTNKU/5ZqvHoDUMrB0YpuJA3ZHc09xknY27HAIGM05M7SJFJ9FWquK1tirchpGDEgZXB7ms6dFDAD5h7jvWzLEWfYHG/O5j2HtVVoGG4SlW75FN3ZDZgXtqkkbI3L9V/wD11kssykQxktnPysMV1M7RhSsfJ6dO1UhKXkDZV1+6FPBA+tESoNnONY3ku8xo8YBAUswAB7k57VXu9GguoUeaWS97NBG5WMe59a669t1uLY28qq0Lrhhk/wA6zZLCBUSIO4xhVQN2rRSeyOmirvUisbK2021Bs7ONLrlFEaABRjkepq3Eoiw7oZrvHO4ZVB2qWCL7MGdTgkcsTz+FTROBHtVvlJO5F6k+5rphVsrM6nGPRHHXlxeRLJFcq/lBy0aKvUmpVjNtHFNeNGkU6kqG5z+FdHqllsaOCNQ9zIMlgc7PYe9U/wCybI23lTN5kiH5m6iMelaJq+5o5wcVocReeEtC1y586w0ofa4v3rPbR8qRzk44/Oug0LxXNogFvd6XDdRDgSQsEfHuK07rW72PSbrSbD7PbWMSnzZlTDY64LDrXkbG/utRljMriIHjau3IqJQ6s86eFp1JWase1XHxN0g2flizvYXIww2A7R+B5rp/CXiLS7y3VrW4DjuMYZfqK+dRa3KrgK7nH8VPtmv7K5E1r5kDp82+Nsf/AK6ycU9iJZV/Kz7BtJkdA8e10PGetTb+OvWvnLw58VNc0lhb3dpb6hETuywMb/8AfQ/wruYPi/pkmxbiwu7ckc/MrgH2xz+lZtNHFUwNaD2PSlmDyMPQ4qzEATkivPtB8b6RdzS4vEBdsgMcGu3sr63nh8yORWB6EGojdLU5505Q3Rck8vB4OaZbqhUD7oHaql7cBInfPQdqdpcvm2sTE8sMmjm96xPQvSIgUEVC4Tqy8D0qSRgBjINVbiQJExpzdkIueWrLuGOahkjCnBFSQEtGvXp1xUV3cxQhmnljjUd3cCmrNXAWBF3noOOlSNGpUiucfxRo9tfSfadUs40CgAtMOTUjeNPDroTBq9lKRxtSUZoWvQfK+xpTKEBzU1pMJIQABkcV53q/xQ0OK4a3jeUuvUhMisofFeztonWzgmuJWyFBXaPzNVyO5rGhUlsj1tyDmuZ8UMkKJcI4SWJgwNeT3/jjxHq+8w3As4v7sZ+b8Sa52+XUL1gt7eXlwTyQZScVapPdm8MBUke4XvxD0Cwswb/U42uMZMMfzsD9BXj/AI7+I82sTvHoto4jI2rLOMZ/4DWLBpUHmBHRVcnGe9aY8NSSofLjRmHfPBFbQpJarU3hgYp+8zzy2sZoLoyXynczEsxGOtdp4f0xb1lS0m2yuR5bg4BPoc1am0JoV2XO7ZkDBGfzPpWpptvHoWqWqOEutPlQPxkcHqvsRVOUlq9juVOFrR3J5bW4sLpbXVrZopcfKwGM+47Gtuzn8lWSci4gxxvG1h+NTWEM0ty8NwZHhPMAmOdi9hmrctsBFjAde64rGdVi5lH3WRrCktvhBuwM561T+yjd03Y+8PaprCZIfNTB2k1LGA0jY4z39aybTQ/avVCQKF4wwjx2qdI8bXzipdu3jjkVV8x03leVHXNZzZPNc0YSQygY565rZtEkRRwCp6EVg2UgmcMOw6VvwSjapDfIvWojscdTcthACSTjI6HvQiFd25uPbtT0kR0z1A4pzkcYHJ5+tBjdlKeLeQSASOw71Sc7WImjIK8qQK05CrOPUc1VukLrz36molqaxl3HR7cEfdXHLDr9KaMMrFAoAH51Jbtk84IAz/8ArpBBidSjbh945HFUrhfuRoFUiNE3beS3rULgb2DMPTj+VXYYsmT5lAPygniqBBSQKo3g9B71QtzL1UbVaRNqFTghe9Z0M26EEovPHSrurMwuGLbSO4HQf/XrPZsyII1J78dBQ730NoJWLDyGQsuew5+lRsFMxZuT97A70qYf5gM7uvFDsfPOOFK9uKV7G0XbYcsbErlhsGSB/Wnyxqpwv1GKZK42qACCOmBULzPCNyrlgBkUKVjRTbLSwlQzB23MCOOoqo6xwRb2XFvGD8nPzN6mkF0SEJ+72buDmkn3ynMROFJHX9K1VS7sXq92U2tkOnQ2cLBhMxnuSR6H5Vz+v5ViPp0NvmZogC4IBbtz2HeuvtYhBbSbfmYDvgZJ9KxNTgldYo5NwaTJRs8HnrXXCpF7kWu7nPR6aZbtAhH7xwAM5zngZ9OtbN14che7eGzLu6ErvOACRxx7ZzWg1slksTxoj3IYMGPOAB3FJbwSi9kSHMu23VvLY8gsMkj1raEIbNhOtJapnL3fhG8t40uJfLUyuQihtzMB3x2HvUkegNImWUAjjGO9dhFItxqUMrPukWNQ5Yfxen4VfukVosxR+UQPvdQTSVJNnRHESaVzzW88MFNuUcE9GxTrFtR0tgLO7nwRkhmJUfhXbvGWkVpZcjbkgjGDVK5sHidSQBnkEYOaznTS2OmPLP3Z2I4PFmtOm144mXbjK5Xdiul0Px61pEq6nYTJAoAEkeGI/DvXLiG5eRzs2IowC3T6iobw3FtazrIVmXB/eIPlxUexjuzmqYCjUdkkeiXnxN8PpAWtpLqaftH5JX8z2/WuZ1P4jaldR7NPsY4QefMf5iPwrgygWGF3SQCRggkCkruxkAnsatypdxRMY22MeM/ex+FVSoKo9UcNfA0MOrl+a41nUSzXmr6hknJVZiqj0AA6Vmz2ErPtkeS4cHJMrk5H4mtWwDtEg8xXYkZYjk1fVraGZNxJbkD0NeksMlHRHje3jz2Wxytxpke9laBApGenSsybTraU+WY0Z1HC45r0C/sQ7K9uAVdeo/h/Csi7s7m1kiMsTxbzxIY8B/pWE6PU9KhNS2ObttNiZxtjVNnqMVPFbZuH3qBzjkcZ9jW9c2guoRLakNu4YdDt9qrJaNN9ns3UgO+xNvXPauV6aHp0nHdiQ26n5UBwOdvf8K2Fsy0QZF5B4yP61AkL6ddwtOm6MfeTP3l9faurYW0VzEbJjJayjyQjDrkcH863il1IqVEtjlpLK2jcNOuSxG7AyPY1u6dEIlkXjEbDqeHU9CKgit3kgmEyqViONwHIzV/SNtxDar1dGMRHcjsPyzS5knoY1XdFXVYUuxGsYTy3+VueVrOtUhaKSzuipeIgRyHvjpWs0MUz3MSLiMMJEcnn3rPvYvm2/LgHr3GKxq1raIiGnUvwy4tYy6nchIGecj0pzXAeLKsQcc/jSaOPOswspMhViOnTPNNuTGkz+VGNnTB71yNXjzNilJO6KkcXls/GS3U1dsY3dFVMM4OBUF2x8pFUgcjmpbGRogj7T1zzxmsr2Yoyb1LUpZYir4yDjnrVeTBJOenUCl1CVixdsBT90U3yzyDghhxQ30LTaWoy2cRXSujHHcV1FjLvjyEGO49a4qOUi52qOhroLC6KN8rZB6iklrcyqxuzoYZUZCFIUZxt71JE+wbHO70JrJilSeUhUYYOc1pQAAt3z2obMHGwjyLGxHDAjOSaqXVwfKJU8DrV+SJTwR24NZOoADK7jnpx3qGVBJsnEskcWR8ozzg/eqxazuc/OEycFapqdvBCnuPepIm8pS/GTkEGquU1dFiaQS4UgZHA/wAazL27MaqIiQhP41PI7BjuX52GM+lULuMmZCsoIHJ9BTv2KhBdTNnwzAMTljzx1qvPPtmcAMqggYqeaYeeFLfWoHZG3A7icE59DTvZaGvKSLId4OT5ajqKXG+LzM/NkA05Nu1E6Keuas+QnmGMFccZPYjFQ9QTSKzkNImCQcEetVJ2ImQZ3A8H8qsTDa5V8IMkjFVryEeTkFsLyeORmquUrKxBIXBPyAIAAQOufWrsBTyyIxyOfpVV5wIhHCoO4YJ6Gn2bBIW2kj09aasNydhzy5fjcxB7H1psiOEYuuOgBHQc5qJZP3wzu5YAkHkCrFxNIwIEbFVJzg9RVRk9maqSuiwhjkjVLkldx5x3qwkMwlaaBT875J3YwoGOvWqtrPvYg4Zc4GOhFasSsVMYH3hg+/tWsKulgnFDbXw+zySXJJiZz+6K/wAQ6D+tXUjmEKwzhIkChlkxkfj6fWrslyEiROQIl4APb2qeyuvMdYiu8tHtIC9frXRGoovQwdSbV2jlLSKSXUp5WkUkMFG0ZBwMZq5rOkCWCWWJz56BQoxxxW3o1kqWPmOMGRiuQOhz/Ko7xJTBK8ZyZJWIUjkgcZpuab9TX23v+69jCFi7xKJX+8CFC96yW0oi2kRpWUIPlA6mu3stOMjO0gI2Q4Ht71njTZlWziD5kkGHDDoME/4VpzRKhXSurnMGyY6XZwQ79nn7nByFzgjOOmcVQvtDuru4iWBGXcWdQO4A612dnayCTTPMVjyMrjjIJ6VovFLZ3aSQYEhR4umSo7Y/A110aqjsjy8wjKpL3Tz86Zc6dbRSudizMBHt+8Tk8e/1qPWImURTRrIFiIWXcpyrGu5vdQaXTUdY/wB9FhQdvyjBzx6HNYtxevfIUuFBLbc8YDEdK6o1rq7R5P1WpJ7EnhWISQEktKZAdqjqMVo3SCTTUZ8PJFnmQdMijSBsngbKxeTyMDGeMU+DBF0kwWQMARnjua5J1Nbnp0KMou7OesIDcq4CL9niyoXHRsfyqrqekNEfMtslo3STjnaR1P51pW7yabqPmJGn2SbcGUnkAGr/ANrX7HMwiIErNgE/NjoP5Vze0ja0j1PZuLuit4hjt5NPtr9VjHn8nb055/LNVNLlV7FIlKpNG+A3p3Vvz4rS0qICzuba4SPywCYg3OCcH+lRLHHaXKxwnCtENxIxkEZ/LNZTqp6iSUU4Fcsy3iRhC6zArJt/iJ7+9PuQttJIFGyMEZYkfLn7p/A5/Op5iVuVbaxSP513Acn+ID2znFVdScCNjuUc7Wzzx71hKd7hvYfcMHKFY0GQclTgDPFZd1I8HIXc4yH+tJ9omYyrGMog3LlgOO4plxMPIDqCrSN161le5lPTQuaTeC3vUDtiOVMDJxz2p0zbonLYOD1A4FYjhgg24LKQc+lbMU6XFksajBHLepNSr7MwTs7lba0s2yEEjjOa1GAKRoeMNg56DiobG33CTaMHG/8AKnXcqylkQBQF4z3/APr1CVjRauyIL0gbDyw6AGleUyQL5WdwzkZ6GoL15zbw5RUdfmVh0YVnxszPJ85T+Ie9JtI35dNSwCDMrnPzitSwdPN2thX7Y7isyyZZJoyoyoPQ+tanlhZAyfe6g4pruRJ9DYctCQY2zv56dK0bQ4jyz/N3GetZK3KeXGr5C/xH0pBcYBP3hnj3pu25HI2jcmlGME/r+tY97nzAwNIJJHwM5470x+MbvvdqzbsSo8hfiwzZbjj/ACKkjfK/vQCAeBWZBdANhweTjNP8x3lKpkg00rBy6lu5w42s2OPzrIu5Bbr7sMmrdw3lruPToKxrqUyYfAIPH0oehrTVyMRs6ksMMRnNRvGcoc5YnaRVtNvDHk45zUTMzh1K4yeCKdrDctRyj5SnA2jOR3qT7RtMOFOe/HX61BbhpIlTI25x05P41NJ87mKJSTjGD3x2peYW7j5QWCFHUYOOfT0qteIAw8okkjBHoKkViLfBUhgcDI6GpoFJXMuM9fp7U76ifumO1tMYicZdR1PaoEkKtKMliRnJ4wfat54jsSM5G7k9D9RWbcWghlJaIoB/Gecg9BVWtqLmvuV7cGSfCsTnAz0X8fap5FEYK7iSTgp6fQ0sLbUcMuGPqM1SvpZmcSKuRgKSBjPGKfQjmfMaNhsUuGwEXoM1es5w4d0LM54+lYSkggY2g/4Vs2ojUKFYA4zg042TNXU0uarS5QRgIZPvHHenwXRCM6D5VGA/cmszCykEZRvryKsKVVDG0inIJGT2quZtj5o2NGwvZreEoZBypGCOlWvtGYsSSsQCzZBGACOtczJMyktvfdnG0HJ/KnQs4i/dsz7+xGeKqJbhGXvHYz6hGLd42LASBI846gU1ZInAklkJy+Mg4KjHGK44XpEjxZbfjJXn86k+3Ou3jcQdw2/SjmI+rpLRnSQ3aGS1dQdsJKf7vHQ0SXi/KwYvtfkkdCBj8ciuba7ZlVhKYxIcken1qhd3p3FTLtBOD7+mKtVXHVDdBNnTOIonZMKS54A6ZIqlOYQw2/KuR2xjjBrH+0SsqSJI6qME4PJ/Gj+0DhVYAkn1qlWm0HsrM2ImWMo7SEqE+fb9eBUi3MMSKwJYbuBnBxXPnVVDMJJFQEYIHIzUP29i7CJt0anOcdfpUOqzRU+50AaJ5WaQKfkZBk/jS/IJ4yyj5cYx3OKx5brchwuCSMMf8Kal1uuSQ5xjnPbtU89x/M14rxI7pDKTsI3Bh2POBVeS+jgdSVLup3EZOCPSqLPm4BPJHAyevFRzruKkFiqneVJ4z6mpWomompLciSHcibQDtKnqPp7VluXedY0XzOdojxyRnmnPO8zrChXzJWwCDgcfWs293RF23DcnVehBxzSaMXKxFcu7AoAV3MQHBztxxz6VJZu13MIs5WNSS2eMVRW6VrdEbaqSMpJIOeeo9xWhptuosywDKsh+UHvimkmc8p30Jp8yQ4jOSPTnp0q3oUexbgyLglflB5JqpE6JJJGp3bx91RjH0rXs4jGgnwcJg7fTPFTe7JWxLazGM4UYLJt9hSXGyRFZcDJA91NEgjS6Egzhhkr1x/jVNoybhiFGwctjgBiaT0OiMVuPudzWaknCqSAM9BWTPjzlAG1gOM960pdvnFD8jM4UDPGO5qrNH/pgEhJCkjPpWco9TRMLWEwMsrL8jHr6+tbCyExIccDI4HasqN2MflMCRk9KuxNthZQxxjp6mqizKae7LJmbyvu9O9Sw7GA8w4qoGKwjcxG4VIPlVcng9qJJ7jjLoasbKsYx19KiuXAHGD6VDC7BAW5Apx2SfNn8KzfYzloyuIQ7byWI7DPersJiwAz49cmqhwQhyV7/AFpjrjGOe/FaX0GrslvphIVRVO0dPeqEw2kYA2k4xU7MVfn5SBkH1qpI+4p94FO+aW+5rDsRxlpHZg21OmAasQwkMvmMWyMDJqvDtkZ+AqjAHvVlnEkgQk46cdcUr6BU30GSjc2IlI+facGrMKhCspV1kGQeeAO4qEt5bNGqHg9RV+6KNAkqNtBBUg9QRRbqK70RSZw0zhD8gXgEY5qZCE2kkNuOCPWoYgyuAA2AeMjOTUreS4Rhu4449aLCkPCqJTIhJReQvp9aq3a748sx54I7H8a0IsxhmBDLJ8rc4xVfeGjWIABQeOOKvSxmncggjUwlJBl0PIbrms+aBBHJuUlgT6jHFbEwHm+YRyxAIXHHHUVVn2zW4KkGUnHA5474q0S0zLjLpGA4ZWUbgfrU9tKoUyNIx29v6U+6BiCMCNmcFlHT8KqXAUsX3b0P8YH+cU0SmyykrM6uv3x3Y8E+lWGuyjhHC5z87MMfhiuWa9ltZGIBkUj+E9al+3LGkwaJWckna+eM9TQa2Z0aureZIsibm5XHQD3pPtYhzESWcDd8vGFPesqxuVlhSNkVGJ4fdkYqSeZW+c4QAdCD+ntTT0uPn6GtG7NH5qkurc1TuJXJQA7F2kLjp9TVRpJIo1Ds4jX5lI4AH19KYfOnhD+TI3fdtI49/UVT2tYFUe5IZWRtpJ83HV+M/wD16rTtHesVVVibPOCcKB2GevrT7uZ9jQz/AHupZuo44/Cs6W5dp2eQIXVQCWPUfnQ1FKxrCbbuaoEwbbbSOICCdzAAsPT8aQqsS/OjZ6A5zWfbzrLEwJHOQqk4pXGxGdlKp22DKgexosmtBSqO4+4iRgcqhT723OCc1JZOE2qYY+BjAfI+lZLTG4GVCLE3BPJxnvT1trmHDKWZGfCbVxvA7iloh+0b3ZrC4JuPMQhVb7sec7OcYqaGZJJiseGZfvZX+tUIJVZDlMFgDu7rzz9auWrAKzIwKMSq4PzEZ9Km9yHUaLQud0pLjCkYGBT5JYVKjecA8qDg/jUC7AoMikY5Hck56U24+W8kiMbHZjeVAI57Aip1Ic77Fa5d2HLhSB07jJqS4SLzljwZGB+fBA3EdeaglSGeR1KTuo5+U4O7+VRQBkQoJNhPHTkDpT2IlJyQbTcTR4hWNS2xI/vAL7n1710S2ZRAkQHy/KSepJ/lVS2gfzUkGWwN2D14HU1rwbtjGRvmIxkjue5ovfczjFoz4dNMMxZCWkIweePyrcgARpVdVYNFwewIqtbxG3G5skkBhzzx1q0SQzRHAd+FA7Z5qLm1mykwMTbyDggAhj0z3FEe5QzkZ3HnHt3rQuIVkkRHXfJjBB6cdMVj2UhJMbxfOcgHPB9DTb2NE7oQTb7gvtDMcjJHAFQKpGoJvwyByCParUCbCzlcCRvlHTOOtV2kU6u6xqQvB9ualvqx3tsSxRrCDIcZLkAegpYlCSkjlS3FW5Xjz5bLnrgjoap28u5lQZBJ/SqtqZczYu4tMyMCVA4qUNvIUnAFUbpnR1kQ8ElSBUlvuDAv3oewluX97kFAfoaUbliDN19Kj8wZ+XgY70yaYHgEc+tZMJaonc7iMckCjzFU7S2WPeqryGNVOQQPaqUczly3JYdM1di0nYt3Ugjk2jO31quztvIDEo3HHWqN9O4nQnt3FSWU+ZiQvJOT9KT3NoqyuX1XKnBbarDcR+tD/JK7DruIA74p4kTe2FOf503yjJO0gGVyCSTQyGySGNvLUfMSScnNWXV9hjypBH5GoApV345yDk9x9KsxukykheTjHHTtSWmg2+o63yoLEltoIPrj2qeJY1AjcAhlyD+vFQ3YIBU5wMYI4xUSwySbSd5MZ4OOn1p7E8t9QIHmSYyOeOeMexqJB8qy7g7J0C8A/T3rQjdo0O5A4X5tpqt+5z5bY2s244HQ+pqtGHkVzdJIH3oy4A+baMr/AIilUY3om11UZVsZz7+30pkqDaFBz361DIm2UsIjjGSQKpMlxvsTwqJI9zAY5Uh8kf8A1qz3gngkdCu3kABW25HZsVHMZ3bKysFUj5R3P0pX89iAoL8/NGwOUz3H+FTzIv2NtSI6SJ2m/dAkHlVfDZ9eetMNi/lK4BkiHAEqZCn0zVhi1sY9zqyFu46Z96uW/mXpaNbhymdw3jgfWrUiZwa16GatofNAhhjwxAxsCjPbnNWo4ypK3kcsbdCqchvpUyWbsZFj2zY+ZtuAAOvXtTYpP3bZf5WGWRs8jtzTTIcLrQie2aBlCxsi9QMhganCXLLtmE5wu4Lu24HrUkcEO9xbKsqBclpn+VSe4FUp4ZI+NhyePMDEKT1yPaqtbqCi3oE/lNIzhW3AAtKwAK8c8f8A1qzzDBKsjx3NuGdum0sw9gcd/etNLK/uczEySOw2glgAfbmlVFhfylVYZ+MPvHAPXtRc0ULFCOzVbeSS23SELiQ+UCFHtVdNL1EFYSLhhIuY0CYyPw9q25LVyGiiaJipxuQ8yH6GkjjjjTDSsJd2Ni/MAfcg8UXsLlMA2HlMotg91hdxTaV8tu4564qwMSQx+a0jMnzDLEhfWtULvlaSUrJbRtwqvgsT+GcCoJLFSzHzHCZ+bPzD9OtJ+Q0l1K09jLLGscO0M2dzFSoAxwaSO1KKgeZGZMDK1pm1aG2eUmTDcI0hKqfXikS3MVo8jXMaGTHyKmTipl5k20M4yJkbjucnAOeAKtxElSAuOOCoxj3pYPMKmN0II42CMdPc1NBaNgu5HlDAyOjH0qQ5e5EtqfLwshJIwT93jPaplsxuXyYApI2rjqf/AK1SrbFmXg7s/LnngfyFTiFktt3msJOSXPQ+wFHqS0IESPaok80hOSeBuzU8TFmLFm2g5bHOT61Vjlg82ELmUhgpBGM/UVeghcTusjbBvy2eAo9KL32HyW3JrTdPKVdgSOCvUk9lqu0e12aRcvvwGB6Y/nVjTRDFKEDhQpLGQ9D6YqlqV15OxpG+U5C+569qLXRcE+ayLdxMXeDLD5924k4A/HtWYyjzAvdckDOeOoqed5Nkca4Jbkg+hof9zer8h3EE4HqRSauO3KiOQqYVQPlioK+xNVQy9B80pcc9+KkmkCyeUg2ruB/GoYov9N2tkYOMk9KCdEi25bcWwOnpVcFRtPKnPNSXxkWIMDhQ3J9apiYqokboW5B7VRlfsOJKowODwSBnpTLadj97kZ/Koc5c89fWmRMcnAwRTkiHKzN6Jt2OBUFwgeQDtUdpKWQVXu7h0lPGRWTJcmTSS+awHO0daVfKL4RcHvUMNwhUhQc+lRm5WO4+71po2u9hmorum3IMBflqK3l8uQ5z6VI/7xiwbFVokD3IPXB4ptdS4z6M1FcBg+SWPBA6f/rqxA4ILk9uR0qgXIWSMMM7sA1LAszKpPGw4Jx60JDbNISmRhg7ZEByfXvUgDFV6AjuKpiJ4gzN93PPuRVm3kABRWPzL+VIL6aF5Q0jRCUnZtwaepNsXeJw0eehPX/69U7GXcVZn3FcjBGKtPHFNJ8vyEdQTkZxkUJBboyEXAAklk2h244P5cVHIY5FyxZWU/MGHFTSwwzIBI4ifnIP8QqmASoibflXzluKbuaRSYuSnzjBXnnHTNVbiR2m4lLR8e2atSQpEw815FjfnIbOM0ySHy/kWQB/7zelK40ktStcfu1llS3OxsYbOSKLRFu5l2zkMfullOMj36/jVnyXYnMomweCOcHHQ1JFFhWYh5CB/FxyP5+lKV7jvoVha3YZok2NG38JIYdeuakezeP76oVUc4OcVqDYYc5XLDlSvB9qFzK5CIY1UENjkge9NmbmzO2RiBiyHIAwBz+dSJGUdJDBjIxnfz/kVMIXRZcEJ7OeW9OKiTT7y6nY3DiNFHBBwc/4U1cNBZbS2eVkeeREC5yycn2FQW5aCRmhlZSeNzJ8wHtWhaQRCLLK0mCR5h7/AEFTT2TYkknUcfdJkHye3X9KvV6grLRlFmiNuFl86V2GUbaAVPuf6U66vJWg2ypb7+B5jxZY9s571JFbbYjLuALA7iKdBDctKrxjK4+RSmcHoTmmrlWRQln8mNVAGxRwTblfzPeovMeWJPs6CKDPXGz5vX1NbizzqAHlO4ceW8eVA9frTntzNImdshGeQM4/wp69xJpboybTbbgRxxxyXDclzlj9cVHMyw+ZKU/efeUzZwD9PWtOGJI7pgXbvtZRyB/hUqqbgsZZBKzHADAfLU62C6vcx45Hnt/tFwJWkI+RTEDjPU/4VZW0t8sZEcHywAWPQjrj1NaEiGNGysmxTkc55Hbjt7VSkvWEheZSYFBVQowFzSv3FrL4UVjCIowruWdiSFxjI6flUckXkAKzKkZOPulvoasmXBZyuSSAW64HY5qw4Ey+b/q3YbBDnJ47+/1ptXB3RTt8ohRyEXr16/hSO6mJhEiZLArj5iSalldQFVUAXATJGe/Ump0hiNwsMR3CP5mI+XPapSJemrMyK08u4Ys7+ZnqvUHv+FXH3vgsBIxYBQfX3q5LERN5kaGJQcHjk/SqcEP+nFZWdRGSUIHFO1ioy5tWPS3kjdNxDtt4A4BYnpVLVrZp3QshEinhVHGB1JrcIEM53Mu4IHJI657Cqd55iW53IoHOJM4PPUZppbjhN3uULbKbWDn5/vEjr3wKZdeZJdRrExYqd+R1Wp1dXQRMWRTmVTjqegGadc+TCkcihhIQo989DQE3qZtzsRhJ1G7qKpyzlpH3SAuWGSDVu7bMsY28hdpJ+vWse9CC5/cIodn+6DSsZNlu7nyFjLErnBqJZCI2Z8E+nf61UuHPyhB8wPIPapUYFJH4JxzmqRyzeoyS4CuWY8DgZp3nALwck89ayNQmK/IQWUnOR/Kn27Z24yAfWlJq9gnpG7Ois5Tt+UdKS8J2bup71TS42RkKcNUM15mIhjzUuNjFzbRomYJkqevWomKFOB8+c/WqC3JcDBBqSefYBjoOtNRNVU0LLv8AKTjGabAVMhVSQzHIqos4lUqpGPepId4dWBAxTs7WKUtS8jEFg/JXpnrV8XAC5UZLL+VUFIGSQSWH40lvOhCANlyOPalaxvF8xoyTORk8L94jNSQsXTcwxjJyO2feqzyI8+wnk4xx1qxYSCVZIgrcEpyMZPt7VLWpomki/Gw2Z2ZZumD0qaJ18xB5ZPz5JHqPrVO3ZFl8mcnAHU9BWvG6C33lCVXHQYzTSvqDlYGjjdNsDlpQdxB6r7CqckaRs8rszofv465q1ArNdF84ikAGQODzRfMqkrG6bupUetD2HF2djPYOcKQJUbnkdvWq+AZA5beM8GrzhGjXzWUbfuDOMnjjNV7lhG64G05wV9/Ws7dTVO+hPGgAOGwSfujpToH2lio4JwD71WSZCXUq7HAKnOAP8alXCoxxl0I4HvVIlruaHlCKDzZV++P3ZpsLiC33nKFmIGDy57fhmqt1exPFHAjhbllbKA54HSqqXccdrG2GkdW2OhXOcdP5VpFdiVBtam5HKVhl+XD4wzgbifVsntSTxTbGUyAoTsOVxu4547gfrWfZ3byW5MsZUTMQQDjK46CnxX3n3EKxfL5I2FdvEfff7mq0FyNMvkpa2bJu/fqBgkc7iOntxU8KstuGvYl+cAozck/7oH8zUU0CIvkFQWOW3l8sx6nn0PpThOotmleMhSmw59j2HtVEbosSJNcXEdtb28aJt3EnCnjqaWa3Zm8yABcMCOOo75HTFS28+x8hA8rMERCfxP6Yqze30hRPLVoy/AXBZsjvjsDT0MnKSaSRn3LFGi3BguCfMxkD2qGVEVExkgglS6kBiPStOa4H2VGjt2uGLBSHJAjPt9fWqV6sskewTrhDkIR8wPqT69qdr7FQlfQoWbuflMBExIKlvun61Xij2y7SCVLMWI7H6fjU9msj3UgjzuZlZSAABgdvxFJfRSfaVmnfbLKCSRxzmomjoT1sRs/lTiGbcY2xknrx6e3Sog0VwLplUnbn5c9VB6/lUqgTSyq6cBMZzggY7f571kzQzQlCjMz7WJA6fT8ql+RcYp+poXMSCOKQZwzZPlnHGOCR9RUMpy5lDfMrBsnjk1SjnkWLBlTC/KDnHyn/AAxT47gDyzLgg/IVXq6nuam6ZTg0Szybn8vb99iD/MVJZyGO5kMLjc688cg+9Ubu5L3G6GNgo+UE8lRnvjr9avBVbbKgBQsV3euByKLailFWNaCQFCu1vPQAxhj94+tS20YW6eR1YsoDbWPGfT6Vj3M4jUMHG5BncDnaDWvbkT6VG1s+1NuXbHf61UX0OWcLK/cbPCROm84LOP4emRVTUYfOSAxncqHbnseeTU8LedHBE+FL7v3hOenXNRuyxI2/5fLU8njd60bgm4mXdbWkKklCwYqvY571SmdsozHbERwzcnNW7fE90xHLlNgB6iqetRjkO7ER4AB4HHcULW5beqRRnn/cbVO4KSzSH+VZe1muGc9iMGopLiU2blJTtDcgjriqrSu53IMdCcnj8KmJlVdie7uB5zqMHHpT45GaLK4wOOKz5Wjlk3DJfcORVu2BWBySMZ4zWm5wuWoy4wwVcDA71CcebnPyjpikkdYgdz5579qrxyhmIJxjmlYmdS+hdacxqcDr1NZt/dZTCnmm3M3JXd8vbmsbULwQq2TxjvTMZS6HQRzmNwWBwe/pWmziWLrnIrn/ADAzbd3JHFXbeVkjKswb6UWNFIvwYMZVD8wqWKQpKqsevesxrkKcryCOR0ps10WVSpHB/KhLQrnOna5KBMt04qnAhN27rJgt0HeqXnO8PzOORwDSW11h1xwRwfehm9OpY6BiHZSxw4XCj1q5ZR+XEC2TIx+UA1QsnG8tKN4I2rVpZ8NnLHacqByaykjrhO+iNtbVH8tXLZb7v+971YlZoIlGd7E42dSPSqFpcCZ1LPswOn+e9Wk3GfvuxuIbjj/Gi3YpPuaMZ8qNJcqCTtKkZ5qO4t4n+dS29QSWOPmPTgU62MRhW3VchvmJJ+6ameJfJDLujQLhz3YZ7fU1bV0JOzOdkEjCNCp3bsLkcVNbiXb5sm3cGK5bkjHatQZ85ZEiUsxyAeq//XqlOQHdcqMZZ3z94+lZuBtz30G20IFzGr8opwx9fT6UWsfnAx3GPKDEB/u547n0FQNKUjEcCMRHw7Oc5J9Pwp8bq8m5y0cMagHCHLsT29PWrWgkmxnkxQ2q3iR7mRN0j9xz8pp1tLPfmacfvBtYOyjHBHOR6e9XoYfLtJD8rx72UKDgEDJzVLT5okuNqxsFlj5VRwoJpvoXe6dtyHUluFsIVEKxBc5fk7ecg1bsrlJmSSSMJjDHB44GCAKsJdGWOS3M6kI4JPUn0qBclo0WNZS4LAA7cdhS6he6s0XYbt1jWZ5S4mYhuM9O1aqq12LlgHKr1ZBhc8Y69fwrE062klcyB/kjbYwVuPfA9/Wty1mje3idoxIATHFEr/KvHOPU+prSLsrnPVsvhLLCUxQTKg89XUEgcIOn61Z/1c7urM8UihGDHhQM9D2NUwII7pbi5I+RdhTedqY9D60jyPeB98WUj+cEDjb2/OmYNXFmuna3je1faAx3MD8+0dO3pUMbrJGJoZY1jY4YlfvYPrVn7Y8KNMqGPcCeBjyx059axoFF66nTJB5crZdDlVHOd2ewziqS3LivkX9XiaWZfs0aAFNzY6gZ6+30qrM32i2iZ3DgnkscFcDp7ZNSC7klWSCVQjB/LYqc+ZjoQfQ1UuWzdCBNsagF2HXt19/Ss2aQT27DIZUaV1YFSh3Enn5e+apTq3miKMu8aybd5I4/Cte2iWNVeOXcpfZuYYGTxz61RtpHt5WglETYG7fjuO+Pp61Jqnq7HPSQ7r15GC7EcqcD+nfIqzb2jpdPBJwT86YYEIB0Ga0r+0tJIVnQBXkk+5ETx+Hb1rHs/MP2mHzIwqMV3ye3I5HelZJm6nzoml3NcloYxHKMEqv8WeDj2pxdlikDDayHcoXk5x0qISo10izDc21X64yBn+lBhl2IGeJQCBv6tkk/ngUXuO1tBZpBLFvi4M+RknoOOK07eNhZRwZYc7mAP3hVBLQpMWO4o4Kg4Gcdq1bYOsiQyb0DRjey+meMexqVF3uzKclayJoW+0ngkMh279uBtPTI/Cq+roquZwNxCYZgehJx0705yJJtg3KGyQd2Dj/IqCRncwpIcKxO7BHzehzV3uc70d0ZCE281y24rKGC/QetM1N1+whY4920FASeST1z61FfXcG93AZ2B2tkc46ZPtVKa+UwiN2bymG1OOtShyvuyjLMkapHsXhecDqawXu2a6aJMg7sNjoBV26nMruqfJsI5HBxWEZHWSTarEk5Ld81pFXRwVZ6s1kdV85jkAdB6U6e7VYlGOFHWso3MaRHcxYnjANUZtQErqMgEdhVW7HI2a3nCRgWOT6Uxzs+cnkVRW6jjhMrkZHTmuZ1zxVDACrttPZR1NCi2S2dDd3qKd7MAq+prjNQ1CXUbwpEf3C5ya5e/wBdvNTm2LIYoc/p71FPqnlQeRbHnu/rW0IpK7M5Xbsj1KPUQsYdjkfXpVuPVF+Vt2VPNefNqskOSg3Ieoq1b65bPtUyBSeMVPs7FKZ6PHMJE3A0NhF3Z69RXN6fqCqMq+V9M1cmvlIHzYGe9Z2dzS6OiiuWQBWwRjvUrs4dCGwuckCufhui6AKQMng1o287SMys2SRj0oQ07HSWdy62+A+QnJB61p212ryFC+DgNn29q5m0ldJOXwwGAvZqs29xsdjt3MVPHU/hUzi0dlGomdhZrCjg5dixwcfwk9DVgT+TcASFyd+G2ngelZGnu0cRnYlkIwSOo+tX4wktskwO+U/MOetZNXR3Rd3c3YJsyq4QnIwrIPvc8/jV68iaS3jgDDa7DBLcgdcVk6TPhgjSbP6fWtR5U89UV2yv3TnhT7e1NO6sRLSWgRzbCUBUYUnHcY6cVDd24MMTuFwoIcjnn0P1/SqJa5mvlMIxISwBx7/MDV6R2eExORsBUrhsY9se9aNaWKs000ZcsTRW2yBSNpCgMMj6VdYSJJEjRqYnBVznIZu30pbiRpOGU5TIK9ASafBIwXczfMh2/ODnGO/rg8VKjrqaX0HKmwSW0QAfOCFOQAeuDVZlaKXEBOxejEZOB7fWkjkW3lupY1dlfhs9ecd/Y9KqRPJEzru2qJAdzdWA/h9s0OxSTLccHlwuVby2JLj39j6VAsqi6QOGSMkM74yfyq9JMWuJpkUmN8HYAMAL0pJZoN6BWEPmKSzMvQk9adtAjJtl+0ngjRFhVWnYFg6NjKnsaS0aOO4kBmZFTdgbQMD29s1lpNb277WRJiVLRyA/dOf51e4ltgIWy2/IZ+wPT8BVRfQzcbavqaL7UsIDOWWQEbJVznOeBitC2L+VGioyLI+0gHsM5zVF2nnt5ZZmUOiADIBU/wC79fX3qDSp7u1+0Nsk2MS6nHJ9snpVOyMWuaLNPV1U2oiE6tbjPmFlyxI6D1qGFXtbOCOGJImdeXHfPbHpVPVbppoXVS8cA+eQ7evt9Kk86Z4vtG5jAMRk4AAAHU/X0obuiVFqKTGToqbijbrl2EakHAUD6+3YVSu5FHzbQrIfmBGD1+9x7U3UkubiYyqwihVwxBOSuR29zSG12tK0/G9d20nOOMD8fapa10OiKSV2ya8uFjtgQhkDSKQvXH+1iqkC+V9qluAjDb8oGcL6c9qr3kkiBGKFYnXywC3zlR7e9OkndNMi3Z8hUPyAdxnA9/rU82pajaPqU7G8uL6ONcZLdP4eB/Kljt445md0BVZC7YXHzdOPwosyCfPkYr5o2tGoxnvj2rXubgFY4TCqleNjcbSRnr9OtKKvuVOTjLRGNfhWN3IzQf6Oqsu4bQw6YA7n3p1sVaxtTIcgk9s54/lVbWf3lwNpwv3WIXknOVHtU6ToqFBGFVMAkg8gkcexzSkle5f2UW7a5W5YImVkjBLAjhR0H1q28nlTr/rCmxR5mM4Pt9KzILRYL2W43mRUHIBzn2960Vux/Z8W4F13MSpGMDufeiF9mY1Er+6FxKWlUeYw2LtOeh96xbrLSwlG8pIWJOeMqeOK04QyeZNOCodh8u7BUMAfw4xWTfbI0aJYwE37jk5P0z6UN2RFtTNvgollWclXYhwo9OwzWVqNwVO1WVVDhzu5+v0q1eyM0+YmUhGBZj1FYGqzIQ+CNzP06cVUVc5q9Tl0Kq3TF3UECVjk8dPSqtzNDb20sjOTt69gTULu0PmXPXIwc9a4Hxd4kYzpawMPLPzSH+lbxjzbbHmSlqbR1AyP+7Y+WctkGonvIoUZ3kAHdmPFcM+vSqCsSjHbPSsu5u57k5mlZvbPFVKUUZqMmdHrPiiSUGGzJCcjcf6VzEsjytukYs3qTUdFYubZqopDgxAwDxTaKKm4zQh1F1OJBkEY4qtNsZt0Z464qClrT2jatIlRSd0aen6xcWhCli6eh6101prUF1bkeZiUdAeK4bNKCQcg4NCnbRicL7HotlrmyVIZhtGflbNbsOo75W+bCjkGvKPtbOoEnLjo2av6frMtq4DNuXODk1ryReqJ95HtFvdrJCrEjcoyTWnHMjLEyZOPmrznSNajfbH5mM9PSuktr+MwoVk2OpwAeM1m4O9jSnOzO/sp2jEhnAAcA9KvadPEFc5KnqqKO3euWguTOhIYZJ9ccVtWZHl7t5Eirg8cn2rCUbHpUatzqFkIIDEMHAw3+NWURxcJFMSgwX54x+FY1rI7bEcAkc7T3q3NMwfcclRhdxPJzWb7nRc07eQRXDNMch0LhjzyP5VaRnuFlRtyzIwIVhgAdiD/ACrCSSWS5MQeExqcAHv9W961IZ23ruXKMApZX+5jsfUVadimiS8UT5QSbS7hc55JHU/zqsZd2y3W5bCnaWAxnHQ1PdoTIFQjfHk46qwJ6inEq1zbPCqAKCWVh6dvx9aq407JDobM/YGEO6UygsWZsFWDZz7g1naq09siyGKNgxWT3IPUg/XtXUXskUNpEsLJID88ZQ4yf7rD1rHlkKQeVfQsoRgwZz14+6TTaVgp1G3zNFG3ie5niUXUhQHcw2gb884Pt6VekjDXavcQOYnG47eSGwR+HaoUbyZozEPKA+ZCR1PpmrsshmiiLwukzZz82F9Rgf0NStrMcpO5DOqCeKTyneLGx8EA5xxxUDgK7xoXC7tuD2A7U9p5B5qPhVY5EbLy3rg060uYYHI2NLHtHzsvRieMVSZOtibTLmWO7Mcbu8bRnCEDKHuQavQXCM6hI7iR1xGpCkgn8OKyJJo3uFSNXRtuMj5WGT0qOaW5SS3FtdRgMp3bZcbgOxp6icU/I6HzH+yqrXFtKrE5VVy2B69qps5JjiCOCpO1SOV467fXPH41iQGaKWSOS5WJVBUQwANtOc5JHWrou4oVjlZhcTTFgXkPzEjueae2geztsXr+cy3KoxwGAHDDAx2z6UkkL27QTErLOOE3fKvrk+tQG5tjAsVtEJIWbLOi/ePpu9OO1Q3Fw5jEhiVZHcYCtuWFRwPr9TUuQ4xeiGQ2iyTEhw8rKWYrknOOn69qZbyGKB0uI2JgPTPyn0FaFhM7zTESMCwJLKOpz1PpWbDJ5zTgeZuVyNzDC7R14qFYq7d7hPMBEzoB5JdY2cjAz3P51ZuSsaRZLSFiBuPAz6/lVdx+8dQu4KFlMY5BJ6bs8Z9aR9y+YJCN8a/KgIAZjzx/hVWY7bDLvZEgeHABbJLDlv8AGop4IpbMyxswjk+Y/N9/HNXI4d0jTnJlLeZtOCPp7UXcKSRBYJvLRzhgVwuepP51N7jUraIhS2VbOS4uJGSBoxiEHlm55qHSbeW4azhkfZFglQ5zhQc5NRPcST3ItxIJbf7qs64p92/lw74js2fIoXsoHNDa0FJtaFm8u45Y3dy5dnByP7o4+lYNyXlWch5HIbgZ+9np+NWbmSV7NJFB8sgnaByRn0rFvNQWLciSeW6feB4IbtS+LcybUEVtQYW8MokLbxjIb1/+tXL6hKMBXRjzuDZ61b1K7WaPbI+SxJ3N3rzrxh4m+zh4bcjzvurhs7fU1vTieTXqOTsHi/xUIbeS0tmHnEbeO3v9a82dmdiWJJPJJpZHaRyzkljySaZRKV9FsZRjYKKKKgoKKmSF2XdjC+tRHrVOLSuxJpiUUUVIwooooAKKKKAClzSUUXAt2l21urDqD09jXS6DrrO4t5tzA8hj61x9PV2RgVJBFbRq23Jcex7hZ3SBEkhl3JjJU9zXSaXqSsgaSYFh0XHANeG6J4lltJgs5P2fuFHQ+teo6DewuEnt8OjDd6g+tOai1uXTqOL1PQ7W/AuVaRSsYHLA/drVYq8RkjcHb8y5rihcjeWR8ALgg85PpmtnTr8/6vnngrXM4HbCqmjQlJLq+7bIrHcmOCfWtO1u0wCZPmJwSo4z7+9YHnNHPuYrtBwQR19jVi22QFvKUqSC6lRkE56Gly32O2Mk1qdRLcRllk2ttIK8HJx2/AU1b3bKJkRfnOBHjKE+nvWVb3xSxG4K6qDnYPmU/SoolWd2kgLpIWDfe2+WfUCqWhSgnub0VxBiSKYhT12AYK/Q+mKklU+a8dvukQrjbIQcfSsW+E8gWKQs0gJBZOMj61XsRKzf8s/KQ4xy2fbmhy6DUNL3NWW4Uzuu5otnOE5UGppLgzsykOXbgkOOo5zg1TkdEkJZl2YwFxyB6e1VHumMUixglg2M+hoeoWvsadrMAIftnmvGrMNy8Yz6elVZ5YvtEhtpSB1CHiqX22R4nMsbOeRkHqR0JFZ9sZJZI5ScuVPTAB+oqb22KUerN2TdPxuGWGGbd0+neojYRrGWTyXnOGJJwWA61Uubh0JX50mXhx1Jz3qOKWaO3ymFYn7xx096rRqwXfRl2OaWDMlqnlwjlpN3JyOhHenaNIl3CTfSrsYltz8AjsCo6f1qjMzmzRGRBJnliSfoadpyxxwIrx70BJODtLN6/nS1LuuXzNuMG4lDwyPCE+UAfLx/u9qs+YsdukT/AHGyxkIwWI/QVkSXD24jZx98ZEn8x+dR3krO6+XPsZcsN7YUHuP/ANVEXdkWv6HQB4vLYiQq0gCxoTjOOrfSo3mjkM0duFeTaFYDv7Vk2sjsHYqPPc4Z5OT0461atv8AR/MigTE0xw0gwxIxz9PoKL2JcbFoSpDFICBN33A55HG33FWkVFy9zsaUnOwDkcdzWT8n2xCikhBtjXOMEf56095ZpnYsiZIwCw4UevvRzcrsS1ctWRZlfgSF5DgbsBB3z+tLezpJCwT541bJboXfHQDsKxZpJVilCuI4TgBiOSPUU6C5ZfJMTB4lPRwMZPfNDsDi97l4sqQo0pHmn5sqRhf8mq148bxtudN7c9M89zTbqZXt9zPhC4DbTjBBrC1S+SPAYhUxtBHXPtSUeiMXO2rJtRuNkQxK6yLjv27fhXD391J9ruBNNuDMG27cDOOTmr9zeu7efMdikEY6vXnfjHxMbKHy4ShupDuC9do9TW8IdzgrV2/dRF4x19I42QOxLnACnBUV5xcTNPKzt39aS4mkuJmlmYs7HJJqKnOd1yrY5oxtqwooqxZwG4uFj7HrWaV3ZDbtqJb20tw22Jc84z2rfsvDxxulyQPXpXQ6HpkcUanaOa0L0pbwsTgYHSuunTSZyTrN7HFa1FHaQGMDB6YrnjWlrVz59wQDkCs4Ak8VlXleVl0N6KtG7G05QWYBQST0FX7TS57g8qVH0rsdC8LquHdCW75rLlY5VFE89oooqTQKKKKACiiigAooooAK6zwHf3EV48CSHyiudvofaiitKe5M9j1K3JJU7j83XB64rUsZHS74djx3OaKKJbF0jY8957MvJgsknBxSPPJHCGRyCMfrRRWaO+iXzIxgWcYD4AIHQ561MzldxwC2cZPoKKKUtzuhsWWkZplXJCqmQAeOatPK0EaCPAHHHrnrRRT6A+glyq/vAEUKCDgd6yNSdrZbhojypOM/Q0UUSCOxnPPIbSBixy7Ann2q1dfu7WKWP5WKc4PB5xRRSjqjWWyEiTcQxZt3TOal+44UD86KKEjJsknkcxMm8gA7BjsKYmVQruYhT3OaKKmW5S2LUX723kZiR5bHAB459amlQKYyACSTyRnGKKKf2QW5ZMzicQsQyhjkt1P41biJdA5JBBAGPeiinHcTG2i+fNc3MhJlX5RjgAelW4iJSqOqkScMe+B29qKKEjGZQljWQz7h9w4FZbtsuLiFAFjRlKgduDRRRbRibdiLVpGREC4GQWOO56VhR/PPc3D/ADPAi7M9OetFFax+M4qz904PxVqt1b27FGBIG8bh3ryK6nkuriSedi8sjbmY9zRRV1fhRwR3ZDRRRWBoKOTXUeHrOEsrEHJ75oorakZVdju7cBLfK9ulc14kuZAMZGM4oorqjucS3OMRRNctv/Sul0zT7c7Ts5xRRUW3Z0VHsjsNOsoBghOeK6i2gjQDavaiiuaZij//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A compressible blue papule is present on the central lower lip.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_12_1219=[""].join("\n");
var outline_f1_12_1219=null;
var title_f1_12_1220="Fluocinolone (otic): Patient drug information";
var content_f1_12_1220=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Fluocinolone (otic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/9/23699?source=see_link\">",
"     see \"Fluocinolone (otic): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/15/29938?source=see_link\">",
"     see \"Fluocinolone (otic): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8097417\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      DermOtic&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10031160\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691827",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat ear infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10031159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702137",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to fluocinolone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10031164\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701537",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to any type of nuts or seeds, talk with your doctor. Some products have nuts in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10031165\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10031167\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698659",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired, weak, or touchy; trembling; having a fast heartbeat, confusion, sweating, or dizziness if you missed a dose or recently stopped this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10031162\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the ear only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695296",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Lie on your side with problem ear up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705870",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Pull the outer ear outward and upward.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695239",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put drops in ear without touching dropper to ear. Stay on side for 2 minutes or put cotton plug in ear.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10031163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10031168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10031169\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11682 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-3548BCC041-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_12_1220=[""].join("\n");
var outline_f1_12_1220=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8097417\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031160\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031159\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031164\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031165\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031167\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031162\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031163\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031168\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031169\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?29/18/29987?source=related_link\">",
"      Fluocinolone (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?3/32/3587?source=related_link\">",
"      Fluocinolone (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?23/9/23699?source=related_link\">",
"      Fluocinolone (otic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/15/29938?source=related_link\">",
"      Fluocinolone (otic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/28/25029?source=related_link\">",
"      Fluocinolone (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?5/16/5380?source=related_link\">",
"      Fluocinolone (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/49/12052?source=related_link\">",
"      Fluocinolone (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_12_1221="Felodipine: Patient drug information";
var content_f1_12_1221=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Felodipine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/45/2775?source=see_link\">",
"     see \"Felodipine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/48/8966?source=see_link\">",
"     see \"Felodipine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F170350\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Plendil&reg;;",
"     </li>",
"     <li>",
"      Renedil&reg;;",
"     </li>",
"     <li>",
"      Sandoz-Felodipine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F15509598\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10011834\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691384",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help a weak heart.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10011833\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702106",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to felodipine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10011838\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take good care of your teeth. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10011839\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698094",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flushing. Wearing layers of clothes or summer clothes and staying in cool places may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in the arms or legs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10011841\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10011836\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow tablet whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10011837\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696480",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take more often than every 24 hours unless told to do so by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10011842\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10011843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11734 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-F9050627AA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_12_1221=[""].join("\n");
var outline_f1_12_1221=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F170350\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15509598\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011834\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011833\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011838\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011839\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011841\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011836\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011837\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011842\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011843\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?2/45/2775?source=related_link\">",
"      Felodipine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/48/8966?source=related_link\">",
"      Felodipine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_12_1222="Gabapentin enacarbil: Drug information";
var content_f1_12_1222=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Gabapentin enacarbil: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?24/21/24916?source=see_link\">",
"    see \"Gabapentin enacarbil: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F12924419\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Horizant&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F12732347\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Anticonvulsant, Miscellaneous",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F12805677\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Postherpetic neuralgia (PHN):",
"     </b>",
"     Oral: Initial: 600 mg once daily in the morning for 3 days, then increase to 600 mg twice daily; increasing to &gt;1200 mg daily provided no additional benefit and increased side effects",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Restless legs syndrome (RLS):",
"     </b>",
"     Oral: 600 mg once daily (at ~5:00 pm); increasing to 1200 mg daily provided no additional benefit and increased side effects",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F12805678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F12805679\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Estimation of renal function for the purpose of drug dosing should be done using the Cockcroft-Gault formula.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PHN:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-59 mL/minute: Initial: 300 mg every morning for 3 days, then increase to 300 mg twice daily. May increase to 600 mg twice daily as needed based on tolerability and efficacy. When discontinuing, reduce current dose to once daily in the morning for 1 week.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     15-29: Initial: 300 mg in the morning on day 1 and on day 3; then increase to 300 mg once daily. May increase to 300 mg twice daily if needed based on tolerability and efficacy. When discontinuing, if current dose is 300 mg twice daily, reduce to 300 mg once daily for 1 week. If current dose is 300 mg once daily, no taper is needed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15: 300 mg every other day in the morning; may increase dose to 300 mg  once daily if needed based on tolerability and efficacy. When discontinuing, no taper is needed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15 and on hemodialysis: 300 mg following every dialysis. May increase to 600 mg following every dialysis if needed based on tolerability and efficacy. When discontinuing, no taper is needed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RLS:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-59 mL/minute: Initial dose: 300 mg daily; increase to 600 mg daily as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     15-29: 300 mg daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15: 300 mg every other day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15 and on hemodialysis: Use is not recommended.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15896298\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F12924420\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, extended release, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Horizant&trade;: 600 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F12805149\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F12805146\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM250398.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM250398.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F12805685\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tablet should be swallowed whole; do not break, chew, cut, or crush. Administer with food.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Restless leg syndrome: Administer  at ~5:00 pm daily.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F12732261\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of moderate-to-severe restless leg syndrome (RLS); management of postherpetic neuralgia (PHN)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F12805162\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Percentages reported are for restless leg syndrome (RLS) 600 mg daily and postherpetic neuralgia (PHN) 1200 mg daily.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%: Central nervous system: Sedation/somnolence (PHN 10%; RLS 20%), dizziness (13% to 17%), headache (10% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cardiovascular: Peripheral edema (PHN 6%; RLS &lt;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Fatigue (6%), irritability (&le;4%), insomnia (PHN 3%), balance disorder (&lt;2%), depression (&lt;2%), disorientation (&lt;2%), lethargy (&lt;2%), drunk feeling (&lt;2%), vertigo (&lt;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Nausea (6% to 8%), flatulence (&le;3%), xerostomia (&le;3%), weight gain (2% to 3%), appetite increased (&le;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Ocular: Blurred vision (&le;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1%, postmarketing, and/or case reports (reported with gabapentin; limited to important or life-threatening): Creatine kinase increased, depression, feeling abnormal, libido decreased",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F12805155\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no contraindications listed within the manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F12805156\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Multiorgan hypersensitivity: Potentially serious, sometimes fatal multiorgan hypersensitivity (also known as drug reaction with eosinophilia and systemic symptoms [DRESS]) has been reported with some antiepileptic drugs, including gabapentin. Monitor for signs and symptoms of possible disparate manifestations associated with lymphatic, hepatic, renal, cardiac, and/or hematologic systems; fever, rash, and eosinophilia may also be present. Discontinue immediately if suspected.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Suicidal ideation: Pooled analysis of trials involving gabapentin and other antiepileptics (regardless of indication) showed an increased risk of suicidal thoughts/behavior (incidence rate: 0.43% treated patients compared to 0.24% of patients receiving placebo); risk observed as early as 1 week after initiation and continued through duration of trials (most trials &le;24 weeks). Gabapentin enacarbil is a prodrug of gabapentin and may also increase patient&rsquo;s risk. Monitor all patients for notable changes in behavior that might indicate suicidal thoughts or depression; notify healthcare provider immediately if symptoms occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; dose adjustment is needed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Sedatives: Effects with other sedative drugs or ethanol may be potentiated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Appropriate use: Restless legs syndrome (RLS): Not recommended for use in patients who are required to sleep during the day and remain awake during the night.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Discontinuation of therapy: To avoid the potential for withdrawal seizure, dose reduction is recommended for patients with postherpetic neuralgia (PHN) receiving twice daily doses or patients with RLS receiving daily doses &gt;600 mg (daily doses of &le;600 mg can be discontinued without tapering in patients with RLS).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Product interchangeability: Gabapentin enacarbil (Horizant&trade;) and other gabapentin products are not interchangeable due to differences in formulation, indications and pharmacokinetics.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Tumorigenic potential: Rat studies demonstrated an association with pancreatic adenocarcinoma (clinical implication unknown).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299374\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F12817729\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): May enhance the CNS depressant effect of Gabapentin Enacarbil. Alcohol (Ethyl) may increase the absorption of Gabapentin Enacarbil. Specifically, the rate of absorption may be enhanced, as alcohol may speed the release of drug from the extended-release tablet.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Nasal): May diminish the therapeutic effect of Anticonvulsants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Systemic): May diminish the therapeutic effect of Anticonvulsants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mefloquine: May diminish the therapeutic effect of Anticonvulsants. Mefloquine may decrease the serum concentration of Anticonvulsants. Management: Mefloquine is contraindicated for malaria prophylaxis in persons with a history of convulsions.  Monitor anticonvulsant concentrations and treatment response closely with concurrent use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F12805662\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ethanol: May increase CNS depression and cause rapid release of gabapentin enacarbil from the extended release tablet.  Management: Avoid ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herb/Nutraceutical: Avoid evening primrose (seizure threshold decreased). Avoid valerian, St John's wort, kava kava, gotu kola (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F12805151\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F12805152\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were observed in animal reproduction studies. Gabapentin enacarbil is the prodrug of gabapentin; bioavailability following gabapentin enacarbil is increased in comparison to gabapentin (Backonja, 2011). Refer to Gabapentin monograph for information related to gabapentin exposure during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F12805153\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F12805154\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if gabapentin enacarbil is excreted in human breast milk; however,  other gabapentin products are excreted in human breast milk. Refer to Gabapentin monograph for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F12805684\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Take with food.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322897\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, 24-hour",
"     </b>",
"     (Horizant Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600 mg (30): $137.26",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F12805687\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Suicidality (eg, suicidal thoughts, depression, behavioral changes)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F12805665\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Gabapentin enacarbil is a prodrug of gabapentin.  Gabapentin is structurally related to GABA. However, it does not bind to GABA",
"     <sub>",
"      A",
"     </sub>",
"     or GABA",
"     <sub>",
"      B",
"     </sub>",
"     receptors, and it does not appear to influence synthesis or uptake of GABA. High affinity gabapentin binding sites have been located throughout the brain; these sites correspond to the presence of voltage-gated calcium channels specifically possessing the alpha-2-delta-1 subunit. This channel appears to be located presynaptically, and may modulate the release of excitatory neurotransmitters. These effects on RLS are unknown.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F12805667\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Mediated by active transport via proton-linked monocarboxylate transporter, MCT-1",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 76 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: &lt;3%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bioavailability: With food: ~75%; Fasting: 42% to 65%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Prodrug hydrolyzed primarily in the intestines to gabapentin (active metabolite)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak, plasma: With food: 7.3 hours; Fasting: 5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: 5-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Urine (94%); feces (5%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Attal N, Cruccu G, Baron R, et al, \"EFNS Guidelines on the Pharmacological Treatment of Neuropathic Pain: 2010 Revision,\"",
"      <i>",
"       Eur J Neurol",
"      </i>",
"      , 2010, 17(9):1113-e88.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/12/1222/abstract-text/20402746/pubmed\" id=\"20402746\" target=\"_blank\">",
"        20402746",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Backonja MM, Canafax DM, and Cundy KC, \"Efficacy of Gabapentin Enacarbil vs Placebo in Patients With Postherpetic Neuralgia and a Pharmacokinetic Comparison With Oral Gabapentin,\"",
"      <i>",
"       Pain Med",
"      </i>",
"      , 2011, 12(7):1098-108.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/12/1222/abstract-text/21627766/pubmed\" id=\"21627766\" target=\"_blank\">",
"        21627766",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bogan RK, Bornemann MA, Kushida CA, et al, &ldquo;Long-term Maintenance Treatment of Restless Legs Syndrome With Gabapentin Enacarbil: A Randomized Controlled Study,&rdquo;",
"      <i>",
"       Mayo Clin Proc",
"      </i>",
"      , 2010, 85(6):512-21.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/12/1222/abstract-text/20511481/pubmed\" id=\"20511481\" target=\"_blank\">",
"        20511481",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Garcia-Borreguero D, Stillman P, Benes H, et al, &ldquo;Algorithms for the Diagnosis and Treatment of Restless Legs Syndrome in Primary Care,&rdquo;",
"      <i>",
"       BMC Neurology",
"      </i>",
"      , 2011, 11(28): 2-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/12/1222/abstract-text/21352569/pubmed\" id=\"21352569\" target=\"_blank\">",
"        21352569",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kushida CA, Becker PM, Ellenbogen AL, et al, &ldquo;Randomized, Double-Blind, Placebo-Controlled Study of XP13512/GSK1838262 in Patients With RLS,&rdquo;",
"      <i>",
"       Neurology",
"      </i>",
"      , 2009, 72(5):439-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/12/1222/abstract-text/19188575/pubmed\" id=\"19188575\" target=\"_blank\">",
"        19188575",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kushida CA, Walters AS, Becker P, et al, &ldquo;A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of XP13512/GSK1838262 in the Treatment of Patients With Primary Restless Legs Syndrome,&rdquo;",
"      <i>",
"       Sleep",
"      </i>",
"      , 2009, 32(2):159-68.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/12/1222/abstract-text/19238802/pubmed\" id=\"19238802\" target=\"_blank\">",
"        19238802",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vignatelli L, Billiard M, Clarenbach P, et al, &ldquo;EFNS Guidelines on Management of Restless Leg Syndrome and Periodic Limb Movement Disorder in Sleep,&rdquo;",
"      <i>",
"       Eur J Neurol",
"      </i>",
"      , 2006, 13(10):1049-65.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/12/1222/abstract-text/16987157/pubmed\" id=\"16987157\" target=\"_blank\">",
"        16987157",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yaltho TC and Ondo WG, &ldquo;The Use of Gabapentin Enacarbil in the Treatment of Restless Legs Syndrome,&rdquo;",
"      <i>",
"       Ther Adv Neurol Disord",
"      </i>",
"      , 2010, 3(5):269-75.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/12/1222/abstract-text/21179617/pubmed\" id=\"21179617\" target=\"_blank\">",
"        21179617",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16486 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-6C4A3AC97D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_12_1222=[""].join("\n");
var outline_f1_12_1222=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12924419\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12732347\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805677\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805678\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805679\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15896298\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12924420\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805149\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805146\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805685\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12732261\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805162\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805155\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805156\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299374\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817729\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805662\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805151\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805152\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805153\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805154\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805684\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322897\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805687\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805665\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805667\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16486\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16486|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?24/21/24916?source=related_link\">",
"      Gabapentin enacarbil: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_12_1223="Nail plate post-surgery";
var content_f1_12_1223=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86421%7EDERM%2F86786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86421%7EDERM%2F86786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nail plate replacement after nail bed surgery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Whenever possible, the nail plate is put back in place after nail bed biopsy to protect the wound and act as a biologic dressing. The nail plate can be taped or sutured in place.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Replacement of a partially avulsed nail plate after surgery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    After partial avulsion, the nail plate is put back in place and secured with Steri-strips.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Rich P. Nail surgery. In: Dermatology, 3rd ed, Bolognia JL, Jorizzo JL, Schaffer JV (Eds), Elsevier 2012. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_12_1223=[""].join("\n");
var outline_f1_12_1223=null;
var title_f1_12_1224="Pathogenesis of the hypercoagulable state associated with malignancy";
var content_f1_12_1224=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis of the hypercoagulable state associated with malignancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/12/1224/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/12/1224/contributors\">",
"     Kenneth A Bauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/12/1224/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/12/1224/contributors\">",
"     Lawrence LK Leung, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/12/1224/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/12/1224/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/12/1224/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients with cancer are in a hypercoagulable state. The spectrum of manifestations ranges from abnormal coagulation tests in the absence of thrombotic symptoms to massive thromboembolism. Thrombotic episodes may precede the diagnosis of malignancy by months or years (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=see_link&amp;anchor=H24#H24\">",
"     \"Overview of the causes of venous thrombosis\", section on 'Malignancy'",
"    </a>",
"    ) and can present in one of the following ways [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Migratory superficial thrombophlebitis (Trousseau's syndrome)",
"     </li>",
"     <li>",
"      Idiopathic deep venous thrombosis and other sites of venous thrombosis",
"     </li>",
"     <li>",
"      Nonbacterial thrombotic endocarditis (marantic endocarditis)",
"     </li>",
"     <li>",
"      Disseminated intravascular coagulation (DIC)",
"     </li>",
"     <li>",
"      Thrombotic microangiopathy (eg, thrombotic thrombocytopenic purpura)",
"     </li>",
"     <li>",
"      Arterial thrombosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic review will discuss the pathogenetic factors that might contribute to the hypercoagulable syndromes that can be associated with malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/2\">",
"     2",
"    </a>",
"    ]. The contributions of chemotherapeutic drugs to the hypercoagulable state are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/36/6730?source=see_link\">",
"     \"Drug-induced thrombosis and vascular disease in patients with malignancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The types of hypercoagulable disorders and their incidences and clinical manifestations are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/43/35514?source=see_link\">",
"     \"Hypercoagulable disorders associated with malignancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of the hypercoagulable state of malignancy involves the interplay of multiple variables. As an example, intact tumor cells may express procoagulant activity that can directly induce thrombin generation; in addition, normal host tissues may express procoagulant activity in response to the tumor. Comorbid factors such as bed rest, infection, surgery, and drugs, may play a contributory role and may determine whether an asymptomatic increase in coagulability becomes manifest clinically [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/36/6730?source=see_link\">",
"     \"Drug-induced thrombosis and vascular disease in patients with malignancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of the causes of venous thrombosis\", section on 'Virchow's triad'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=see_link&amp;anchor=H24#H24\">",
"     \"Overview of the causes of venous thrombosis\", section on 'Malignancy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/43/35514?source=see_link\">",
"     \"Hypercoagulable disorders associated with malignancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Early reports noted that many tumors associated with thrombotic complications were mucin-secreting adenocarcinomas of the gastrointestinal tract [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. However, many nonmucin-producing tumors are also associated with hypercoagulability and it has not been possible to purify a unique procoagulant moiety from mucin. The substances that have been isolated from animal and human tumors with procoagulant activity fall into two major categories: tissue factor-like procoagulant and cancer procoagulant [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/43/35514?source=see_link&amp;anchor=H3#H3\">",
"     \"Hypercoagulable disorders associated with malignancy\", section on 'Mucin'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Tissue factor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissue factor (TF) forms a complex with factor VII to activate factor IX and factor X, thereby initiating blood coagulation. TF is a transmembrane protein expressed by some normal human parenchymal and connective tissue cells and many malignant counterparts such as sarcoma, melanoma, neuroblastoma, lymphoma, pancreatic and colorectal cancer, ovarian cancer (especially the clear cell variant), and acute promyelocytic leukemia (APL) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/8-16\">",
"     8-16",
"    </a>",
"    ]. Tissue factor expression may correlate inversely with the degree of differentiation of the tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, data indicating the importance of TF expressed on tumor cells as a procoagulant should be interpreted with caution, since the expression of TF antigen and activity depends heavily upon the source of malignant tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/19\">",
"     19",
"    </a>",
"    ]. As an example, TF expression is frequently studied in cell culture, a milieu that may not be representative of that found in vivo [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/16,20\">",
"     16,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tissue factor has been implicated in the hypercoagulable state associated with APL and, less often, other subtypes of acute myeloid leukemia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/8,21-23\">",
"     8,21-23",
"    </a>",
"    ]. Myeloid precursor cells from normal bone marrow do not possess procoagulant activity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/24\">",
"     24",
"    </a>",
"    ]. The induction of leukemia cell differentiation with all-trans-retinoic acid downregulates the expression of TF, cancer procoagulant, and annexin II and improves the hypercoagulable state [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/25-28\">",
"     25-28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one series, for example, plasma fibrinogen began to increase and D-dimer and thrombin-antithrombin complex levels began to fall within two to four days after the onset of all-trans-retinoic acid therapy; the values were normal or near normal by eight days [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/12/200?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of acute promyelocytic leukemia in adults\", section on 'Disseminated intravascular coagulation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Tissue factor-bearing microparticles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissue factor antigen is present in plasma [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/29\">",
"     29",
"    </a>",
"    ]. Some of the molecules are truncated, or result from alternative splicing of TF mRNA, and lack the transmembrane domain [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/30\">",
"     30",
"    </a>",
"    ]. There is considerable interest in assessing the physiologic importance of such blood-borne TF in microparticles [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/31-35\">",
"     31-35",
"    </a>",
"    ], as well as their potential role in the pathogenesis of the hypercoagulable state accompanying cancer, sepsis, and sickle cell disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/36-38\">",
"     36-38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Using impedance-based flow cytometry, tissue factor-bearing microparticles (TFMP) were studied in patients with malignancy, leading to the following salient observations [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/39\">",
"     39",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      TFMP were detected in patients with advanced malignancy, including two-thirds of patients with pancreatic carcinoma.",
"     </li>",
"     <li>",
"      Elevated levels of TFMP were associated with VTE in a cohort of 96 cancer patients of different histologies (adjusted OR 3.72; 95% CI 1.18-11.8).",
"     </li>",
"     <li>",
"      In a group of 60 cancer patients without VTE, a retrospective analysis revealed a cumulative incidence of VTE of 34.8 versus zero percent at one year in those with (4 of 16) or without (zero of 44) TFMP, respectively.",
"     </li>",
"     <li>",
"      Pancreatectomy with curative intent in three patients eliminated or nearly eliminated these microparticles. Microparticles in these patients coexpressed the epithelial tumor antigen MUC-1 found on pancreatic tumor cells, providing evidence that they were derived from the tumor cells rather than from platelets or other cells of hematologic origin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cancer procoagulant",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cancer procoagulant (CP) is a calcium-dependent cysteine protease that has been found in malignant and fetal tissue, but not normally differentiated tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. It activates factor X directly, independent of the tissue",
"    <span class=\"nowrap\">",
"     factor/factor",
"    </span>",
"    VIIa complex [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/43\">",
"     43",
"    </a>",
"    ]. Cancer procoagulant has been reported to be present in extracts of cells obtained from patients with acute promyelocytic leukemia, malignant melanoma, and cancers of the colon, breast, lung, and kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/8,44,45\">",
"     8,44,45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To date, only a small amount of sequence has been obtained and the cDNA of this procoagulant has not been cloned. CP is not currently felt to be important in the pathogenesis of the hypercoagulable state associated with malignancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Procoagulant activities expressed by host tissues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal cells can be stimulated to express procoagulant activity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/46\">",
"     46",
"    </a>",
"    ]. In patients harboring a malignancy, these normal cells can play an important role in activating the hemostatic mechanism and ultimately in fibrin deposition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     P-selectin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among these activators is the cell adhesion molecule P-selectin, found in the alpha granules of platelets and the Weibel-Palade bodies of endothelial cells. Among other functions, P-selectin increases the expression of tissue factor on monocytes and endothelial cells.",
"   </p>",
"   <p>",
"    High plasma levels of P-selectin are prothrombotic in experimental animals [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/47\">",
"     47",
"    </a>",
"    ], and have been associated with an increased risk of VTE in cancer patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/54/36711?source=see_link&amp;anchor=H4#H4\">",
"     \"Leukocyte-endothelial adhesion in the pathogenesis of inflammation\", section on 'Selectins'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Monocytes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monocytes constitutively express little if any procoagulant activity (PCA). However, they can be induced to produce tissue factor and other direct factor X activators [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/49\">",
"     49",
"    </a>",
"    ] by T lymphocytes, antigens, cytokines, lipoproteins, immune complexes, endotoxin and complement [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/50-54\">",
"     50-54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Monocytes may also become activated by tumor-specific antigens, immune complexes involving tumor antigens, or indirectly by cytokines secreted by other immune cells in response to tumor related antigens. In a study of patients with lung cancer, for example, pulmonary alveolar macrophages close to the tumor expressed increased tissue factor activity in vitro compared with cells from normal controls or macrophages from the contralateral side of the neoplasm [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Platelets",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased platelet reactivity secondary to either clonal abnormalities (eg, myeloproliferative disorders) or tumor-platelet interactions could contribute to hypercoagulability. Substances have been obtained from various animal and human tumors that can directly aggregate platelets [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. However, efforts to recover and purify the active species from detergent-solubilized tumor cell membranes have thus far been unsuccessful.",
"   </p>",
"   <p>",
"    Other mechanisms proposed for increased platelet activation in malignancy include tumor-induced thrombin generation, ADP production by tumor cells, and elevated levels of von Willebrand factor (vWF) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/58-60\">",
"     58-60",
"    </a>",
"    ]. It is postulated that platelet proaggregatory moieties may lead to clot formation on the vascular subendothelium, thereby stimulating hemostatic activation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Endothelial cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endothelial cells may become procoagulant under the influence of inflammatory cytokines and other peptide products. In particular, both tumor necrosis factor (TNF) and interleukin (IL)-1 increase the expression of leukocyte adhesion molecules, platelet activating factor, and tissue factor. TNF also suppresses endothelial fibrinolytic activity, increases endothelial cell production of IL-1, and downregulates thrombomodulin expression, which diminishes the activation of the anticoagulant protein C.",
"   </p>",
"   <p>",
"    By virtue of these effects, TNF is able to dramatically enhance the procoagulant and suppress the anticoagulant properties of cultured vascular endothelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. In one study, infusion of TNF into patients with cancer produced a substantial net procoagulant stimulus to the hemostatic system [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Whether or not TNF levels are significantly and consistently elevated in patients with malignancy has not been determined. In one series, increased serum TNF concentrations were noted in as many as 50 percent of cancer patients with active disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/64\">",
"     64",
"    </a>",
"    ]. However, other reports have only infrequently observed elevated serum TNF in such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/65,66\">",
"     65,66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Endothelial damage is thought to underlie hepatic sinusoidal obstruction syndrome (SOS; veno-occlusive disease of the liver). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/4/40009?source=see_link&amp;anchor=H3#H3\">",
"     \"Pathogenesis and clinical features of hepatic sinusoidal obstruction syndrome (veno-occlusive disease) following hematopoietic cell transplantation\", section on 'Pathology and pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Tumor-specific mechanisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain malignancies are more likely to be associated with venous thromboembolism (VTE) and other hypercoagulable disorders. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Certain solid tumors (eg, pancreatic cancer, brain tumors) are associated with a higher incidence of VTE. Advanced tumor stage is also associated with greater risk of VTE. A more detailed discussion of the tumor types implicated in hypercoagulable states is presented separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/43/35514?source=see_link&amp;anchor=H5#H5\">",
"       \"Hypercoagulable disorders associated with malignancy\", section on 'Known malignancy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Myeloproliferative neoplasms are associated with VTE and microcirculatory disorders (eg, erythromelalgia). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/52/21322?source=see_link&amp;anchor=H2181747#H2181747\">",
"       \"Overview of the myeloproliferative neoplasms\", section on 'Thrombosis and bleeding'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Trousseau's syndrome was mimicked in an animal model by targeting the activated human MET oncogene to the murine liver, causing slowly progressing hepatocarcinogenesis [",
"      <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/67\">",
"       67",
"      </a>",
"      ]. This was preceded and accompanied by a hypercoagulable state (venous thromboses), evolving towards fatal internal hemorrhages. The syndrome was apparently driven by the transcriptional response to the MET oncogene, including upregulation of the plasminogen activator inhibitor type 1 and cyclooxygenase-2 genes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/60/21450?source=see_link&amp;anchor=H19#H19\">",
"       \"Thrombotic and hemorrhagic disorders due to abnormal fibrinolysis\", section on 'Plasminogen activator inhibitor'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Patient comorbidities",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of clinical factors may contribute to the thrombotic tendency in cancer patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1224/abstract/68\">",
"     68",
"    </a>",
"    ]. These include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vascular stasis due to obstruction of blood flow by the tumor or patient immobility (ie, bedrest, hospitalization)",
"     </li>",
"     <li>",
"      Sepsis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      disseminated intravascular coagulation (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/56/8073?source=see_link\">",
"       \"Pathogenesis and etiology of disseminated intravascular coagulation\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Advanced age (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38282?source=see_link&amp;anchor=H23810861#H23810861\">",
"       \"Normal aging\", section on 'Hematopoietic system'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Thrombocytosis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      leukocytosis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/6/24681?source=see_link&amp;anchor=H30#H30\">",
"       \"Approach to the patient with thrombocytosis\", section on 'Thrombosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/43/35514?source=see_link&amp;anchor=H5789505#H5789505\">",
"       \"Hypercoagulable disorders associated with malignancy\", section on 'VTE risk assessment scores'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Certain antineoplastic agents (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/36/6730?source=see_link\">",
"       \"Drug-induced thrombosis and vascular disease in patients with malignancy\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Erythropoiesis stimulating agents (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38138?source=see_link&amp;anchor=H264001313#H264001313\">",
"       \"Role of erythropoiesis-stimulating agents in the treatment of anemia in patients with cancer\", section on 'Thromboembolic risk'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Indwelling central venous catheters used for administration of chemotherapy (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/26/27050?source=see_link\">",
"       \"Catheter-induced upper extremity venous thrombosis\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H781183754\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The spectrum of hypercoagulable manifestations in cancer patients ranges from abnormal coagulation tests in the absence of thrombotic symptoms to massive thromboembolism. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/43/35514?source=see_link\">",
"       \"Hypercoagulable disorders associated with malignancy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Migratory superficial thrombophlebitis (Trousseau's syndrome)",
"     </li>",
"     <li>",
"      Idiopathic deep venous thrombosis and other sites of venous thrombosis",
"     </li>",
"     <li>",
"      Nonbacterial thrombotic endocarditis (marantic endocarditis)",
"     </li>",
"     <li>",
"      Disseminated intravascular coagulation (DIC)",
"     </li>",
"     <li>",
"      Thrombotic microangiopathy (eg, thrombotic thrombocytopenic purpura)",
"     </li>",
"     <li>",
"      Arterial thrombosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The pathogenesis of the hypercoagulable state of malignancy involves the interplay of multiple variables, including the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Tissue factor is a transmembrane protein expressed by some normal human parenchymal and connective tissue cells and many malignant counterparts such as sarcoma, melanoma, neuroblastoma, lymphoma, pancreatic and colorectal cancer, ovarian cancer (especially the clear cell variant), and acute promyelocytic leukemia. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Tissue factor'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A number of normal host tissues can be stimulated to express procoagulant activity. These include platelets, endothelial cells, and monocytes. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Procoagulant activities expressed by host tissues'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Certain malignancies and advanced malignancies are associated with increased risk of thromboembolic disease. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Tumor-specific mechanisms'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/43/35514?source=see_link&amp;anchor=H5#H5\">",
"       \"Hypercoagulable disorders associated with malignancy\", section on 'Known malignancy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A number of clinical factors may contribute to the thrombotic tendency in cancer patients. These include vascular stasis, hepatic involvement and dysfunction, sepsis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      disseminated intravascular coagulation, advanced age, thrombocytosis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      leukocytosis, certain antineoplastic agents, erythropoiesis stimulating agents, and indwelling central venous catheters. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Patient comorbidities'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/1\">",
"      Levine M. Treatment of thrombotic disorders in cancer patients. Haemostasis 1997; 27 Suppl 1:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/2\">",
"      Dipasco PJ, Misra S, Koniaris LG, Moffat FL Jr. Thrombophilic state in cancer, part I: biology, incidence, and risk factors. J Surg Oncol 2011; 104:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/3\">",
"      Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 2005; 6:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/4\">",
"      Young A, Chapman O, Connor C, et al. Thrombosis and cancer. Nat Rev Clin Oncol 2012; 9:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/5\">",
"      Amico L, Caplan LR, Thomas C. Cerebrovascular complications of mucinous cancers. Neurology 1989; 39:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/6\">",
"      Pinzon R, Drewinko B, Trujillo JM, et al. Pancreatic carcinoma and Trousseau's syndrome: experience at a large cancer center. J Clin Oncol 1986; 4:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/7\">",
"      Edwards RL, Morgan DL, Rickles FR. Animal tumor procoagulants: registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society of Thrombosis and Haemostasis. Thromb Haemost 1990; 63:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/8\">",
"      Barbui T, Finazzi G, Falanga A. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood 1998; 91:3093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/9\">",
"      Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983; 62:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/10\">",
"      Rao LV. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev 1992; 11:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/11\">",
"      Callander NS, Varki N, Rao LV. Immunohistochemical identification of tissue factor in solid tumors. Cancer 1992; 70:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/12\">",
"      Yu JL, May L, Lhotak V, et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 2005; 105:1734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/13\">",
"      Uno K, Homma S, Satoh T, et al. Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer 2007; 96:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/14\">",
"      Khorana AA, Francis CW, Menzies KE, et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 2008; 6:1983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/15\">",
"      Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. J Clin Oncol 2009; 27:4834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/16\">",
"      Yokota N, Koizume S, Miyagi E, et al. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. Br J Cancer 2009; 101:2023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/17\">",
"      Kakkar AK, Lemoine NR, Scully MF, et al. Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg 1995; 82:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/18\">",
"      Hamada K, Kuratsu J, Saitoh Y, et al. Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 1996; 77:1877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/19\">",
"      Zucchella M, Pacchiarini L, Tacconi F, et al. Different expression of procoagulant activity in human cancer cells cultured \"in vitro\" or in cells isolated from human tumor tissues. Thromb Haemost 1993; 69:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/20\">",
"      Curatolo L, Alessio MG, Casali B, et al. Procoagulant activity of mouse transformed cells: different expression in freshly isolated or cultured cells. In Vitro Cell Dev Biol 1988; 24:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/21\">",
"      Koyama T, Hirosawa S, Kawamata N, et al. All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells. Blood 1994; 84:3001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/22\">",
"      Guarini A, Gugliotta L, Timoncini C, et al. Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukaemia. Scand J Haematol 1985; 34:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/23\">",
"      Wada H, Nagano T, Tomeoku M, et al. Coagulant and fibrinolytic activities in the leukemic cell lysates. Thromb Res 1983; 30:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/24\">",
"      Guarini A, Gugliotta L, Valvassori L, et al. Human myeloid precursor cells do not possess or produce procoagulant activity (PCA). Exp Hematol 1986; 14:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/25\">",
"      Falanga A, Consonni R, Marchetti M, et al. Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood 1998; 92:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/26\">",
"      Saito T, Koyama T, Nagata K, et al. Anticoagulant effects of retinoic acids on leukemia cells. Blood 1996; 87:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/27\">",
"      Falanga A, Iacoviello L, Evangelista V, et al. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid. Blood 1995; 86:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/28\">",
"      Arbuthnot C, Wilde JT. Haemostatic problems in acute promyelocytic leukaemia. Blood Rev 2006; 20:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/29\">",
"      Giesen PL, Rauch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 1999; 96:2311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/30\">",
"      Bogdanov VY, Balasubramanian V, Hathcock J, et al. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003; 9:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/31\">",
"      Falati S, Liu Q, Gross P, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003; 197:1585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/32\">",
"      Chou J, Mackman N, Merrill-Skoloff G, et al. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004; 104:3190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/33\">",
"      Day SM, Reeve JL, Pedersen B, et al. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood 2005; 105:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/34\">",
"      Tesselaar ME, Romijn FP, Van Der Linden IK, et al. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 2007; 5:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/35\">",
"      Wang JG, Geddings JE, Aleman MM, et al. Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood 2012; 119:5543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/36\">",
"      Hron G, Kollars M, Weber H, et al. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 2007; 97:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/37\">",
"      Tesselaar ME, Romijn FP, van der Linden IK, et al. Microparticle-associated tissue factor activity in cancer patients with and without thrombosis. J Thromb Haemost 2009; 7:1421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/38\">",
"      Zahra S, Anderson JA, Stirling D, Ludlam CA. Microparticles, malignancy and thrombosis. Br J Haematol 2011; 152:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/39\">",
"      Zwicker JI, Liebman HA, Neuberg D, et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 2009; 15:6830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/40\">",
"      Gordon SG, Cross BA. A factor X-activating cysteine protease from malignant tissue. J Clin Invest 1981; 67:1665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/41\">",
"      Falanga A, Gordon SG. Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue. Biochemistry 1985; 24:5558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/42\">",
"      Gordon SG, Mielicki WP. Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue. Blood Coagul Fibrinolysis 1997; 8:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/43\">",
"      Gordon SG, Franks JJ, Lewis B. Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res 1975; 6:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/44\">",
"      Tallman MS, Kwaan HC. Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood 1992; 79:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/45\">",
"      Donati MB, Gambacorti-Passerini C, Casali B, et al. Cancer procoagulant in human tumor cells: evidence from melanoma patients. Cancer Res 1986; 46:6471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/46\">",
"      Semeraro N, Colucci M. Tissue factor in health and disease. Thromb Haemost 1997; 78:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/47\">",
"      Andr&eacute; P, Hartwell D, Hrachovinov&aacute; I, et al. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A 2000; 97:13835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/48\">",
"      Ay C, Simanek R, Vormittag R, et al. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 2008; 112:2703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/49\">",
"      Altieri DC, Edgington TS. The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. J Biol Chem 1988; 263:7007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/50\">",
"      Edwards RL, Rickles FR. The role of leukocytes in the activation of blood coagulation. Semin Hematol 1992; 29:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/51\">",
"      Edwards RL, Rickles FR, Bobrove AM. Mononuclear cell tissue factor: cell of origin and requirements for activation. Blood 1979; 54:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/52\">",
"      Conkling PR, Greenberg CS, Weinberg JB. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood 1988; 72:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/53\">",
"      Gregory SA, Kornbluth RS, Helin H, et al. Monocyte procoagulant inducing factor: a lymphokine involved in the T cell-instructed monocyte procoagulant response to antigen. J Immunol 1986; 137:3231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/54\">",
"      Levy GA, Schwartz BS, Curtiss LK, Edgington TS. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro. J Clin Invest 1981; 67:1614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/55\">",
"      Edwards RL, Rickles FR, Cronlund M. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation. J Lab Clin Med 1981; 98:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/56\">",
"      Hara Y, Steiner M, Baldini MG. Characterization of the platelet-aggregating activity of tumor cells. Cancer Res 1980; 40:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/57\">",
"      Pearlstein E, Salk PL, Yogeeswaran G, Karpatkin S. Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line. Proc Natl Acad Sci U S A 1980; 77:4336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/58\">",
"      Uchiyama T, Matsumoto M, Kobayashi N. Studies on the pathogenesis of coagulopathy in patients with arterial thromboembolism and malignancy. Thromb Res 1990; 59:955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/59\">",
"      Sweeney JD, Killion KM, Pruet CF, Spaulding MB. von Willebrand factor in head and neck cancer. Cancer 1990; 66:2387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/60\">",
"      Nash GF, Turner LF, Scully MF, Kakkar AK. Platelets and cancer. Lancet Oncol 2002; 3:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/61\">",
"      Bevilacqua MP, Pober JS, Majeau GR, et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A 1986; 83:4533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/62\">",
"      Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/63\">",
"      Bauer KA, ten Cate H, Barzegar S, et al. Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 1989; 74:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/64\">",
"      Balkwill F, Osborne R, Burke F, et al. Evidence for tumour necrosis factor/cachectin production in cancer. Lancet 1987; 2:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/65\">",
"      Scuderi P, Sterling KE, Lam KS, et al. Raised serum levels of tumour necrosis factor in parasitic infections. Lancet 1986; 2:1364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/66\">",
"      Waage A, Espevik T, Lamvik J. Detection of tumour necrosis factor-like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients. Scand J Immunol 1986; 24:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/67\">",
"      Boccaccio C, Sabatino G, Medico E, et al. The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature 2005; 434:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1224/abstract/68\">",
"      Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost 2013; 11:223.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1353 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-122.72.80.101-F770B2E4D0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_12_1224=[""].join("\n");
var outline_f1_12_1224=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H781183754\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Tissue factor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Tissue factor-bearing microparticles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cancer procoagulant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Procoagulant activities expressed by host tissues",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - P-selectin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Monocytes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Platelets",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Endothelial cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Tumor-specific mechanisms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Patient comorbidities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H781183754\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/6/24681?source=related_link\">",
"      Approach to the patient with thrombocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/26/27050?source=related_link\">",
"      Catheter-induced upper extremity venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/12/200?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of acute promyelocytic leukemia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/36/6730?source=related_link\">",
"      Drug-induced thrombosis and vascular disease in patients with malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/43/35514?source=related_link\">",
"      Hypercoagulable disorders associated with malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/54/36711?source=related_link\">",
"      Leukocyte-endothelial adhesion in the pathogenesis of inflammation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38282?source=related_link\">",
"      Normal aging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=related_link\">",
"      Overview of the causes of venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/52/21322?source=related_link\">",
"      Overview of the myeloproliferative neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/4/40009?source=related_link\">",
"      Pathogenesis and clinical features of hepatic sinusoidal obstruction syndrome (veno-occlusive disease) following hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/56/8073?source=related_link\">",
"      Pathogenesis and etiology of disseminated intravascular coagulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38138?source=related_link\">",
"      Role of erythropoiesis-stimulating agents in the treatment of anemia in patients with cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/60/21450?source=related_link\">",
"      Thrombotic and hemorrhagic disorders due to abnormal fibrinolysis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_12_1225="Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)";
var content_f1_12_1225=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/12/1225/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/12/1225/contributors\">",
"     Talmadge E King, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/12/1225/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/12/1225/contributors\">",
"     Kevin R Flaherty, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/12/1225/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/12/1225/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/12/1225/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 3, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypersensitivity pneumonitis (HP), also called extrinsic allergic alveolitis, is a complex syndrome of varying intensity, clinical presentation, and natural history rather than a single, uniform disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/1-11\">",
"     1-11",
"    </a>",
"    ]. Numerous inciting agents have been described including, but not limited to, agricultural dusts, bioaerosols, microorganisms (fungal, bacterial, or protozoal), and certain reactive chemical species. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34087?source=see_link\">",
"     \"Epidemiology and causes of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnostic evaluation of patients with suspected HP will be reviewed here. The classification, clinical manifestations, and treatment of HP are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/49/19222?source=see_link\">",
"     \"Classification and clinical manifestations of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/34/7719?source=see_link\">",
"     \"Treatment and prognosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prompt diagnosis of HP is important, as the disease is reversible when diagnosed early in its course. Correct diagnosis is based upon exposure history, clinical assessment, radiographic and physiologic findings, and, if possible, the result of removal of the patient from the suspected etiologic exposure. Other tests, such as BAL and lung biopsy, are helpful in ruling out other potential diagnoses and in lending further support to the diagnosis of HP. Of note, cigarette smokers have a lower risk of developing HP than nonsmokers because of diminished antibody production following exposure to inhaled antigens. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34087?source=see_link\">",
"     \"Epidemiology and causes of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC CRITERIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several different diagnostic criteria for HP have been proposed [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/8,12,13\">",
"     8,12,13",
"    </a>",
"    ]. All have significant problems that limit their utility:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      All were developed before the common use of high resolution CT scanning and bronchoalveolar lavage",
"     </li>",
"     <li>",
"      Most apply only to typical, acute cases",
"     </li>",
"     <li>",
"      No clear diagnostic criteria exist for subacute or chronic disease",
"     </li>",
"     <li>",
"      All rely on the presence of an abnormal chest radiograph or positive serum precipitins, findings which are often absent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The proposed diagnostic criteria for HP are based upon the presence of some or all of the following [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    &nbsp;1. Known exposure to offending antigen(s) identified by:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;A. History of appropriate exposure.",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;B. Aerobiologic or microbiologic investigations of the environment that confirm the presence of an inciting antigen [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;C. The presence of specific IgG antibodies in serum against the identified antigen (serum precipitins). A positive precipitin test even in the presence of a clear history of exposure to the identified antigen is merely suggestive of, rather than diagnostic of, a potential etiology.",
"   </p>",
"   <p>",
"    &nbsp;2. Compatible clinical, radiographic, or physiologic findings:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;A. Respiratory (&plusmn; constitutional) symptoms and signs, such as crackles on chest exam, weight loss, cough, breathlessness, febrile episodes, wheezing, and fatigue. These findings are especially suggestive if present, appearing, or worsening several hours after antigen exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;B. Reticular, nodular, or ground glass opacity on chest radiograph or HRCT [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;C. Altered spirometry",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lung volumes (may be restrictive, obstructive, or mixed pattern), reduced DLCO, altered gas exchange either at rest or with exercise testing.",
"   </p>",
"   <p>",
"    &nbsp;3. BAL with lymphocytosis:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;A. Usually with low CD4 to CD8 ratio",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;B. Positive specific immune response to the antigen by lymphocyte transformation testing (currently not available in most centers)",
"   </p>",
"   <p>",
"    &nbsp;4. Positive inhalation challenge testing by:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;A. Reexposure to the environment (",
"    <a class=\"graphic graphic_figure graphicRef52421 \" href=\"UTD.htm?20/59/21438\">",
"     figure 1",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;B. Inhalation challenge to the suspected antigen in a hospital setting (",
"    <a class=\"graphic graphic_figure graphicRef75805 \" href=\"UTD.htm?3/14/3310\">",
"     figure 2",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    &nbsp;5. Histopathology showing compatible changes:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;A. Poorly formed, noncaseating granulomas",
"    <strong>",
"     OR",
"    </strong>",
"    B. Mononuclear cell infiltrate",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Definite HP",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient is considered to have definite HP under the following circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Criteria 1, 2, and 3 are met &ndash; Histopathologic confirmation of the diagnosis is not needed in the majority of such cases.",
"     </li>",
"     <li>",
"      Criteria 1, 2, and 4A are met &ndash; BAL or histopathologic confirmation of the diagnosis is not needed in the majority of these cases but may be important to allow decision-making regarding management.",
"     </li>",
"     <li>",
"      Criteria 1, 2A, 3, and 5 are met &ndash; These patients are usually identified as part of a case cluster. The index cases usually have more severe disease.",
"     </li>",
"     <li>",
"      Criteria 2, 3, and 5 are met &ndash; In these cases, the diagnosis is first suspected after BAL or transbronchial lung biopsy. It is critical that every attempt be made to identify the specific antigen. This often requires aggressive surveillance of the home and work environment by an experienced industrial hygienist. Complete removal of the patient from his or her usual environment for two to three weeks may lead to spontaneous improvement, and reexposure may result in acute symptoms that help identify environmental precipitants.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Probable or subclinical HP",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient is considered to have probable HP if criteria 1, 2A, and 3 are present, and subclinical HP if criteria 1 and 3A are present. Sensitization, rather than HP, is present in patients who only fulfill criterion 1.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Clinical diagnosis of HP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The utility of specific clinical parameters in establishing the diagnosis of HP was assessed using a cohort of 400 patients, 116 of whom were ultimately diagnosed with HP [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/16\">",
"     16",
"    </a>",
"    ]. This prediction rule was subsequently validated using a second cohort of 261 patients, 83 of whom were eventually diagnosed with HP. The authors used logistic regression analysis to identify six significant variables associated with HP. These included exposure to a known offending antigen, recurrent episodes of symptoms, symptoms occurring within 4 to 8 hours after exposure, weight loss, crackles on chest exam, and the presence of serum precipitins. The probability of HP was then summarized based on the presence or absence of these predictors (",
"    <a class=\"graphic graphic_table graphicRef61899 \" href=\"UTD.htm?32/51/33597\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SERUM PRECIPITINS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum can be assayed for precipitating IgG antibodies against many potential antigens, such as molds, fungi, grain dust, or blood or other secretions from animal sources [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/19\">",
"     19",
"    </a>",
"    ]. Unfortunately, the presence of precipitins does not make a definite diagnosis. As an example, 30 to 40 percent of farmers have positive serum precipitins to common causes of HP in the absence of clinical disease. The incidence of serum precipitins in asymptomatic bird breeders is even higher, probably due to more intense and prolonged exposure to inciting antigens.",
"   </p>",
"   <p>",
"    Another problem is that the absence of serum precipitins does not rule out HP. We have found the routine precipitin panel in most laboratories to be virtually",
"    <strong>",
"     useless",
"    </strong>",
"    because of the high rate of falsely negative results. Although this is primarily because commercial assays test for only a small fraction of the potential causative antigens, the test may be non-reactive in some cases even if the correct antigen is included.",
"   </p>",
"   <p>",
"    If one's reference laboratory has the capability, it is more helpful to obtain a sample of likely causative antigens from the original source and test it against the patient's blood. A positive reaction is based upon the presence of a precipitin band against the antigen. In many cases, the main value of a positive result is to convince a patient that he or she is indeed sensitive to something in the environment, particularly when it implies that a valued and loved pet may require removal.",
"   </p>",
"   <p>",
"    There is often misunderstanding that skin test reactivity has the same implication as the finding of serum precipitins. However, skin tests are not helpful in the diagnosis of HP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     INHALATION CHALLENGE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhalation challenge by reexposure of the patient to the environment of the supposed agent is commonly recommended. It can demonstrate a relationship between symptoms and a particular environment and thus support the diagnosis of HP (",
"    <a class=\"graphic graphic_figure graphicRef52421 \" href=\"UTD.htm?20/59/21438\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/20-23\">",
"     20-23",
"    </a>",
"    ]. Two patterns of response are observed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most commonly, fever, malaise, headache, crackles on chest exam, peripheral neutrophilia, and decreased FVC occur 8 to 12 hours after exposure. Hypoxemia and radiologic abnormalities (increase in ground glass opacities or nodularity) may occur in severe reactions. Consequently, the patient should be monitored closely or have ready access to medical care for at least 24 hours (",
"      <a class=\"graphic graphic_figure graphicRef52421 \" href=\"UTD.htm?20/59/21438\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Less commonly, a two stage reaction can occur in atopic individuals, with immediate, transient wheezing and a decrease in the FEV",
"      <sub>",
"       1",
"      </sub>",
"      but preservation of the diffusing capacity. This is followed in 4 to 6 hours by decreased FEV",
"      <sub>",
"       1",
"      </sub>",
"      and FVC, fever, and leukocytosis (",
"      <a class=\"graphic graphic_figure graphicRef75805 \" href=\"UTD.htm?3/14/3310\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another method, inhalation challenge to a preparation of a suspected antigen in a hospital setting, is",
"    <strong>",
"     not",
"    </strong>",
"    generally performed because it may induce progressive disease, and because there are no standardized antigen preparations available. While we do not recommend such challenges at present, some studies suggest such testing may have utility in selected cases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/23-25\">",
"     23-25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These challenges have often been performed in asymptomatic but exposed persons following the discovery of an outbreak. A positive test in the absence of symptoms is thought to reflect the \"healthy worker\" effect: certain workers under even heavy exposure will, for unclear reasons, report less frequent symptoms as compared to those who are less heavily exposed to a particular respiratory irritant [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     HIGH RESOLUTION CT SCAN",
"    </span>",
"    &nbsp;&mdash;&nbsp;High resolution computed tomography (HRCT) is increasingly used in the diagnosis of HP [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/16\">",
"     16",
"    </a>",
"    ]. Although the HRCT pattern is variable depending on the stage of disease, the characteristic appearance is a mid-to-upper zone predominance of centrilobular ground-glass or nodular opacities with signs of air-trapping [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/27-30\">",
"     27-30",
"    </a>",
"    ]. In the proper clinical setting (eg, fulfilling criteria 2 and 3 above) and with the presence of a \"classic\" high resolution CT (HRCT) scan, a presumptive diagnosis of HP can be established even without the identification of the source of exposure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Acute HP",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the setting of acute HP, HRCT is often used to confirm the presence of pneumonitis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59749 \" href=\"UTD.htm?0/1/23\">",
"     image 1",
"    </a>",
"    ). The typical finding is ground-glass opacification; however, the HRCT may be normal due to the fleeting nature of the radiographic opacities [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Subacute HP",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with subacute HP, typical HRCT findings include diffuse micronodules, ground-glass attenuation, focal air trapping or emphysema, and mild fibrotic changes (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71870 \" href=\"UTD.htm?3/31/3568\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Chronic HP",
"    </span>",
"    &nbsp;&mdash;&nbsp;In chronic HP, the HRCT tends to show ground-glass attenuation and parenchymal micronodules, accompanied by honeycombing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    emphysema (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52041 \" href=\"UTD.htm?32/58/33711\">",
"     image 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/25\">",
"     25",
"    </a>",
"    ]. The major difficulty is differentiating chronic HP from idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP) on HRCT. Certain features have been suggested as favoring HP over IPF or NSIP: lobular areas with decreased attenuation and vascularity, centrilobular nodules, and lack of lower zone predominance of abnormalities (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59749 \" href=\"UTD.htm?0/1/23\">",
"     image 1",
"    </a>",
"    ). However, HRCT features allowed confident distinction of chronic HP from IPF and NSIP only about 50 percent of the time [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HRCT findings may serve as a useful prognostic indicator [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. As an example, in a retrospective series of 69 patients with HP, the presence and extent of fibrosis by HRCT scan were associated with increased mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/30\">",
"     30",
"    </a>",
"    ]. However, a smaller retrospective series of 26 patients did not find this association [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     BRONCHOALVEOLAR LAVAGE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchoalveolar lavage (BAL) may be helpful in supporting the diagnosis of hypersensitivity pneumonitis. BAL is the most sensitive tool to detect an alveolitis in patients suspected of having HP [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16968?source=see_link\">",
"     \"Role of bronchoalveolar lavage in diagnosis of interstitial lung disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evolution of the alveolitis in HP remains ill-defined, but BAL findings appear to mirror the stage of disease and intensity of the exposure to the inciting antigen. It is important to recognize, however, that BAL abnormalities (both cellular changes and the presence of specific antibodies) may be found in asymptomatic individuals with antigen exposure.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A marked BAL lymphocytosis (greater than 20 percent and often exceeding 50 percent of the white blood cells recovered) is a nonspecific but helpful finding since this level of lymphocytosis is uncommon in diseases generally considered in the differential diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The BAL",
"      <span class=\"nowrap\">",
"       CD4+/CD8+",
"      </span>",
"      ratio is usually decreased to less than 1.0 (normal ratio &plusmn; SEM = 2.3 &plusmn; 0.2). Patients with a marked elevation in the number of CD8+ T-cells may have a lower probability of progression to pulmonary fibrosis [",
"      <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The alveolitis of hypersensitivity pneumonitis appears to be characterized by the presence of BAL lymphocytes of the",
"      <span class=\"nowrap\">",
"       CD3+/CD8+/CD56+/CD57+/CD10-",
"      </span>",
"      phenotype. The density of these phenotypic markers on BAL T-lymphocytes is greater than that seen in sarcoidosis, BOOP, or healthy controls [",
"      <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      BAL neutrophils may be elevated to more than 5 percent of white cells after recent antigen exposure, or in advanced disease [",
"      <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      BAL eosinophilia (greater than 5 percent of recovered white cells) may be seen in advanced cases and usually accompanies the finding of increased BAL neutrophils [",
"      <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The finding of substantial numbers of mast cells (greater than 1 percent of recovered white cells), especially if associated with a marked BAL lymphocytosis, may be specific for HP. The presence of mast cells may also be helpful in monitoring for ongoing exposure to the responsible antigen. Mast cells are usually increased following acute exposure and decline toward normal within one to three months [",
"      <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      BAL fluid contains increased levels of IgG, IgA, and IgM in some patients with HP [",
"      <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/37\">",
"       37",
"      </a>",
"      ]. The presence of plasma cells and higher immunoglobulin and IgG to albumin ratios in BAL may be a sign of active alveolitis [",
"      <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Increased hyaluronic acid and procollagen 3 N-terminal peptide levels in BAL fluid are found almost exclusively among symptomatic versus asymptomatic individuals with farmer's lung [",
"      <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/39\">",
"       39",
"      </a>",
"      ]. They may prove valuable markers for more active and severe HP.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     LUNG BIOPSY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histopathologic confirmation of the diagnosis is required in many instances and should be attempted by transbronchial lung biopsy except in cases of advanced disease, when surgical specimens have a higher yield [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/40\">",
"     40",
"    </a>",
"    ]. We obtain surgical lung biopsy most often when the HRCT features are not classic for definite usual interstitial pneumonia (UIP) (ie, atypical patterns) and therefore it is not clear what the histopathologic pattern is likely to be. In addition, it is not uncommon to discover histopathologic findings consistent with HP at surgical lung biopsy when the diagnosis was not anticipated (usually inciting antigen was not suspected from the exposure history or serologic testing was negative) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/26/424?source=see_link\">",
"     \"Role of lung biopsy in the diagnosis of interstitial lung disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is critical that the pathologist be informed when HP is being considered; the findings are often subtle and must be interpreted with knowledge of the clinical setting [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/42\">",
"     42",
"    </a>",
"    ]. Histopathologic findings in HP may include (",
"    <a class=\"graphic graphic_picture graphicRef62359 graphicRef50605 graphicRef73716 \" href=\"UTD.htm?11/5/11354\">",
"     picture 1A-C",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef73426 graphicRef54489 \" href=\"UTD.htm?18/62/19434\">",
"     picture 2A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef70392 graphicRef56574 \" href=\"UTD.htm?19/3/19512\">",
"     picture 3A-B",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Small, poorly-formed noncaseating granulomas located near respiratory or terminal bronchioles. These ill-defined aggregates of epithelioid macrophages may be associated with multinucleated giant cells. Well-formed granulomas are not commonly seen, in contrast to their frequent identification in patients with sarcoidosis.",
"     </li>",
"     <li>",
"      A patchy mononuclear cell infiltration (predominantly lymphocytes and plasma cells) of the alveolar walls, typically in a bronchocentric distribution.",
"     </li>",
"     <li>",
"      Large histiocytes with foamy cytoplasm present in the alveoli and the interstitium.",
"     </li>",
"     <li>",
"      Peribronchiolar fibrosis in association with isolated giant cells, poorly formed granulomas, or Schaumann bodies supports the diagnosis of HP [",
"      <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are two essential factors for obtaining the maximal diagnostic yield of transbronchial biopsies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Multiple biopsies (more than five to seven \"good\" samples of tissue) must be taken from areas of radiographic involvement. As with sarcoidosis, the biopsy of radiographically normal lung will sometimes show abnormal histology, but yield is not predictable.",
"     </li>",
"     <li>",
"      Step sectioning of tissue specimens and subsequent examination of a large number of levels frequently is required to identify key histopathologic features.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With the increased use of surgical lung biopsy in the diagnosis of the idiopathic interstitial pneumonias, it has been recognized that many cases of chronic HP (especially bird fancier's lung), are characterized by varying patterns of organizing pneumonia, NSIP (cellular or fibrotic) and UIP-like lesions. Often these patterns of injury are seen in the absence of granulomas. Also, the fibrotic changes are commonly located in both centrilobular and perilobular areas, consistent with the pattern suggestive of HP. Multinucleated giant cells with cholesterol clefts are also seen and suggest chronic HP [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     REASONS FOR MISSED DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of HP requires a high index of suspicion. Unfortunately, many cases go unrecognized both in the workplace and in the home. There are several reasons why misdiagnosis and delays in diagnosis occur:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Careful review of the patient's potential occupational, avocational, or domestic exposures is not performed, or a relationship between the exposure and the illness is dismissed.",
"     </li>",
"     <li>",
"      The clinician fails to ask the right questions or to recognize features that suggest an etiologic environmental or occupational exposure (",
"      <a class=\"graphic graphic_table graphicRef55505 \" href=\"UTD.htm?5/33/5659\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The clinician dismisses HP because of the presence of a normal chest radiograph. A meta-analysis of published reports of outbreaks of HP showed a statistically significant decline in the sensitivity of chest radiographs for the diagnosis of HP over the years 1950 through 1980. Chest radiographs were also less likely to be abnormal when a population-based approach to the diagnosis of disease had been undertaken [",
"      <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The presence of negative serum precipitins is accepted as ruling out the possibility of HP.",
"     </li>",
"     <li>",
"      Presence of obstructive ventilatory defects is assumed to mitigate against a diagnosis of HP (even in a nonsmoker) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Presence of a \"negative\" or \"inadequate\" transbronchial lung biopsy is accepted to rule out HP.",
"     </li>",
"     <li>",
"      Incorrect pathological interpretation of the lung biopsy is obtained, usually because subtle findings are assumed to be insignificant. This is particularly common in mild or early cases. In addition, in patients with advanced disease, extensive fibrosis with honeycomb changes may make it difficult to distinguish HP from UIP [",
"      <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     MIMICS OF HP",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several important clinical syndromes that occur as a result of inhalation of organic agents but are not true forms of HP. Nevertheless, they are important to recognize and manage. In particular, inhalation fever, organic dust toxic syndrome, chronic bronchitis, asthma, and chronic airflow limitation have been found in patients with exposure to agricultural products, wood dust, and to a lesser extent among persons with other exposures [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/49-51\">",
"     49-51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Inhalation fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhalation fevers (eg, \"Monday morning miseries\", \"metal fume fever\", \"humidifier fever\") are characterized by fevers, chills, malaise, headaches, and myalgias without prominent pulmonary findings [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/52\">",
"     52",
"    </a>",
"    ]. Mild dyspnea, cough, and chest tightness may occur. The onset usually occurs 4 to 12 hours after exposure, and attack rates can be very high. There are no long-term sequelae.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Organic dust toxic syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Organic dust toxic syndrome (ODTS or pulmonary mycotoxicosis) results from the deleterious actions of mycotoxins or endotoxin [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/53-56\">",
"     53-56",
"    </a>",
"    ]. The toxins enter the body after exposure to bioaerosols contaminated with toxin-producing fungi. The syndrome has been associated with exposure to grains, moldy hay, and textile materials contaminated with Fusarium, an aflatoxin-producing fungus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fever, chills, dyspnea, and myalgias occur four to six hours after exposure (often a first exposure) to contaminated dust [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/57\">",
"     57",
"    </a>",
"    ]. Leukocytosis, diffuse opacities on chest radiograph, restrictive ventilatory defects, and reduced DLCO are common laboratory abnormalities. Obliterative bronchiolitis without granulomas is usually present on lung biopsy; desquamative interstitial pneumonitis and diffuse alveolar damage may also be seen. These cases are thought not to represent true cases of HP because no prior sensitization is required and there is a lack of serologic response to common fungal antigens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Chronic bronchitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic obstructive lung disease is the most common respiratory syndrome among agricultural workers and the most common cause of severe lung disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. The prevalence of chronic bronchitis in farm workers approaches 10 percent (a large portion of whom are nonsmokers) versus a prevalence of HP of 1 to 2 percent. Chronic bronchitis is more common in men and increases in frequency with age and with altitude.",
"   </p>",
"   <p>",
"    Findings in farmers and bird breeders suggest a common or related immunoallergic mechanism between the pathogenesis of HP and of chronic bronchitis in nonsmoking subjects. In such individuals who are also smokers, atopy and smoking appear to have additive effects on both the prevalence and incidence of chronic bronchitis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/47,60\">",
"     47,60",
"    </a>",
"    ]. Evidence for an association between chronic bronchitis and HP includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is a demonstrated relationship between exposure to thermophilic actinomycetes, the culprit antigen of farmer's lung, and chronic bronchitis.",
"     </li>",
"     <li>",
"      Chronic bronchitis occurs more frequently in agricultural workers with a prior history of farmer's lung, particularly HP with a subacute presentation.",
"     </li>",
"     <li>",
"      The frequency of serum precipitins is more likely to be elevated in farm workers with chronic bronchitis than in asymptomatic agricultural workers. There are no strong associations, however, between chronic bronchitis and the intensity of antigenic exposure.",
"     </li>",
"     <li>",
"      Nonsmokers without evidence of farmer's lung who suffer from chronic bronchitis have a pulmonary function pattern and a BAL cellular profile characteristic of HP following provocation with moldy hay.",
"     </li>",
"     <li>",
"      The prevalence of chronic bronchitis correlates with the level of antibody to pigeon gamma-globulin in pigeon breeders.",
"     </li>",
"     <li>",
"      Obstructive airways disease is an important feature of the acute form of pigeon breeder's disease and consists of a hypersecretory state similar to chronic bronchitis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Airway-centered interstitial fibrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airway-centered interstitial fibrosis, also known as chronic bronchiolitis with fibrosis, represents a chronic airway-centered injury characterized by bronchiolitis and fibrosis and accompanied by prominent epithelial hyperplasia involving adjacent alveolar septa [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/61\">",
"     61",
"    </a>",
"    ]. Many of the cases described were mistakenly thought to be HP on clinical grounds although specific antigens were not identified. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/43/24247?source=see_link&amp;anchor=H9#H9\">",
"     \"Bronchiolitis in adults\", section on 'Airway-centered interstitial fibrosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Fire-eater's lung",
"    </span>",
"    &nbsp;&mdash;&nbsp;A rare but well described entity, fire-eater's lung, is caused by aspiration of flammable petrochemical derivatives used during \"fire-eating\" demonstrations [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/62\">",
"     62",
"    </a>",
"    ]. Typically, a viscous organic solvent (kerdan) is accidentally aspirated, with immediate symptoms including choking, coughing, and respiratory distress. Pleuritic pain and fever are common, but hemoptysis is unusual. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/5/27736?source=see_link\">",
"     \"Hydrocarbon poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chest radiographic findings include dense, dependent alveolar infiltrates with prominent cystic changes noted on computed tomographic scans. Bronchoalveolar lavage may reveal a predominance of macrophages with numerous lipoid inclusions [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/63\">",
"     63",
"    </a>",
"    ]. Treatment is supportive, and respiratory symptoms generally resolve within 72 hours. Limited six month follow-up suggests that most patients recover completely [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1225/abstract/62,63\">",
"     62,63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prompt diagnosis of hypersensitivity pneumonitis (HP) is important, as the disease is reversible when diagnosed early in its course. Correct diagnosis is based upon exposure history, clinical assessment, radiographic and physiologic findings, and, if possible, the response to avoidance of the suspected etiologic agent. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The key diagnostic criteria are: known exposure to offending antigen(s); compatible clinical, radiographic, or physiologic findings; bronchoalveolar lavage with lymphocytosis; positive inhalation challenge testing; and histopathology showing poorly formed, noncaseating granulomas",
"      <strong>",
"       OR",
"      </strong>",
"      a mononuclear cell infiltrate. Not all of these features are present in all patients. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Diagnostic criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most laboratory panels for measurement of serum precipitins have a high false negative rate. Testing of a patient's serum against likely causative antigens from the original environmental source may be more helpful. Skin tests are not helpful in the diagnosis of HP. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Serum precipitins'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The characteristic high resolution CT scan (HRCT) appearance is a mid-to-upper zone predominance of centrilobular ground-glass or nodular opacities with signs of air-trapping. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'High resolution CT scan'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bronchoalveolar lavage (BAL) may be helpful in supporting the diagnosis of hypersensitivity pneumonitis. A marked BAL lymphocytosis (greater than 20 percent and often exceeding 50 percent) may be seen. The BAL",
"      <span class=\"nowrap\">",
"       CD4+/CD8+",
"      </span>",
"      ratio is usually decreased to less than 1.0 and the typical lymphocyte phenotype in BAL is",
"      <span class=\"nowrap\">",
"       CD3+/CD8+/CD56+/CD57+/CD10-.",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Bronchoalveolar lavage'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The histopathologic findings on transbronchial biopsy in HP usually include: poorly formed granulomata located near respiratory or terminal bronchioles and a patchy mononuclear cell infiltration of the alveolar walls. The findings may be subtle and the pathologist should be alerted to look specifically for this diagnosis. In chronic HP, the lung pathology may more closely resemble usual interstitial pneumonitis (UIP). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Lung biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several diseases may mimic HP; in particular, inhalation \"metal fume\" fever, organic dust toxic syndrome, chronic bronchitis, asthma, and airway-centered interstitial fibrosis should be considered in the differential diagnosis. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Mimics of HP'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/1\">",
"      Mohr LC. Hypersensitivity pneumonitis. Curr Opin Pulm Med 2004; 10:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/2\">",
"      Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin Chest Med 2004; 25:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/3\">",
"      Agostini C, Trentin L, Facco M, Semenzato G. New aspects of hypersensitivity pneumonitis. Curr Opin Pulm Med 2004; 10:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/4\">",
"      Yi ES. Hypersensitivity pneumonitis. Crit Rev Clin Lab Sci 2002; 39:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/5\">",
"      Wild LG, Lopez M. Hypersensitivity pneumonitis: a comprehensive review. J Investig Allergol Clin Immunol 2001; 11:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/6\">",
"      Bourke SJ, Dalphin JC, Boyd G, et al. Hypersensitivity pneumonitis: current concepts. Eur Respir J Suppl 2001; 32:81s.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/7\">",
"      Patel AM, Ryu JH, Reed CE. Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol 2001; 108:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/8\">",
"      Cormier, Y, Lacasse, Y. Keys to the diagnosis of hypersensitivity pneumonitis: The role of serum precipitins, lung biopsy, and high-resolution computed tomography. Clin Pulm Med 1996; 3:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/9\">",
"      Rose C, King TE Jr. Controversies in hypersensitivity pneumonitis. Am Rev Respir Dis 1992; 145:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/10\">",
"      Selman M, Pardo A, King TE Jr. Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med 2012; 186:314.",
"     </a>",
"    </li>",
"    <li>",
"     Selman M. Hypersensitivity pneumonitis. In: Interstitial Lung Disease, 5th ed, Schwarz MI, King TE Jr.  (Eds), People's Medical Publishing House - USA, Shelton, CT 2011 p.597.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/12\">",
"      Richerson HB, Bernstein IL, Fink JN, et al. Guidelines for the clinical evaluation of hypersensitivity pneumonitis. Report of the Subcommittee on Hypersensitivity Pneumonitis. J Allergy Clin Immunol 1989; 84:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/13\">",
"      Terho, EO. Diagnostic criteria for farmer's lung. Am J Ind Med 1986; 10:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/14\">",
"      Schuyler M, Cormier Y. The diagnosis of hypersensitivity pneumonitis. Chest 1997; 111:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/15\">",
"      Muilenberg, ML. Aeroallergen assessment by microscopy and culture. Immunol Allergy Clin North Am 1989; 9:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/16\">",
"      Lacasse Y, Selman M, Costabel U, et al. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 2003; 168:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/17\">",
"      Glazer CS, Rose CS, Lynch DA. Clinical and radiologic manifestations of hypersensitivity pneumonitis. J Thorac Imaging 2002; 17:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/18\">",
"      Silva CI, M&uuml;ller NL, Lynch DA, et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008; 246:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/19\">",
"      Fenoglio CM, Reboux G, Sudre B, et al. Diagnostic value of serum precipitins to mould antigens in active hypersensitivity pneumonitis. Eur Respir J 2007; 29:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/20\">",
"      Fink JN. The use of bronchoprovocation in the diagnosis of hypersensitivity pneumonitis. J Allergy Clin Immunol 1979; 64:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/21\">",
"      Hendrick DJ. Bronchopulmonary disease in the workplace. Challenge testing with occupational agents. Ann Allergy 1983; 51:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/22\">",
"      Reynolds SP, Jones KP, Edwards JH, Davies BH. Inhalation challenge in pigeon breeder's disease: BAL fluid changes after 6 hours. Eur Respir J 1993; 6:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/23\">",
"      Ram&iacute;rez-Venegas A, Sansores RH, P&eacute;rez-Padilla R, et al. Utility of a provocation test for diagnosis of chronic pigeon Breeder's disease. Am J Respir Crit Care Med 1998; 158:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/24\">",
"      Ohtani Y, Kojima K, Sumi Y, et al. Inhalation provocation tests in chronic bird fancier's lung. Chest 2000; 118:1382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/25\">",
"      Morell F, Roger A, Reyes L, et al. Bird fancier's lung: a series of 86 patients. Medicine (Baltimore) 2008; 87:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/26\">",
"      McMichael AJ. Standardized mortality ratios and the \"healthy worker effect\": Scratching beneath the surface. J Occup Med 1976; 18:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/27\">",
"      Lynch DA, Rose CS, Way D, King TE Jr. Hypersensitivity pneumonitis: sensitivity of high-resolution CT in a population-based study. AJR Am J Roentgenol 1992; 159:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/28\">",
"      Lynch DA, Newell JD, Logan PM, et al. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR Am J Roentgenol 1995; 165:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/29\">",
"      Sahin H, Brown KK, Curran-Everett D, et al. Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival. Radiology 2007; 244:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/30\">",
"      Hanak V, Golbin JM, Hartman TE, Ryu JH. High-resolution CT findings of parenchymal fibrosis correlate with prognosis in hypersensitivity pneumonitis. Chest 2008; 134:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/31\">",
"      Remy-Jardin, M, Remy, J, Wallaert, B, Muller, NL. Subacute and chronic bird breeder hypersensitivity pneumonitis: sequential evaluation with CT and correlation with lung function tests and bronchoalveolar lagave. Radiol 1993; 180:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/32\">",
"      D'Ippolito R, Chetta A, Foresi A, et al. Induced sputum and bronchoalveolar lavage from patients with hypersensitivity pneumonitis. Respir Med 2004; 98:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/33\">",
"      Murayama J, Yoshizawa Y, Ohtsuka M, Hasegawa S. Lung fibrosis in hypersensitivity pneumonitis. Association with CD4+ but not CD8+ cell dominant alveolitis and insidious onset. Chest 1993; 104:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/34\">",
"      Satake N, Nagai S, Kawatani A, et al. Density of phenotypic markers on BAL T-lymphocytes in hypersensitivity pneumonitis, pulmonary sarcoidosis and bronchiolitis obliterans with organizing pneumonia. Eur Respir J 1993; 6:477.",
"     </a>",
"    </li>",
"    <li>",
"     Klech HH, Pohl WW. Use of bronchoalveolar lavage in interstitial lung disease (chapter 2). In: Pulmonary and Critical Care Medicine, part M, Bone RC (Ed), Mosby, St. Louis 1997. p.1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/36\">",
"      Semenzato G, Bjermer L, Costabel U, et al. Clinical guidelines and indications for bronchoalveolar lavage (BAL): extrinsic allergic alveolitis. Eur Respir J 1990; 3:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/37\">",
"      Reynolds HY. Hypersensitivity pneumonitis. Clin Chest Med 1982; 3:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/38\">",
"      Drent M, Wagenaar S, van Velzen-Blad H, et al. Relationship between plasma cell levels and profile of bronchoalveolar lavage fluid in patients with subacute extrinsic allergic alveolitis. Thorax 1993; 48:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/39\">",
"      Larsson K, Eklund A, Malmberg P, et al. Hyaluronic acid (hyaluronan) in BAL fluid distinguishes farmers with allergic alveolitis from farmers with asymptomatic alveolitis. Chest 1992; 101:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/40\">",
"      Trahan S, Hanak V, Ryu JH, Myers JL. Role of surgical lung biopsy in separating chronic hypersensitivity pneumonia from usual interstitial pneumonia/idiopathic pulmonary fibrosis: analysis of 31 biopsies from 15 patients. Chest 2008; 134:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/41\">",
"      Hanak V, Golbin JM, Ryu JH. Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis. Mayo Clin Proc 2007; 82:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/42\">",
"      Takemura T, Akashi T, Ohtani Y, et al. Pathology of hypersensitivity pneumonitis. Curr Opin Pulm Med 2008; 14:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/43\">",
"      Churg A, Muller NL, Flint J, Wright JL. Chronic hypersensitivity pneumonitis. Am J Surg Pathol 2006; 30:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/44\">",
"      Ohtani Y, Saiki S, Kitaichi M, et al. Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 2005; 60:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/45\">",
"      Vourlekis JS, Schwarz MI, Cool CD, et al. Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis. Am J Med 2002; 112:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/46\">",
"      Hodgson MJ, Parkinson DK, Karpf M. Chest X-rays in hypersensitivity pneumonitis: a metaanalysis of secular trend. Am J Ind Med 1989; 16:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/47\">",
"      Bourke SJ, Carter R, Anderson K, et al. Obstructive airways disease in non-smoking subjects with pigeon fanciers' lung. Clin Exp Allergy 1989; 19:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/48\">",
"      Katzenstein AL, Mukhopadhyay S, Myers JL. Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum Pathol 2008; 39:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/49\">",
"      Enarson DA, Chan-Yeung M. Characterization of health effects of wood dust exposures. Am J Ind Med 1990; 17:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/50\">",
"      Malmberg P. Health effects of organic dust exposure in dairy farmers. Am J Ind Med 1990; 17:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/51\">",
"      Jacobsen G, Schl&uuml;nssen V, Schaumburg I, Sigsgaard T. Increased incidence of respiratory symptoms among female woodworkers exposed to dry wood. Eur Respir J 2009; 33:1268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/52\">",
"      Antonini JM, Lewis AB, Roberts JR, Whaley DA. Pulmonary effects of welding fumes: review of worker and experimental animal studies. Am J Ind Med 2003; 43:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/53\">",
"      Lougheed MD, Roos JO, Waddell WR, Munt PW. Desquamative interstitial pneumonitis and diffuse alveolar damage in textile workers. Potential role of mycotoxins. Chest 1995; 108:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/54\">",
"      Jagielo PJ, Thorne PS, Watt JL, et al. Grain dust and endotoxin inhalation challenges produce similar inflammatory responses in normal subjects. Chest 1996; 110:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/55\">",
"      Emanuel DA, Wenzel FJ, Lawton BR. Pulmonary mycotoxicosis. Chest 1975; 67:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/56\">",
"      Smith, DD. Immunologic and clinical features of toxic inhalations. Immunol Allergy Clin North Am 1992; 12:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/57\">",
"      Malmberg P, Rask-Andersen A, Rosenhall L. Exposure to microorganisms associated with allergic alveolitis and febrile reactions to mold dust in farmers. Chest 1993; 103:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/58\">",
"      Terho EO. Work-related respiratory disorders among Finnish farmers. Am J Ind Med 1990; 18:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/59\">",
"      Dalphin JC, Debieuvre D, Pernet D, et al. Prevalence and risk factors for chronic bronchitis and farmer's lung in French dairy farmers. Br J Ind Med 1993; 50:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/60\">",
"      Terho EO, Husman K, Vohlonen I. Prevalence and incidence of chronic bronchitis and farmer's lung with respect to age, sex, atopy, and smoking. Eur J Respir Dis Suppl 1987; 152:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/61\">",
"      Visscher DW, Myers JL. Bronchiolitis: the pathologist's perspective. Proc Am Thorac Soc 2006; 3:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/62\">",
"      Gentina T, Tillie-Leblond I, Birolleau S, et al. Fire-eater's lung: seventeen cases and a review of the literature. Medicine (Baltimore) 2001; 80:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1225/abstract/63\">",
"      Burkhardt O, Merker HJ, Shakibaei M, Lode H. Electron microscopic findings in BAL of a fire-eater after petroleum aspiration. Chest 2003; 124:398.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4313 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-93.125.6.160-7DBF348CA4-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_12_1225=[""].join("\n");
var outline_f1_12_1225=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIAGNOSTIC CRITERIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Definite HP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Probable or subclinical HP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Clinical diagnosis of HP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SERUM PRECIPITINS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      INHALATION CHALLENGE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      HIGH RESOLUTION CT SCAN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Acute HP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Subacute HP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Chronic HP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      BRONCHOALVEOLAR LAVAGE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      LUNG BIOPSY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      REASONS FOR MISSED DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      MIMICS OF HP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Inhalation fever",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Organic dust toxic syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Chronic bronchitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Airway-centered interstitial fibrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Fire-eater's lung",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4313\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4313|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/1/23\" title=\"diagnostic image 1\">",
"      Acute EAA CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/31/3568\" title=\"diagnostic image 2\">",
"      Subacute HP CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/58/33711\" title=\"diagnostic image 3\">",
"      Chronic EAA CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4313|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/59/21438\" title=\"figure 1\">",
"      HP caused by Cladosporium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/14/3310\" title=\"figure 2\">",
"      Thermophilic actinomycetes HP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4313|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/9/40080\" title=\"picture 1A\">",
"      HP infiltrate Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/12/30918\" title=\"picture 1B\">",
"      HP granulomas Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/44/37568\" title=\"picture 1C\">",
"      HP giant cells Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/39/29299\" title=\"picture 2A\">",
"      HP bronchiolitis Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/9/27800\" title=\"picture 2B\">",
"      Bronchiolitis obliterans Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/61/9171\" title=\"picture 3A\">",
"      Chronic HP Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/10/22691\" title=\"picture 3B\">",
"      Chronic farmers lung Light",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4313|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/51/33597\" title=\"table 1\">",
"      Probability of HP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/33/5659\" title=\"table 2\">",
"      Helpful clues in recognizing HP",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/43/24247?source=related_link\">",
"      Bronchiolitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/49/19222?source=related_link\">",
"      Classification and clinical manifestations of hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34087?source=related_link\">",
"      Epidemiology and causes of hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/5/27736?source=related_link\">",
"      Hydrocarbon poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16968?source=related_link\">",
"      Role of bronchoalveolar lavage in diagnosis of interstitial lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/26/424?source=related_link\">",
"      Role of lung biopsy in the diagnosis of interstitial lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/34/7719?source=related_link\">",
"      Treatment and prognosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_12_1226="Placement and management of thoracostomy tubes";
var content_f1_12_1226=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Placement and management of thoracostomy tubes",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/12/1226/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/12/1226/contributors\">",
"     Peter Doelken, MD, FCCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/12/1226/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/12/1226/contributors\">",
"     Steven A Sahn, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/12/1226/contributors\">",
"     Allan B Wolfson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/12/1226/contributors\">",
"     Joseph S Friedberg, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/12/1226/contributors\">",
"     Anne M Stack, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/12/1226/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/12/1226/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/12/1226/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tube thoracostomy is a procedure in which a tube is placed through the chest wall into the pleural cavity primarily to drain an air or fluid collection from the pleural space, but the tube can also be used to instill medications for pleurodesis.",
"   </p>",
"   <p>",
"    The indications, contraindications, technique, management and complications of thoracostomy tube placement will be reviewed here. Specific medical and surgical conditions that result in the need to perform thoracostomy for pleural drainage are discussed in separate topic reviews.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thoracostomy tube placement is indicated for the following conditions:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pneumothorax",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Spontaneous pneumothorax (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=see_link\">",
"       \"Primary spontaneous pneumothorax in adults\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Traumatic pneumothorax (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=see_link&amp;anchor=H23#H23\">",
"       \"Initial evaluation and management of blunt thoracic trauma in adults\", section on 'Pneumothorax'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Iatrogenic pneumothorax, most commonly due to central line placement",
"     </li>",
"     <li>",
"      Tension pneumothorax (see",
"      <a class=\"local\" href=\"#H254983688\">",
"       'Tension pneumothorax'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Bronchopleural fistula, postoperative or due to mechanical ventilation (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24486?source=see_link\">",
"       \"Management of bronchopleural fistula in patients on mechanical ventilation\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hemothorax",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Chest trauma (blunt or penetrating)",
"     </li>",
"     <li>",
"      Postoperative following thoracic or upper abdominal surgery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pleural effusion",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Sterile effusion",
"     </li>",
"     <li>",
"      Infected effusion (ie, empyema, parapneumonic effusion) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28089?source=see_link\">",
"       \"Parapneumonic effusion and empyema in adults\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Malignant effusion (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/6/13416?source=see_link\">",
"       \"Management of malignant pleural effusions\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Chylothorax (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37192?source=see_link\">",
"       \"Etiology, clinical presentation, and diagnosis of chylothorax\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Other effusion (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/22/28009?source=see_link&amp;anchor=H654433#H654433\">",
"       \"Recognition and management of diaphragmatic injury in adults\", section on 'Biliary fistula'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pleurodesis &ndash; Chest tube insertion to facilitate the instillation of sclerosing agents into the pleural space is indicated for the treatment of refractory effusion (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/6/13416?source=see_link\">",
"       \"Management of malignant pleural effusions\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/29/37334?source=see_link\">",
"       \"Management of refractory nonmalignant pleural effusions\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticoagulation, coagulopathy or a bleeding diathesis are relative contraindications in a patient undergoing elective chest tube placement for pleurodesis. Transudative pleural effusions due to liver failure are not generally managed with thoracostomy drainage.",
"   </p>",
"   <p>",
"    Blind insertion of a chest tube is dangerous in a patient with pleural adhesions from infection, previous pleurodesis, or prior pulmonary surgery; guidance by ultrasound or CT scan without contrast is preferred. (See",
"    <a class=\"local\" href=\"#H254982123\">",
"     'Role of ultrasound or other imaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to placement of a chest tube, the proper equipment should be gathered and the patient assessed to determine the optimal chest tube size and location of placement. The equipment needed for tube thoracostomy is listed in the table (",
"    <a class=\"graphic graphic_table graphicRef67371 \" href=\"UTD.htm?19/19/19771\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Techniques'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H733687288\">",
"    <span class=\"h2\">",
"     Antibiotic prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The need for prophylactic antibiotics prior to the placement of thoracostomy tubes depends upon the clinical circumstances. Prophylactic antibiotics are",
"    <strong>",
"     not",
"    </strong>",
"    warranted for chest tubes placed in the setting of spontaneous pneumothorax or other non-traumatic indications [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prophylactic antibiotics are warranted for chest tubes placed in the setting of trauma, particularly in patients with penetrating injury. A meta-analysis of five trials that included patients with blunt or penetrating thoracic trauma found significant reductions in the risk of empyema (relative risk [RR] 0.19, 95% CI, 0.04-0.70) and pneumonia (RR 0.44, 95% CI, 0.15-0.87) in patients who received antibiotic prophylaxis compared with placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/4\">",
"     4",
"    </a>",
"    ]. In the three trials that included blunt injury mechanisms, two did not evaluate outcomes by injury mechanism [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/3,5\">",
"     3,5",
"    </a>",
"    ], and in the other, the patients who developed infectious complications had sustained penetrating thoracic injures (gunshot, stab) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/6\">",
"     6",
"    </a>",
"    ]. None of the trials controlled for the effectiveness of chest tube drainage, a factor that may be important in reducing the incidence of infectious complications (eg, empyema, pneumonia) related to hemothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The optimal duration of antibiotic therapy is uncertain; a single dose may be administered, or in cases of penetrating injury, antibiotic therapy may be continued for up to 24 hours. There is no evidence of benefit for continuation of antibiotics for longer than 24 hours. A trial that randomly assigned 229 patients to antibiotics until chest tube removal, 24 hours of antibiotics, or placebo, found no significant differences in rates of infectious complications between the groups [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The microbiology of empyema in the setting of chest tube placement typically reflects infection with Staphylococcus aureus or Streptococcus species [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/7\">",
"     7",
"    </a>",
"    ]. Appropriate antibiotic therapy consists of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/2/4136?source=see_link\">",
"     Cefazolin",
"    </a>",
"    (single dose 1 to 2 gm depending upon body size) for a maximum of three doses. For patients with penicillin hypersensitivity,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    are appropriate alternative choices. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H885075\">",
"    <span class=\"h2\">",
"     Tube selection",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20043970\">",
"    <span class=\"h3\">",
"     General considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest tubes are silicone or polyvinyl chloride (PVC) tubes that have a radiopaque strip with a gap that serves to mark the most proximal drainage hole (",
"    <a class=\"graphic graphic_picture graphicRef79934 \" href=\"UTD.htm?34/29/35295\">",
"     picture 1",
"    </a>",
"    ). Chest tubes of silicone (Silastic&reg;) are preferred over older latex rubber tubes which had fewer drainage holes, were not well visualized on chest radiographs, produced more pleural inflammation and may have been associated with latex allergy.",
"   </p>",
"   <p>",
"    Alternative",
"    <span class=\"nowrap\">",
"     tubes/catheters",
"    </span>",
"    are available to serve as thoracostomy drains (eg, Blake 19 Fr, 24 Fr). Specialty tubes (eg, Nightengale&reg;, Wayne&reg;,Thal-Quick&reg;, Fuhrman), can be used to evacuate pneumothorax and can be used with or without imaging guidance (",
"    <a class=\"graphic graphic_figure graphicRef57330 \" href=\"UTD.htm?11/59/12218\">",
"     figure 1",
"    </a>",
"    ). For patients with a large pneumothorax, a smaller tube can be placed with a Seldinger technique without imaging. The presence of the large pneumothorax assures safe entry into the chest and causes less pain than a standard chest tube. For patients with a loculated collection, imaging (ultrasound, computed tomography) should be performed during placement. These tubes have a small bore, which minimizes the incision needed for their placement. These tubes are used predominantly to drain air or thin nonviscous liquids.",
"   </p>",
"   <p>",
"    A chest tube's internal diameter (d) and the viscosity (&mu;) of the fluid determine volume of fluid flow. Chest tubes are available in a range of French sizes from 14 to 40 Fr (diameter in",
"    <span class=\"nowrap\">",
"     French/3",
"    </span>",
"    = diameter in millimeter). A 28 Fr tube will drain about 15",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    for air but about thirty times less for liquids. Compared with a transudate or sterile exudate, the drainage of more viscous fluids (eg, pus or blood) requires a larger bore chest tube to obtain the same flow rate.",
"   </p>",
"   <p>",
"    Since these tubes can get plugged easily with blood or purulent drainage, a large tube is needed. We prefer a 32 Fr or larger tube (36 Fr for trauma) to manage hemothorax since it will allow evacuation of gelatinous clot. Due to the minimal viscosity of air, smaller tubes (&le;24 Fr) can be placed for persistent air leak. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Pneumothorax'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H254981857\">",
"     'Hemothorax'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H8\">",
"     'Malignant effusion'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H9\">",
"     'Parapneumonic effusion'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Chest tubes can be straight or angled (",
"    <a class=\"graphic graphic_picture graphicRef70103 \" href=\"UTD.htm?17/19/17727\">",
"     picture 2",
"    </a>",
"    ). Angled chest tubes are used often in the surgical setting to assure placement in the posterior costophrenic sulcus. &nbsp;",
"   </p>",
"   <p>",
"    Chest tubes typically come in two standard lengths and either length may be appropriate for an adult. The length of a thoracostomy tube is determined by the ability to place all lateral perforations inside the pleural cavity without kinking of the tube. &nbsp;",
"   </p>",
"   <p>",
"    Multiple tubes in the same hemithorax are generally indicated when a single tube is not accomplishing its task. Some surgeons place two tubes following surgery (pulmonary resection, decortication) with the goal of preventing fluid loculations or air collections that will prevent the lung from staying fully expanded. Bilateral tubes are generally only needed for independent indications. Bilateral chest tubes are painful for the patient, and ambulation and patient care are more difficult.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Pneumothorax",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial management is dictated by the severity of the patient's symptoms and the size of the pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/8\">",
"     8",
"    </a>",
"    ]. The general principles for selecting patients who require a chest tube are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=see_link&amp;anchor=H11#H11\">",
"     \"Primary spontaneous pneumothorax in adults\", section on 'Initial management'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/35/24121?source=see_link&amp;anchor=H10#H10\">",
"     \"Secondary spontaneous pneumothorax in adults\", section on 'Initial management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Once the decision has been made to proceed with drainage of the pneumothorax, the size of the chest tube selected depends upon whether high-volume air leakage (eg, large pneumothorax, mechanical ventilation)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    concomitant blood drainage (eg, traumatic pneumothorax, large pleural air-fluid level) are anticipated [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      For the majority of patients with spontaneous or iatrogenic pneumothoraces, a small bore catheter (8 to 14 Fr) is sufficient, as these air leaks are due to alveolar-pleural fistulae [",
"      <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/8,9\">",
"       8,9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      For patients at risk for a large air leak due to bronchial-pleural fistulae (eg, on mechanical ventilation, bronchial dehiscence), we prefer a larger bore tube (20 to 28 Fr). The management of bronchopleural fistula is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24486?source=see_link\">",
"       \"Management of bronchopleural fistula in patients on mechanical ventilation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      For traumatic pneumothorax, we use a 36 to 40 Fr chest tube because of the potential need to drain blood as well as air. Occasionally, more than one ipsilateral chest tube is needed, especially in the mechanically ventilated patient.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When managing a pneumothorax, suction is not routinely employed [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/8\">",
"     8",
"    </a>",
"    ]. Instead, the chest tube is attached to the drainage system that contains a valve mechanism to allow air and fluid to exit, but prevents air or fluid from entering the pleural cavity from the outside [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Valved drainage systems may use underwater seal drainage or a unidirectional flutter valve (ie, Heimlich valve). The underwater seal system can be easily converted to suction, while the unidirectional flutter valve allows the patient to be mobile. If re-expansion of the pneumothorax does not occur with these methods, suction is applied using a high-volume, low-pressure system and pressures of -10 to -20 cm H2O [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Air leaks can be semi-quantified by the number of air leak chambers that are bubbling, along with noting when in the respiratory cycle the air leak occurs (eg, intermittent one chamber leak, continuous five chamber leak) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/10\">",
"     10",
"    </a>",
"    ]. The size of the potential air leak cannot be known before putting in the chest tube, and the tube that is chosen may be too small. Thus, if pneumothorax does not resolve, the first step is increasing the level of suction and only if maximal suction fails to resolve the pneumothorax should a second tube be considered. (See",
"    <a class=\"local\" href=\"#H335594267\">",
"     'Assessing air leak'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H254983688\">",
"    <span class=\"h3\">",
"     Tension pneumothorax",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tension pneumothorax is a life-threatening emergency that requires immediate decompression. In the absence of hemodynamic compromise, the suspicion for tension pneumothorax should ideally be confirmed on chest radiograph prior to thoracostomy. However, the patient with worsening dyspnea, hypotension, diminished breath sounds on the affected side, distended neck veins and tracheal deviation away from the affected side should be treated without a chest radiograph. If immediately available, a standard thoracostomy tube (24 or 28 Fr, 36 Fr for trauma) should be placed; otherwise needle thoracostomy should be performed, followed by chest tube placement as soon as possible. If a chest tube is not immediately available, needle decompression can be a life saving, albeit temporizing, measure that must be performed in an arresting patient for whom tension pneumothorax is the presumptive diagnosis. (See",
"    <a class=\"local\" href=\"#H254982395\">",
"     'Tube thoracostomy'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H254983853\">",
"     'Needle thoracostomy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H254981857\">",
"    <span class=\"h3\">",
"     Hemothorax",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemothorax is most commonly a result of closed chest trauma, but spontaneous hemothorax can also occur (eg, malignancy, anticoagulation, aneurysm rupture) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/11\">",
"     11",
"    </a>",
"    ]. The goals of tube thoracostomy in acute hemothorax are drainage of fresh blood, measurement of the rate of bleeding, evacuation of any coexisting pneumothorax, and tamponade of the bleeding site by apposition of the pleural surfaces. Large-bore tubes (36 to 40 Fr) are required to reliably achieve these goals. Occasionally, a hemothorax may cause a loculated pneumothorax, which can be treated with multiple smaller-bore catheters or potentially by instilling a lytic agent to break up the septations that have formed. However, loculated pneumothorax in trauma patients may require operative intervention to evacuate. Lytic agents are used only selectively in trauma patients. Treatment of hemothorax is individualized and typically managed in consultation with a thoracic surgery service.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Malignant effusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small-bore catheter (8 to 18 Fr) placed under ultrasound or CT guidance is usually adequate to drain a malignant pleural effusion or perform pleurodesis (depending on the viscosity of the sclerosant) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/12-15\">",
"     12-15",
"    </a>",
"    ]. Chronic indwelling catheters (eg, Pleurx&reg;) are available for outpatient treatment of recurrent malignant effusion. These catheters come in a kit that includes disposable suction bottles and the appropriate tubing and connectors to access the catheter.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Parapneumonic effusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;For parapneumonic effusion that is amenable to drainage with a single catheter, we prefer initial image-guided placement of a small catheter (10 to 14 Fr), with or without intrapleural fibrinolytic agents. We prefer to try a smaller tube size first, since this is generally more comfortable for patients, particularly if more than one tube is needed. However, if the fluid appears more viscous, a larger tube (16 to 24 Fr) should be used to minimize the risk of occlusion with fibrinous debris. Unsuccessful drainage of an effusion using a small catheter indicates the presence of multiple loculations or very viscous material. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28089?source=see_link\">",
"     \"Parapneumonic effusion and empyema in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H733687048\">",
"    <span class=\"h3\">",
"     Empyema",
"    </span>",
"    &nbsp;&mdash;&nbsp;For empyema, a 28 Fr or larger tube will likely be needed to manage the thicker drainage, particularly if there is debris draining with the pus. Failure to achieve drainage with a single tube should prompt thoracic surgery consultation for drainage using video-assisted thoracoscopic surgery (VATS) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/16-21\">",
"     16-21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Insertion site",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chest tube insertion site depends upon the indication for tube placement. Fluid collects in the dependent portion of the chest cavity, while air collects in the nondependent portion.",
"   </p>",
"   <p>",
"    For evacuating pneumothorax, most clinicians insert the chest tube via an incision at the 4",
"    <sup>",
"     th",
"    </sup>",
"    or 5",
"    <sup>",
"     th",
"    </sup>",
"    intercostal space in the anterior axillary or midaxillary line [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. In males, this corresponds to the nipple line, and, in females, to the inframammary crease. When placed at this level, it is important to direct the tube anteriorly because the tube tends to track between the lobes in patients who have complete fissures. If this happens, the tube may get walled off by the lung and cease functioning. For draining pneumohemothorax, the chest tube is directed posteriorly.",
"   </p>",
"   <p>",
"    The second intercostal space in the midclavicular line has been suggested as an alternative site for tubes, and requires placement through the pectoralis muscle. We suggest this approach only for a loculated anterior pneumothorax using a small (10 to 14 Fr) catheter (eg, Thal-Quick&reg;) rather than a standard chest tube. Placement at this site can be performed at the bedside for most patients, and a large occlusive dressing is used to cover the insertion site.",
"   </p>",
"   <p>",
"    Chest tube insertion at any site is uncomfortable or even painful for most patients, but in emergent clinical settings, the chest tube can readily be inserted under local anesthesia (eg, 1%",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    ), with or without an intercostal nerve block. In the elective setting, oral or intravenous sedation can be administered prior to the insertion.",
"   </p>",
"   <p>",
"    For draining pleural effusions, the tube can be placed lower in the chest. The technique for using ultrasound to guide the placement of a catheter to drain pleural effusion is discussed elsewhere. (See",
"    <a class=\"local\" href=\"#H254982123\">",
"     'Role of ultrasound or other imaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H254981216\">",
"    <span class=\"h2\">",
"     Drainage system",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wet or dry suction-control, closed drainage systems are typically used, and each is effective. The configuration and function of a typical wet control, closed drainage system (ie, Pleur-evac&reg;) is detailed in the figure (",
"    <a class=\"graphic graphic_figure graphicRef80960 graphicRef73270 \" href=\"UTD.htm?33/41/34457\">",
"     figure 2A-B",
"    </a>",
"    ). Other closed suction systems are available that allow the patient to be mobile.",
"   </p>",
"   <p>",
"    Chest tube drainage systems usually incorporate a pressure release valve which rapidly equilibrates the collection chamber pressure with atmospheric pressure, without disconnecting the suction tubing. This feature can be used if the patient develops chest pain as a result of too rapid an evacuation of large pneumothoraces, or pleural effusions. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Re-expansion pulmonary edema'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20044135\">",
"    <span class=\"h3\">",
"     Level of suction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The typical level of suction used in the clinical setting is -20 cm of water. Commercial closed drainage systems typically allow the suction level to be adjusted between 0 and -40 cm of water.",
"   </p>",
"   <p>",
"    The amount of suction that should be used depends upon the indication. Suggested starting suction levels are given below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For spontaneous air leaks, the least amount of suction (including none) needed to maintain full expansion of the lung is appropriate. Anything more may potentiate the leak and can delay pleural healing. We suggest starting at -10 cm of water and increasing the amount of suction only as needed, as determined by chest radiograph.",
"     </li>",
"     <li>",
"      For a collapsed lung due to pneumothorax or copious pleural effusion, large differential pressure gradients should be avoided during lung reexpansion to prevent reexpansion pulmonary edema. (See",
"      <a class=\"local\" href=\"#H335595192\">",
"       'Managing initial drainage'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H18\">",
"       'Re-expansion pulmonary edema'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      When the chest tube is placed for fluid drainage, -20 cm of water is a reasonable place to start and the level of suction should be increased as indicated with the goal of achieving full lung expansion as determined by chest radiograph.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Following lung surgery, pleural leaks seal more quickly if suction can be eliminated (water seal for wet drainage systems); suction tends to prolong the duration of the leak [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/10,25\">",
"     10,25",
"    </a>",
"    ]. This is a slightly different scenario because there is likely some residual pleural space following a pulmonary resection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     TECHNIQUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two techniques are most commonly used to place a chest tube. The standard technique employs blunt dissection to access the pleural space. In contrast, the Seldinger technique uses serial dilatation over a guidewire. Although some clinicians use a trocar to aid in the insertion of a chest tube, we and others believe the trocar method should",
"    <strong>",
"     never",
"    </strong>",
"    be used, since this technique significantly increases the risk of organ perforation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H254982123\">",
"    <span class=\"h2\">",
"     Role of ultrasound or other imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound or other imaging modalities (eg, fluoroscopy, computed tomography) can be used to guide chest tube placement.",
"   </p>",
"   <p>",
"    Ultrasound can localize a fluid collection and image the lung to help prevent lung laceration during tube placement. For pleural fluid drainage, the proposed site of chest tube insertion can be confirmed by first performing a thoracentesis using ultrasound guidance. If air or fluid is not obtained during diagnostic thoracentesis, the insertion site is reassessed by reviewing the available chest radiographs or computed tomography. Occasionally, fluid may not be able to be aspirated with a small needle due to high viscosity of the pleural fluid. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/56/21384?source=see_link\">",
"     \"Imaging of pleural effusions in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26408?source=see_link\">",
"     \"Thoracic ultrasound: Indications, advantages, and technique\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H254982395\">",
"    <span class=\"h2\">",
"     Tube thoracostomy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Standard technique",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who are hemodynamically stable, attention should be paid to providing adequate pain control for this procedure with local anesthetic infiltration and the use of conscious sedation (if feasible). Supplemental oxygen is provided as needed. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/29/15833?source=see_link\">",
"       \"Sedative-analgesic medications in critically ill patients: Selection, initiation, maintenance, and withdrawal\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Place the patient in the supine position with the ipsilateral arm abducted and the elbow flexed to position the hand comfortably over the patient&rsquo;s head.",
"     </li>",
"     <li>",
"      Prepare the skin around the area of insertion, preferably with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/36/12870?source=see_link\">",
"       chlorhexidine",
"      </a>",
"      or alternatively with 10 percent povidone-iodine solution. Thoracostomy tubes should be placed with full barrier precautions (gloves, gown, mask, eye protection) and, whenever possible, full body drapes.",
"     </li>",
"     <li>",
"      Using 1%",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      , anesthetize a 2 to 3 cm area of skin and subcutaneous tissue one intercostal space below the intercostal space that will be used to place the tube. For example, if the chest tube will be placed in the 5",
"      <sup>",
"       th",
"      </sup>",
"      intercostal space, anesthetize the skin overlying the 6",
"      <sup>",
"       th",
"      </sup>",
"      intercostal space. This allows the creation of a tunnel of subcutaneous tissue through which the chest tube will be placed, which helps to prevent re-entry of air once the chest tube is removed.",
"     </li>",
"     <li>",
"      Make a 1 to 2 cm incision in the skin at the site of the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      injection parallel to the intercostal space. Anesthetize the periosteum of the rib above and the rib below the planned intercostal insertion site and include the muscular tissue of the intercostal space.",
"      <strong>",
"      </strong>",
"      The lower rib margin is avoided to prevent injury to the neurovascular bundle.",
"     </li>",
"     <li>",
"      Using a Kelly clamp, bluntly dissect and create a short subcutaneous tunnel from the incision site cephalad towards the intercostal space through which the chest tube will be inserted. Grasp the Kelly clamp with one hand controlling the handle and the other braced on the patient and holding the clamp near its tip to avoid plunging the clamp into the patient&rsquo;s chest.",
"     </li>",
"     <li>",
"      With the Kelly clamp in a closed position, push the clamp over the superior portion of the rib (to avoid injury to the neurovascular bundle that runs along the inferior aspect of the rib) and through the parietal pleura. Open the Kelly clamp to spread the intercostal muscles and parietal pleura.",
"     </li>",
"     <li>",
"      Insert a finger through the tract into the pleural space to confirm proper position and make sure there are no adhesions between the lung and the pleural surface. Only easily disrupted adhesions should be lysed with the operator's finger, as significant bleeding can occur if more organized adhesions are torn. It is very important to understand that lung parenchyma that is adherent to the chest wall can be mistaken for pleural adhesions. Although the visceral pleura has significant structural integrity, once it is violated, the lung parenchyma is easily torn. Sweeping a finger through the lung can lead to significant bleeding and air leak, possibly requiring surgical intervention to repair. If the operator is not expecting but encounters significant adhesions, the site should be abandoned and another site of entry selected. Additional imaging studies or specialty consultation may be warranted prior to proceeding.",
"     </li>",
"     <li>",
"      Clamp the chest tube at the insertion end with the Kelly clamp. With the aid of the clamp, insert the chest tube through the tract into the pleural space and direct it either apically for a pneumothorax or inferiorly and posteriorly for a pleural effusion. As a general rule, tubes that track posteriorly are better for draining fluid, and tubes that track anteriorly are better for draining air.",
"     </li>",
"     <li>",
"      Remove the Kelly clamp and confirm that the chest tube is in the thoracic cavity by observing condensation within the tube with respiration, or drainage from the tube. Advance the chest tube until the last drainage hole is within the thoracic cavity by at least 2 cm.",
"     </li>",
"     <li>",
"      Place a suture to anchor the chest tube, loosely tying over the tube and then tying firmly around the tube to indent the tube enough to avoid dislodgement but not tight enough to obstruct the tube. (If the incision was large, an additional suture may be needed to close the incision) (",
"      <a class=\"graphic graphic_picture graphicRef71845 \" href=\"UTD.htm?42/9/43156\">",
"       picture 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Following chest tube placement, obtain a chest radiograph to confirm tube position and assess lung expansion. Make sure that the gap in the radiopaque marker which marks the most distal chest tube drainage hole is within the pleural space (",
"      <a class=\"graphic graphic_picture graphicRef79934 \" href=\"UTD.htm?34/29/35295\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Monitor the initial drainage from the tube. If the lung has been in a state of significant compression due to a large effusion or pneumothorax, the clinician must be aware of the possible complication of reexpansion pulmonary edema and be prepared to treat it. If a patient starts coughing while fluid is draining from a newly placed chest tube, it is reasonable to clamp the tube for a period of time before removing more fluid. (See",
"      <a class=\"local\" href=\"#H335595192\">",
"       'Managing initial drainage'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H18\">",
"       'Re-expansion pulmonary edema'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Seldinger technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;As an alternative approach to chest tube placement, some clinicians prefer to use commercially available kits in which the chest tube is placed over a guidewire (ie, Seldinger technique). This technique is useful for the placement of smaller bore tubes that drain air and nonviscous fluids, and is typically performed with the aid of ultrasound or fluoroscopy to confirm the placement and positioning of the wire or catheter within the chest cavity (",
"    <a class=\"graphic graphic_figure graphicRef57330 \" href=\"UTD.htm?11/59/12218\">",
"     figure 1",
"    </a>",
"    ). In the setting of a large pneumothorax or large effusion, where radiographic imaging has confirmed that the lung is significantly displaced from the chest wall at the planned entry site, it may be safe to place these tubes without imaging guidance; however, if there is any doubt, imaging guidance or standard tube placement should be performed. (See",
"    <a class=\"local\" href=\"#H254982123\">",
"     'Role of ultrasound or other imaging'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H14\">",
"     'Standard technique'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A disadvantage of this technique is the inability to assess the presence of adhesions between the lung and pleural surface during tube insertion. If the introducer needle and guidewire are inserted in an area of dense pleural adhesions, the tube may inadvertently pass into the lung parenchyma. Ultrasonography can be used for this purpose but only if drainage of fluid is the objective. (See",
"    <a class=\"local\" href=\"#H254982123\">",
"     'Role of ultrasound or other imaging'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Once the site is prepared and anesthetized, and the skin incision performed as described above for the standard technique, we proceed as follows (",
"    <a class=\"graphic graphic_figure graphicRef57330 \" href=\"UTD.htm?11/59/12218\">",
"     figure 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Insert an introducer needle into the pleural space.",
"     </li>",
"     <li>",
"      Insert the guidewire through the introducer needle into the pleural space. The wire should pass without resistance and if this is not the case, the procedure should be abandoned. Direct the guidewire apically for a pneumothorax or inferiorly for a fluid collection. Verify guidewire position (eg, fluoroscopy).",
"     </li>",
"     <li>",
"      Pass the dilators sequentially over the guidewire to dilate the tract.",
"     </li>",
"     <li>",
"      Pass the chest",
"      <span class=\"nowrap\">",
"       tube/dilator",
"      </span>",
"      combination into the pleural space.",
"     </li>",
"     <li>",
"      Remove the dilator and guidewire, leaving the chest tube in place.",
"     </li>",
"     <li>",
"      Suture the tube into place, dress with gauze, connect the drainage system, obtain a chest radiograph to confirm tube position and assess lung expansion, and monitor the initial drainage from the tube as described above. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Standard technique'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H254983853\">",
"    <span class=\"h2\">",
"     Needle thoracostomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient with a suspected tension pneumothorax needs immediate decompression, preferably with a thoracostomy tube using a standard technique. As an alternative, a large bore angiocatheter can be used in hemodynamically unstable patients for whom a suspicion of tension pneumothorax is high. (See",
"    <a class=\"local\" href=\"#H254983688\">",
"     'Tension pneumothorax'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A 14 to 16 gauge intravenous",
"    <span class=\"nowrap\">",
"     needle/catheter",
"    </span>",
"    attached to a 5 or 10 mL syringe is inserted along the superior margin of the second or third rib in the midclavicular line. The intravenous",
"    <span class=\"nowrap\">",
"     needle/catheter",
"    </span>",
"    is advanced until air is aspirated into the syringe. The needle is withdrawn and the angiocatheter is left open to air. An immediate rush of air out of the chest indicates the presence of a tension pneumothorax, which has thus been converted to a simple pneumothorax.",
"   </p>",
"   <p>",
"    Because these catheters are small bore thin-walled catheters, they are prone to kinking and they may not completely relieve a tension pneumothorax. Dislodgement can also occur and lead to reaccumulation of air and recurrent tension pneumothorax. Thus, immediately following needle decompression, a standard thoracostomy tube should be performed, the size of which depends upon the expected pathology. (See",
"    <a class=\"local\" href=\"#H885075\">",
"     'Tube selection'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Other complications of needle thoracostomy include lung laceration and air embolism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H335594259\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF THORACOSTOMY TUBES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H335594267\">",
"    <span class=\"h2\">",
"     Assessing air leak",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of air leak should be assessed daily to determine whether the tube can be removed. (See",
"    <a class=\"local\" href=\"#H254982314\">",
"     'Criteria: Effusion'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Qualitatively, air leaks are classified as follows with increasing severity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/10,26,27\">",
"     10,26,27",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Forced expiratory, occurs only with coughing or Valsalva (FE1 to FE7)",
"     </li>",
"     <li>",
"      Expiratory, alveolar-pleural fistulas (E1 to E7)",
"     </li>",
"     <li>",
"      Inspiratory, ventilated patient, bronchopleural fistula, alveolar-pleural fistula (I1 to I7)",
"     </li>",
"     <li>",
"      Continuous, ventilated patient, true bronchopleural fistula (C1 to C7)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The number of chambers that are bubbling in a wet, suction-controlled, closed drainage provides a semi-quantitative measure of the severity of the leak. It does not indicate flow in any precise manner, but can provide an indication of any day-to-day increases or decreases in the degree of air leak. If the lung is fully inflated, the suction can be adjusted to the least amount needed to maintain lung inflation (ideally elimination of suction).",
"   </p>",
"   <p>",
"    In a study of 669 postoperative patients, predictors of persistent air leak included male sex, steroid therapy, and lobectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/28\">",
"     28",
"    </a>",
"    ]. All patients with persistent postoperative air leaks were discharged with a one-way flutter valve and most air leaks sealed within two weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H335595192\">",
"    <span class=\"h2\">",
"     Managing initial drainage",
"    </span>",
"    &nbsp;&mdash;&nbsp;The amount of thoracostomy drainage should be assessed on a regular basis, hourly in the setting of trauma. Generally, an immediate drainage of 20",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    or the accumulation of &gt;3",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per hour of blood is an indication for thoracotomy to identify and manage thoracic vascular injury.",
"   </p>",
"   <p>",
"    The rapid removal of large volumes of fluid from the pleural space can be associated with re-expansion pulmonary edema, although this complication is more likely to result from rapid re-expansion of a large pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Re-expansion pulmonary edema'",
"    </a>",
"    below.) &nbsp;",
"   </p>",
"   <p>",
"    To minimize the likelihood of developing re-expansion pulmonary edema, if the patient develops coughing, chest pain, shortness of breath, or oxygen desaturation after chest tube placement, the chest tube should be clamped and no additional fluid should be removed. We limit initial fluid drainage to 1 to 1.5 liters by clamping the chest tube and waiting two to four hours before draining additional fluid, provided symptoms have resolved.",
"   </p>",
"   <p>",
"    Patients with large effusions and mediastinal shift contralateral to the chest tube may tolerate a larger amount of initial fluid removal [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/30\">",
"     30",
"    </a>",
"    ]. Patients without mediastinal shift or with mediastinal shift ipsilateral to the chest tube may have a marked decrease in pleural pressure with a small amount of fluid removal and an increased risk of reexpansion pulmonary edema.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H335594567\">",
"    <span class=\"h2\">",
"     Troubleshooting thoracostomy tubes",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a closed suction system becomes disconnected, the tube should be cleaned with an antiseptic (eg, alcohol,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/0/32768?source=see_link\">",
"     povidone iodine",
"    </a>",
"    ) and the tubing reconnected. If a new closed suction apparatus is immediately available, the new one should be connected and the old one discarded. The chest tube should not be clamped, because doing so in a patient who has an air leak can lead to tension pneumothorax.",
"   </p>",
"   <p>",
"    If the chest tube is no longer draining and there is a suspicion that it is full of clot or debris, the tube can be stripped. Hold the chest tube near its insertion site with the nondominant hand, compress the tube between the first and second fingers of the dominant hand and gently pull toward the drainage system. Because there can be a significant amount of friction between fingers and tube, it is helpful to apply a lubricant (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/0/13316?source=see_link\">",
"     mineral oil",
"    </a>",
"    , petrolatum) to the tube prior to stripping. One danger of stripping a chest tube is the potential buildup of negative pressure within the pleural cavity. Therefore, this procedure should not be performed if the position of the tube is not absolutely known to be in the correct position (ie,",
"    <strong>",
"     not",
"    </strong>",
"    adjacent to mediastinal structures). &nbsp;",
"   </p>",
"   <p>",
"    If stripping the tube once or twice does not clear the tube and re-establish respiratory variation in the drainage system, other maneuvers can be performed under sterile conditions. These include twisting the tube 360 degrees, pulling the tube out 1 to 2 cm, passing a sterile endotracheal tube suction catheter, injecting a small volume of sterile saline with a few drops of povidone-iodine, or attempting to clear with a Fogarty balloon catheter. These maneuvers should only be performed by an experienced clinician. If all these fail to resolve the problem and the patient still has indications for thoracostomy, then a new tube should be placed and the nonfunctioning tube removed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20043718\">",
"    <span class=\"h2\">",
"     Management during thoracic procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whether to keep the current thoracostomy tube in place or remove it prior to a planned thoracic surgical procedure (thoracotomy, VATS) must be individualized depending upon the nature of the surgery, presence or absence of air leak and type of anesthesia (eg, one lung ventilation). In general, the tube is removed just before surgery during the course of preparation and draping, and a new tube is placed through a separate site after the procedure is completed. For video-assisted thoracoscopic surgery, the chest tube insertion site may be used to introduce the thoracoscope.",
"   </p>",
"   <p>",
"    In other situations, the chest tube may need to be maintained. Examples include the patient with a loculated effusion, or the patient with a large air leak in whom there is difficulty achieving, or maintaining, lung isolation; removal of the tube during preparation could lead to tension pneumothorax. Under this circumstance, the chest tube is maintained until the chest has been entered, and then the tube is removed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H335594811\">",
"    <span class=\"h2\">",
"     Outpatient management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Outpatient management of thoracostomy tubes is safe and cost-effective. In one study, readmission rates for tube failure or complication (eg, recurrent pneumothorax) occurred in only 4 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/31\">",
"     31",
"    </a>",
"    ]. Indications for and outcomes for specific pulmonary conditions are discussed in separate topic reviews.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H254981706\">",
"    <span class=\"h2\">",
"     Removal",
"    </span>",
"    &nbsp;&mdash;&nbsp;To minimize the risk of infectious complications, the tube should be removed as soon as it is safe to do so. The following criteria should be met prior to chest tube removal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H335594944\">",
"    <span class=\"h3\">",
"     Criteria: Pneumothorax",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The lung is fully expanded",
"     </li>",
"     <li>",
"      No visible air leak is present and air does not accumulate when suction is removed. If there is any question as to whether an air leak has resolved, a &ldquo;clamp trial&rdquo; can be performed. The chest tube is clamped and a chest radiograph repeated at intervals (eg, 2 hours, 6 hours, 12 hours). If air does not re-accumulate, the tube can be removed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Opinion is divided as to whether a chest tube placed for pneumothorax in a patient receiving mechanical ventilation should remain in place as long as the patient requires mechanical ventilation even when no air leak is present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H254982314\">",
"    <span class=\"h3\">",
"     Criteria: Effusion",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The lung is fully expanded",
"     </li>",
"     <li>",
"      Daily fluid output is less than about 100 to 300",
"      <span class=\"nowrap\">",
"       mL/day.",
"      </span>",
"      The threshold is individualized depending upon the indication for the insertion and patient factors (eg, body mass)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42723770\">",
"    <span class=\"h3\">",
"     Removal technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the removal criteria above are met, the suction is eliminated. Some clinicians remove the chest tube if the lung remains fully expanded on a chest radiograph performed off suction. Other clinicians prefer to clamp the chest tube for four to six hours, and confirm that pneumothorax has not recurred prior to removing the tube [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/32\">",
"     32",
"    </a>",
"    ]. If there is any question whether the leak has completely sealed, it is safer to perform a clamp trial prior to removing the tube. Proponents suggest that a trial of clamping will identify small, intermittent air leaks that would not be detected by monitoring the pleural drainage unit. Prior to removing the chest tube, the likelihood of developing respiratory distress due to recurrent pneumothorax should be considered and the patient should be monitored accordingly after removal.",
"   </p>",
"   <p>",
"    In preparation for removal, obtain a petroleum gauze dressing and cut the sutures anchoring the chest tube to the skin. If the sutures holding the skin together have loosened, tighten them prior to chest tube removal [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/33\">",
"     33",
"    </a>",
"    ]. Have several strips of occlusive tape already dispensed to apply to the dressing once the tube has been removed.",
"   </p>",
"   <p>",
"    Prior to removing the tube, it should be explained to patients that they will need to inspire deeply and hold their breath during tube removal. The patient should rehearse this several times prior to the actual tube removal to prevent gasping and thus causing negative intrathoracic pressure that could draw air into the chest and lead to recurrent pneumothorax. Holding the dressing near the chest tube insertion site with the nondominant hand, ask the patient to inspire and hold his or her breath, then remove the tube quickly with the dominant hand while simultaneously covering the insertion site with the gauze dressing. Tape the dressing into place, and obtain a chest radiograph immediately following chest tube removal, and 24 hours later to evaluate for recurrence of pneumothorax",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    reaccumulation of fluid. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/19/22838?source=see_link\">",
"     \"Imaging of pneumothorax\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications related to chest tube placement are related to the experience and training of the clinician, the indication for placement, and the circumstances under which the tube is placed (ie, elective versus emergent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/34\">",
"     34",
"    </a>",
"    ]. Excluding recurrent pneumothorax, complications of chest tube placement include malposition, infection (eg, empyema, pneumonia), organ injury (eg, lung, diaphragm, heart, liver or spleen) and pulmonary edema related to rapid pulmonary expansion (RPE).",
"   </p>",
"   <p>",
"    The incidence of these complications ranges from 1 to 3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. In one study of 126 chest tube placements by pulmonologists at a teaching hospital, the majority of complications reported were related to clotting, kinking or dislodgement, which occurred in 8 percent of the patients studied [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/38\">",
"     38",
"    </a>",
"    ]. More significant complications (eg, pulmonary laceration) occurred in 3 percent of patients.",
"   </p>",
"   <p>",
"    Rare complications, including intercostal artery aneurysm, and cardiac compression leading to cardiogenic shock, have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Chest tube malposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest tube malposition is the most common complication of tube thoracostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/41-43\">",
"     41-43",
"    </a>",
"    ]. Chest tubes that are malpositioned represent a form of penetrating trauma and should be managed accordingly. Consultation with a pulmonary or thoracic surgery service should be strongly considered before making any changes to a stable patient with a tube that is malpositioned. For example, an intrapulmonary chest tube should not be removed until a second functioning chest tube has been placed into the pleural space. The clinician should be prepared to manage bleeding, as well as a potentially immediate massive air leak, when the malpositioned tube is removed. Without a second functioning tube in place, tension pneumothorax could arise very quickly.",
"   </p>",
"   <p>",
"    In one study of 77 chest tubes placed emergently in 51 trauma patients, malpositioning was detected in 20 (26 percent) of the chest tubes upon chest computed tomography (CT) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/41\">",
"     41",
"    </a>",
"    ]. Nine chest tubes were intrafissural, five were intraparenchymal, and two were subcutaneous. Location (intraparenchymal versus intrafissural) could not be determined for four tubes. Persistent pneumothorax (including two tension pneumothoraces) and hemothorax were associated with 16 of the 20 (80 percent) chest tube malpositions. Only one of the five intraparenchymal chest tubes was diagnosed by chest radiograph, and only four of the nine intrafissural chest tubes were suspected on chest radiograph. Thus, a CT scan should be obtained if a patient's plain film or expected clinical course (eg, chest tube not draining) is consistent with chest tube malposition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H254984443\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumonia and empyema complicate the course of chest tube placement in 1 to 3 percent of patients. Increasing duration of chest tube placement and retained hemothorax increases the risk of infection, which is more common in patients sustaining penetrating chest trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/5,44\">",
"     5,44",
"    </a>",
"    ]. The early evacuation of retained hemothorax decreases the incidence of empyema, and chest CT is more useful than plain films in making a determination of who should be treated [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19562?source=see_link&amp;anchor=H68783416#H68783416\">",
"     \"Inpatient management of traumatic rib fractures\", section on 'Empyema'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A benefit of antibiotic therapy in preventing infection has not been uniformly demonstrated. (See",
"    <a class=\"local\" href=\"#H733687288\">",
"     'Antibiotic prophylaxis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H254986176\">",
"    <span class=\"h2\">",
"     Organ injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lung is the most common organ injured with thoracostomy tube placement, occurring in 0.2 to 0.6 percent of chest tube insertions. Perforation of other organs, including the heart (right ventricle, right atrium), spleen, liver, stomach, colon, and diaphragm, have all been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/23,24,46-49\">",
"     23,24,46-49",
"    </a>",
"    ]. Perforation of mediastinal structures and death are more likely to occur with uncontrolled entry into the chest.",
"   </p>",
"   <p>",
"    Delayed perforation of the lung by the chest tube can also occur, and autopsies have noted pulmonary perforations that were not suspected antemortem [",
"    <a class=\"abstract\" href=\"UTD.htm?1/12/1226/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Re-expansion pulmonary edema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Re-expansion pulmonary edema (RPE) is a potentially life-threatening complication of tube thoracostomy that usually occurs after rapid re-expansion of large pneumothorax, but can also occur with the drainage of large volumes of pleural fluid. Patients developing RPE typically present soon after chest tube placement with cough, dyspnea and hypoxemia, but the clinical presentation can be delayed for up to 24 hours. Treatment is supportive and although the disease is usually self-limited, the mortality rate is significant. The diagnosis and management of reexpansion pulmonary edema is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/57/1944?source=see_link&amp;anchor=H14#H14\">",
"     \"Noncardiogenic pulmonary edema\", section on 'Reexpansion pulmonary edema'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/30/40418?source=see_link\">",
"       \"Patient information: Pneumothorax (collapsed lung) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thoracostomy tube placement into the pleural cavity is performed to drain abnormal collections of air or fluid, or as a means to instill medications. Indications for tube thoracostomy include pneumothorax, hemothorax, and pleural effusion, including malignant effusion, chylous effusion, parapneumonic effusion, and empyema. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with adhesions from infection, previous pleurodesis, or prior pulmonary surgery, a computed tomography (CT) scan of the chest should be obtained to guide chest tube placement. Blind insertion of a chest tube is dangerous in these patients. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Contraindications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend administering prophylactic antibiotics prior to chest tube placement in patients with",
"      <strong>",
"       penetrating",
"      </strong>",
"      thoracic injury over no prophylaxis (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Patients with penetrating trauma have significantly decreased rates of empyema and pneumonia when given antibiotics prior to chest tube placement, as compared with placebo. No consistent reduction in infectious complications has been found in patients with blunt thoracic injury or nontraumatic indications for tube thoracostomy; thus, prophylactic antibiotic treatment in these populations is not necessary. (See",
"      <a class=\"local\" href=\"#H733687288\">",
"       'Antibiotic prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The choice of thoracostomy device, including its size, shape and insertion site depend upon the indication for placement and the nature of the fluid to be drained. (See",
"      <a class=\"local\" href=\"#H885075\">",
"       'Tube selection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Two techniques are most commonly used for tube thoracostomy. Following appropriate preparation and local anesthetic administration, the standard technique uses blunt dissection to access the pleural space, whereas the Seldinger technique uses serial dilatation over a guidewire. We recommend",
"      <strong>",
"       not",
"      </strong>",
"      using a sharp trocar to access the pleural space (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ); mediastinal injury and fatal exsanguination have occurred. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Techniques'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H254986176\">",
"       'Organ injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the hemodynamically unstable patient for whom there is a high suspicion for tension pneumothorax, needle thoracostomy may be life-saving when equipment or clinicians trained in tube thoracostomy placement are unavailable. Following needle decompression of the chest, we suggest placement of a thoracostomy tube using a standard technique as soon as possible, because needle thoracostomy may not completely relieve the tension pneumothorax and technical issues may lead to recurrent tension pneumothorax (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H254983853\">",
"       'Needle thoracostomy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H254983688\">",
"       'Tension pneumothorax'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dry and wet suction-control and closed drainage systems are both effective for draining pleural air and fluid. Unidirectional flutter valves can be used in patients who have small pneumothoraces with minimal or no air leak or nonviscous malignant pleural effusions, allowing the patient to remain ambulatory. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Techniques'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H254981216\">",
"       'Drainage system'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common complication of thoracostomy tube placement is malposition of the tube. Other complications are rare but include infection (eg, pneumonia, empyema), organ injury and reexpansion pulmonary edema. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Reexpansion pulmonary edema is a life-threatening complication that is usually due to the rapid expansion of larger pneumothorax, but it can also occur as a result of rapid drainage of large volumes of pleural fluid. To minimize the risk for reexpansion pulmonary edema, we suggest limiting initial drainage to 1 to 1.5 liters (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H335595192\">",
"       'Managing initial drainage'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/1\">",
"      Olgac G, Aydogmus U, Mulazimoglu L, Kutlu CA. Antibiotics are not needed during tube thoracostomy for spontaneous pneumothorax: an observational case study. J Cardiothorac Surg 2006; 1:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/2\">",
"      LeBlanc KA, Tucker WY. Prophylactic antibiotics and closed tube thoracostomy. Surg Gynecol Obstet 1985; 160:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/3\">",
"      Stone HH, Symbas PN, Hooper CA. Cefamandole for prophylaxis against infection in closed tube thoracostomy. J Trauma 1981; 21:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/4\">",
"      Sanabria A, Valdivieso E, Gomez G, Echeverry G. Prophylactic antibiotics in chest trauma: a meta-analysis of high-quality studies. World J Surg 2006; 30:1843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/5\">",
"      Maxwell RA, Campbell DJ, Fabian TC, et al. Use of presumptive antibiotics following tube thoracostomy for traumatic hemopneumothorax in the prevention of empyema and pneumonia--a multi-center trial. J Trauma 2004; 57:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/6\">",
"      Flynn PM, Shenep JL, Mao L, et al. Influence of needle gauge in Mantoux skin testing. Chest 1994; 106:1463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/7\">",
"      Luchette FA, Barrie PS, Oswanski MF, et al. Practice Management Guidelines for Prophylactic Antibiotic Use in Tube Thoracostomy for Traumatic Hemopneumothorax: the EAST Practice Management Guidelines Work Group. Eastern Association for Trauma. J Trauma 2000; 48:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/8\">",
"      MacDuff A, Arnold A, Harvey J, BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 Suppl 2:ii18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/9\">",
"      Havelock T, Teoh R, Laws D, et al. Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 Suppl 2:ii61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/10\">",
"      Cerfolio RJ, Bass C, Katholi CR. Prospective randomized trial compares suction versus water seal for air leaks. Ann Thorac Surg 2001; 71:1613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/11\">",
"      Ali HA, Lippmann M, Mundathaje U, Khaleeq G. Spontaneous hemothorax: a comprehensive review. Chest 2008; 134:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/12\">",
"      Morrison MC, Mueller PR, Lee MJ, et al. Sclerotherapy of malignant pleural effusion through sonographically placed small-bore catheters. AJR Am J Roentgenol 1992; 158:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/13\">",
"      Parker LA, Charnock GC, Delany DJ. Small bore catheter drainage and sclerotherapy for malignant pleural effusions. Cancer 1989; 64:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/14\">",
"      Patz EF Jr, McAdams HP, Erasmus JJ, et al. Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage. Chest 1998; 113:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/15\">",
"      Seaton KG, Patz EF Jr, Goodman PC. Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy. AJR Am J Roentgenol 1995; 164:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/16\">",
"      Silverman SG, Mueller PR, Saini S, et al. Thoracic empyema: management with image-guided catheter drainage. Radiology 1988; 169:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/17\">",
"      Reinhold C, Illescas FF, Atri M, Bret PM. Treatment of pleural effusions and pneumothorax with catheters placed percutaneously under imaging guidance. AJR Am J Roentgenol 1989; 152:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/18\">",
"      Merriam MA, Cronan JJ, Dorfman GS, et al. Radiographically guided percutaneous catheter drainage of pleural fluid collections. AJR Am J Roentgenol 1988; 151:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/19\">",
"      Moulton JS. Image-guided drainage techniques. Semin Respir Infect 1999; 14:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/20\">",
"      Bouros D, Schiza S, Siafakas N. Utility of fibrinolytic agents for draining intrapleural infections. Semin Respir Infect 1999; 14:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/21\">",
"      Sahn SA. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas. Thorax 1998; 53 Suppl 2:S65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/22\">",
"      Miller KS, Sahn SA. Chest tubes. Indications, technique, management and complications. Chest 1987; 91:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/23\">",
"      Symbas PN. Chest drainage tubes. Surg Clin North Am 1989; 69:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/24\">",
"      Dalbec DL, Krome RL. Thoracostomy. Emerg Med Clin North Am 1986; 4:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/25\">",
"      Marshall MB, Deeb ME, Bleier JI, et al. Suction vs water seal after pulmonary resection: a randomized prospective study. Chest 2002; 121:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/26\">",
"      Cerfolio RJ. Air leaks and the pleural space. Chest Surg Clin N Am 2002; 12:ix.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/27\">",
"      Cerfolio RJ. Chest tube management after pulmonary resection. Chest Surg Clin N Am 2002; 12:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/28\">",
"      Cerfolio RJ, Bass CS, Pask AH, Katholi CR. Predictors and treatment of persistent air leaks. Ann Thorac Surg 2002; 73:1727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/29\">",
"      Mahfood S, Hix WR, Aaron BL, et al. Reexpansion pulmonary edema. Ann Thorac Surg 1988; 45:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/30\">",
"      American Thoracic Society. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000; 162:1987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/31\">",
"      Ponn RB, Silverman HJ, Federico JA. Outpatient chest tube management. Ann Thorac Surg 1997; 64:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/32\">",
"      Baumann MH, Strange C, Heffner JE, et al. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest 2001; 119:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/33\">",
"      Vasseur BG. A simplified technique for closing thoracostomy incisions. Ann Thorac Surg 2004; 77:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/34\">",
"      Ball CG, Lord J, Laupland KB, et al. Chest tube complications: how well are we training our residents? Can J Surg 2007; 50:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/35\">",
"      Daly RC, Mucha P, Pairolero PC, Farnell MB. The risk of percutaneous chest tube thoracostomy for blunt thoracic trauma. Ann Emerg Med 1985; 14:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/36\">",
"      Millikan JS, Moore EE, Steiner E, et al. Complications of tube thoracostomy for acute trauma. Am J Surg 1980; 140:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/37\">",
"      Helling TS, Gyles NR 3rd, Eisenstein CL, Soracco CA. Complications following blunt and penetrating injuries in 216 victims of chest trauma requiring tube thoracostomy. J Trauma 1989; 29:1367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/38\">",
"      Collop NA, Kim S, Sahn SA. Analysis of tube thoracostomy performed by pulmonologists at a teaching hospital. Chest 1997; 112:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/39\">",
"      Muthuswamy P, Samuel J, Mizock B, Dunne P. Recurrent massive bleeding from an intercostal artery aneurysm through an empyema chest tube. Chest 1993; 104:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/40\">",
"      Kollef MH, Dothager DW. Reversible cardiogenic shock due to chest tube compression of the right ventricle. Chest 1991; 99:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/41\">",
"      Baldt MM, Bankier AA, Germann PS, et al. Complications after emergency tube thoracostomy: assessment with CT. Radiology 1995; 195:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/42\">",
"      Stark DD, Federle MP, Goodman PC. CT and radiographic assessment of tube thoracostomy. AJR Am J Roentgenol 1983; 141:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/43\">",
"      Webb WR, LaBerge JM. Radiographic recognition of chest tube malposition in the major fissure. Chest 1984; 85:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/44\">",
"      Coselli JS, Mattox KL, Beall AC Jr. Reevaluation of early evacuation of clotted hemothorax. Am J Surg 1984; 148:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/45\">",
"      Velmahos GC, Demetriades D, Chan L, et al. Predicting the need for thoracoscopic evacuation of residual traumatic hemothorax: chest radiograph is insufficient. J Trauma 1999; 46:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/46\">",
"      Kopec SE, Conlan AA, Irwin RS. Perforation of the right ventricle: a complication of blind placement of a chest tube into the postpneumonectomy space. Chest 1998; 114:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/47\">",
"      Meisel S, Ram Z, Priel I, et al. Another complication of thoracostomy--perforation of the right atrium. Chest 1990; 98:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/48\">",
"      Rashid MA, Wikstr&ouml;m T, Ortenwall P. Mediastinal perforation and contralateral hemothorax by a chest tube. Thorac Cardiovasc Surg 1998; 46:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/49\">",
"      Gerard PS, Kaldawi E, Litani V, et al. Right-sided pneumothorax as a result of a left-sided chest tube. Chest 1993; 103:1602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/50\">",
"      Resnick DK. Delayed pulmonary perforation. A rare complication of tube thoracostomy. Chest 1993; 103:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/12/1226/abstract/51\">",
"      Fraser RS. Lung perforation complicating tube thoracostomy: pathologic description of three cases. Hum Pathol 1988; 19:518.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7816 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-122.96.59.103-ECAAE0F0B7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_12_1226=[""].join("\n");
var outline_f1_12_1226=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H733687288\">",
"      Antibiotic prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H885075\">",
"      Tube selection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20043970\">",
"      - General considerations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Pneumothorax",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H254983688\">",
"      - Tension pneumothorax",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H254981857\">",
"      - Hemothorax",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Malignant effusion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Parapneumonic effusion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H733687048\">",
"      - Empyema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Insertion site",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H254981216\">",
"      Drainage system",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20044135\">",
"      - Level of suction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      TECHNIQUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H254982123\">",
"      Role of ultrasound or other imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H254982395\">",
"      Tube thoracostomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Standard technique",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Seldinger technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H254983853\">",
"      Needle thoracostomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H335594259\">",
"      MANAGEMENT OF THORACOSTOMY TUBES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H335594267\">",
"      Assessing air leak",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H335595192\">",
"      Managing initial drainage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H335594567\">",
"      Troubleshooting thoracostomy tubes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20043718\">",
"      Management during thoracic procedures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H335594811\">",
"      Outpatient management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H254981706\">",
"      Removal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H335594944\">",
"      - Criteria: Pneumothorax",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H254982314\">",
"      - Criteria: Effusion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H42723770\">",
"      - Removal technique",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Chest tube malposition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H254984443\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H254986176\">",
"      Organ injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Re-expansion pulmonary edema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/7816\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/7816|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/59/12218\" title=\"figure 1\">",
"      Placement of Thal-Quick thoracostomy tube",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/42/25253\" title=\"figure 2A\">",
"      Chest tube suction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/38/14949\" title=\"figure 2B\">",
"      Pleur evac",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/7816|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/29/35295\" title=\"picture 1\">",
"      Radio-opaque marking thoracotomy tube",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/19/17727\" title=\"picture 2\">",
"      Shape of thoracostomy tube",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/9/43156\" title=\"picture 3\">",
"      Thoracostomy tube fixation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/7816|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/19/19771\" title=\"table 1\">",
"      Equipment tube thoracostomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37192?source=related_link\">",
"      Etiology, clinical presentation, and diagnosis of chylothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/56/21384?source=related_link\">",
"      Imaging of pleural effusions in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/19/22838?source=related_link\">",
"      Imaging of pneumothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=related_link\">",
"      Initial evaluation and management of blunt thoracic trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19562?source=related_link\">",
"      Inpatient management of traumatic rib fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24486?source=related_link\">",
"      Management of bronchopleural fistula in patients on mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/6/13416?source=related_link\">",
"      Management of malignant pleural effusions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/29/37334?source=related_link\">",
"      Management of refractory nonmalignant pleural effusions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/57/1944?source=related_link\">",
"      Noncardiogenic pulmonary edema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28089?source=related_link\">",
"      Parapneumonic effusion and empyema in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/30/40418?source=related_link\">",
"      Patient information: Pneumothorax (collapsed lung) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=related_link\">",
"      Primary spontaneous pneumothorax in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/22/28009?source=related_link\">",
"      Recognition and management of diaphragmatic injury in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/35/24121?source=related_link\">",
"      Secondary spontaneous pneumothorax in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/29/15833?source=related_link\">",
"      Sedative-analgesic medications in critically ill patients: Selection, initiation, maintenance, and withdrawal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26408?source=related_link\">",
"      Thoracic ultrasound: Indications, advantages, and technique",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_12_1227="Indications rigid bronchoscopy";
var content_f1_12_1227=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F67992&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F67992&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Indications for rigid bronchoscopy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Large endotracheal or endobronchial tumor debulking",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Foreign body removal (if unable to remove with flexible bronchoscope)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Placement and removal of silicone or other airway stents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Massive hemoptysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tracheal dilation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Laser or other ablative treatment",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_12_1227=[""].join("\n");
var outline_f1_12_1227=null;
var title_f1_12_1228="Safety of MS drugs in pregnancy";
var content_f1_12_1228=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F73903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F73903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Safety during pregnancy of drugs used to treat multiple sclerosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Category B - No evidence of human risk in controlled studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glatiramer acetate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oxybutynin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Selective serotonin reuptake inhibitors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Category C - Risk cannot be ruled out",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dalfampridine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glucocorticoids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fingolimod",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interferon beta-1a (Avonex, Rebif)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interferon beta-1b (Betaseron)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Natalizumab",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Baclofen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amantidine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Modafinil",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tizanidine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbamazepine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Category D - Positive evidence of risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Azathioprine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cladribine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cyclophosphamide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mitoxantrone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Category X - Contraindicated in pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methotrexate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Teriflunomide",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: Damek DM, Shuster EA, Mayo Clin Proc 1997; 72:977.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_12_1228=[""].join("\n");
var outline_f1_12_1228=null;
var title_f1_12_1229="PEFR in children";
var content_f1_12_1229=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F64420&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F64420&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Predicted average peak expiratory flow rates for normal children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Height",
"       </td>",
"       <td class=\"subtitle1\">",
"        PEFR",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Height",
"       </td>",
"       <td class=\"subtitle1\">",
"        PEFR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        (inches)",
"       </td>",
"       <td>",
"        (cm)",
"       </td>",
"       <td>",
"        (L/min)",
"       </td>",
"       <td>",
"        (inches)",
"       </td>",
"       <td>",
"        (cm)",
"       </td>",
"       <td>",
"        (L/min)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        43",
"       </td>",
"       <td>",
"        109",
"       </td>",
"       <td>",
"        147",
"       </td>",
"       <td>",
"        56",
"       </td>",
"       <td>",
"        142",
"       </td>",
"       <td>",
"        320",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        44",
"       </td>",
"       <td>",
"        112",
"       </td>",
"       <td>",
"        160",
"       </td>",
"       <td>",
"        57",
"       </td>",
"       <td>",
"        145",
"       </td>",
"       <td>",
"        334",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        45",
"       </td>",
"       <td>",
"        114",
"       </td>",
"       <td>",
"        173",
"       </td>",
"       <td>",
"        58",
"       </td>",
"       <td>",
"        147",
"       </td>",
"       <td>",
"        347",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        46",
"       </td>",
"       <td>",
"        117",
"       </td>",
"       <td>",
"        187",
"       </td>",
"       <td>",
"        59",
"       </td>",
"       <td>",
"        150",
"       </td>",
"       <td>",
"        360",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        47",
"       </td>",
"       <td>",
"        119",
"       </td>",
"       <td>",
"        200",
"       </td>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        152",
"       </td>",
"       <td>",
"        373",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        48",
"       </td>",
"       <td>",
"        122",
"       </td>",
"       <td>",
"        214",
"       </td>",
"       <td>",
"        61",
"       </td>",
"       <td>",
"        155",
"       </td>",
"       <td>",
"        387",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        49",
"       </td>",
"       <td>",
"        124",
"       </td>",
"       <td>",
"        227",
"       </td>",
"       <td>",
"        62",
"       </td>",
"       <td>",
"        157",
"       </td>",
"       <td>",
"        400",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        127",
"       </td>",
"       <td>",
"        240",
"       </td>",
"       <td>",
"        63",
"       </td>",
"       <td>",
"        160",
"       </td>",
"       <td>",
"        413",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        51",
"       </td>",
"       <td>",
"        130",
"       </td>",
"       <td>",
"        254",
"       </td>",
"       <td>",
"        64",
"       </td>",
"       <td>",
"        163",
"       </td>",
"       <td>",
"        427",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        52",
"       </td>",
"       <td>",
"        132",
"       </td>",
"       <td>",
"        267",
"       </td>",
"       <td>",
"        65",
"       </td>",
"       <td>",
"        165",
"       </td>",
"       <td>",
"        440",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        53",
"       </td>",
"       <td>",
"        135",
"       </td>",
"       <td>",
"        280",
"       </td>",
"       <td>",
"        66",
"       </td>",
"       <td>",
"        168",
"       </td>",
"       <td>",
"        454",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        54",
"       </td>",
"       <td>",
"        137",
"       </td>",
"       <td>",
"        293",
"       </td>",
"       <td>",
"        67",
"       </td>",
"       <td>",
"        170",
"       </td>",
"       <td>",
"        467",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        55",
"       </td>",
"       <td>",
"        140",
"       </td>",
"       <td>",
"        307",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Polger, G, Promedhat, V. Pulmonary function testing in children: techniques and standards. WB Saunders, Philadelphia 1971. Copyright &copy; 1971 Elsevier Science (USA).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_12_1229=[""].join("\n");
var outline_f1_12_1229=null;
var title_f1_12_1230="Contents: Neuromuscular and chest wall";
var content_f1_12_1230=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?8/24/8590\">",
"       Pulmonary, Critical Care, and Sleep Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Neuromuscular and chest wall",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Neuromuscular and chest wall",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/15/14584\">",
"           Causes and diagnosis of bilateral diaphragmatic paralysis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/61/12247\">",
"           Causes and diagnosis of unilateral diaphragmatic paralysis and eventration",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/6/33896\">",
"           Continuous noninvasive ventilatory support for patients with neuromuscular or chest wall disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/4/40008\">",
"           Control of ventilation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/43/10934\">",
"           Diaphragmatic pacing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/63/22520\">",
"           Disorders of ventilatory control",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/36/41543\">",
"           Practical aspects of nocturnal noninvasive ventilation in neuromuscular and chest wall disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/28/42439\">",
"           Respiratory complications of spinal cord injury",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/20/35142\">",
"           Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/28/3528\">",
"           Respiratory muscle weakness due to neuromuscular disease: Management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/49/23321\">",
"           Respiratory physiologic changes following spinal cord injury",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/27/44469\">",
"           Treatment of diaphragmatic paralysis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/3/43060\">",
"           Troubleshooting problems with noninvasive positive pressure ventilation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/29/27095\">",
"           Types of noninvasive nocturnal ventilatory support in neuromuscular and chest wall disease",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-24DB5B8A11-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f1_12_1230=[""].join("\n");
var outline_f1_12_1230=null;
var title_f1_12_1231="Contents: COPD";
var content_f1_12_1231=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?8/24/8590\">",
"       Pulmonary, Critical Care, and Sleep Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       COPD",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			COPD",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Alpha-1-antitrypsin deficiency",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/8/6281\">",
"           Clinical manifestations, diagnosis, and natural history of alpha-1 antitrypsin deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/45/18136\">",
"           Extrapulmonary manifestations of alpha-1 antitrypsin deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/62/16361\">",
"           Treatment of alpha-1 antitrypsin deficiency",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cardiac complications",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/21/8538\">",
"           Arrhythmias in COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/17/36119\">",
"           Cor pulmonale",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/30/17898\">",
"           Management of the patient with severe COPD and cardiovascular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/20/38216\">",
"           Multifocal atrial tachycardia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/62/2021\">",
"           Treatment of hypertension in asthma and COPD",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cystic fibrosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/22/41322\">",
"           Cystic fibrosis: Antibiotic therapy for lung disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/49/28442\">",
"           Cystic fibrosis: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/45/27351\">",
"           Cystic fibrosis: Clinical manifestations of pulmonary disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/11/39095\">",
"           Cystic fibrosis: Genetics and pathogenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/22/39274\">",
"           Cystic fibrosis: Overview of the treatment of lung disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Diagnosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/10/16553\">",
"           Approach to the patient with dyspnea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/14/30954\">",
"           Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/10/12458\">",
"           Clinical manifestations and diagnosis of bronchiectasis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/18/5418\">",
"           Evaluation of subacute and chronic cough in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/17/25878\">",
"           Flow-volume loops",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Epidemiology and pathogenesis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/33/35351\">",
"           Chronic obstructive pulmonary disease: Prognostic factors and comorbid conditions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/60/6089\">",
"           Chronic obstructive pulmonary disease: Risk factors and risk reduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/38/36454\">",
"           Dynamic hyperinflation in patients with COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/44/37575\">",
"           Emphysema-like disease in HIV infection",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/0/12298\">",
"           Cigarette smoking and other risk factors for lung cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/36/22089\">",
"           Moraxella catarrhalis infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/36/32329\">",
"           Sequelae and complications of pneumonectomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/10/28840\">",
"           Traveling with oxygen aboard commercial air carriers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/32/29192\">",
"           Treatment of the obesity hypoventilation syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/53/10072\">",
"           Women and lung cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Symptoms",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/10/16553\">",
"           Approach to the patient with dyspnea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/10/12458\">",
"           Clinical manifestations and diagnosis of bronchiectasis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/18/5418\">",
"           Evaluation of subacute and chronic cough in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/35/25144\">",
"           Exercise physiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/40/8839\">",
"           Physiology of dyspnea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/16/27913\">",
"           Treatment of subacute and chronic cough in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Treatment",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/57/28568\">",
"           Bullectomy for giant bullae in COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/30/13800\">",
"           Emerging therapies for COPD: Bronchoscopic treatment of emphysema",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/60/8136\">",
"           Evaluation and medical management of giant bullae in COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/14/42215\">",
"           Long-term supplemental oxygen therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/30/33257\">",
"           Lung volume reduction surgery in COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/5/23641\">",
"           Management of acute exacerbations of chronic obstructive pulmonary disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/43/7866\">",
"           Management of infection in acute exacerbations of chronic obstructive pulmonary disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/26/39338\">",
"           Management of stable chronic obstructive pulmonary disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/30/17898\">",
"           Management of the patient with severe COPD and cardiovascular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/59/8120\">",
"           Mechanical ventilation in acute respiratory failure complicating COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/39/19063\">",
"           Nocturnal ventilatory support in COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/39/43639\">",
"           Nutritional support in advanced lung disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/3/23609\">",
"           Overview of smoking cessation management in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/26/21927\">",
"           Oxygen conserving devices",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/13/17626\">",
"           Pharmacotherapy for smoking cessation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/54/30568\">",
"           Physiology and clinical use of heliox",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/59/38840\">",
"           Pulmonary rehabilitation in COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/56/28549\">",
"           Respiratory muscle training and resting in COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/33/33305\">",
"           Role of anticholinergic therapy in COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/21/5463\">",
"           Role of inhaled glucocorticoid therapy in stable COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/28/25031\">",
"           Role of methylxanthines in the treatment of COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/53/34648\">",
"           Role of mucoactive agents in the treatment of COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/7/10360\">",
"           Role of systemic glucocorticoid therapy in COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/38/12904\">",
"           Smoking cessation counseling strategies in primary care",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/16/13578\">",
"           Theophylline poisoning",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/9/37015\">",
"           Transtracheal oxygen therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/10/28840\">",
"           Traveling with oxygen aboard commercial air carriers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/11/38073\">",
"           Treatment of bronchiectasis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/52/9030\">",
"           Treatment of sleep-disordered breathing in COPD",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/63/3064\">",
"           Use of oxygen in patients with hypercapnia",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-B8B1DCC6F6-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f1_12_1231=[""].join("\n");
var outline_f1_12_1231=null;
